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Abstract 
Gut microbiota are an important component of the human organism, contributing to metabolism and 
believed to play a role in the maintenance of health. Preterm babies are exposed to different early life 
interventions than full-term ones. They are exposed to prolonged courses of antibiotics and often fed 
parenterally, with delayed or limited enteral nutrition intake.  
The aim of this research was to assess how early life interventions (type of parenteral nutrition, type 
of milk, mode of delivery) and other factors (gestational age at birth, postnatal age, sex of the baby) 
affect the development of gut microbiota and the consequent metabolic impact in preterm babies. 
Two thousand stool and urine samples were collected from 160 babies. Gut microbiota were identified 
by 16S rRNA gene sequencing, while the activity of bacteria was assessed by metabolic profiling 
using 
1
H NMR. A new DNA and faecal water extraction method was developed and validated. 
Metabolic differences in stool and urine in relation to early life interventions were observed. Higher 
postnatal age was associated with vit. B5 and vit. B1, while lower was associated with increased bile 
acids and sugars. Increasing GA was correlated with higher concentration of GABA and glutamate. 
Breast-fed babies had higher concentration of lactose than formula-fed ones. There was no metabolic 
difference in relation to mode of delivery or sex of the baby. Microbial profiles were mostly affected 
by route of nutrition (oral – more Staphylococcaceae, intravenous – more Enterobacteriaceae), type 
of milk (breast milk – more Enterobacteraceae) and mode of delivery (Caesarean section – more 
Staphylococcus and Clostridium). The most abundant phylum was Proteobacteria. Average 
abundance of Bifidobacteria was 10%.  
Those results contribute to current understanding of the establishment of gut microbiota in preterm 
babies. Future work should focus on repeating the analysis on a larger sample set from a trial designed 
for this purpose.  
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Chapter 1 – Background 
1.1  Introduction 
The gut microbiota is believed to have an important function for human health. There are many 
reports suggesting an association between changes in microbial profiles and functional clinical 
outcomes such as obesity, diabetes, allergy and asthma. What is more, it is believed that the pattern of 
colonisation of the gut immediately after birth may affect the long-term health. There have been a 
number of studies analysing the development of gut microbiota in full term neonates, however the 
detailed knowledge regarding the colonisation of preterm babies is lacking. Preterm babies undergo 
different early-life interventions than infants born at full term. This thesis focuses on understanding 
the intestinal colonisation in preterm babies and assessing how early-life interventions, such as mode 
of delivery route of nutrition and type of diet, affect this process. 
1.2 Gut microbiota    
The gastro-intestinal microbiota is a substantial component of the human organism. In the adult 
human gut there are around 10
14
 bacteria composed of at least 500 species, of which only 30-40 are of 
high abundance and represent 99% of the total gut microbial population [1-4]. The composition of 
microbiota in different parts of the gastro-intestinal tract differs. The concentration of bacteria 
increases from stomach to the colon. In the human gut there are 10
3
 colony forming units (live 
bacterial cells) per ml of sample in the stomach and duodenum, 10
4
-10
8
 in the jejunum and ileum and 
10
9
-10
12
 in the colon [5]. In fact, one-third of dry stool weight is believed to be bacteria, although the 
majority of them are dead. There are approximately 10
10
 live bacteria per gram of faeces which means 
thatin the body there are 10x more bacterial cells than human ones [3, 6, 7]. 
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1.2.i Importance of gut microbiota 
The gut microbiota has a number of important functions in the human body. It supports nutrition, 
assists with the gut maturation and immunological system development, inhibits the growth of 
pathogenic bacteria and when off balance can contribute to development of diseases [4].  
The method most utilised to-date to assess the influence of the gut microbiota on the host is 
experimentation involving germ-free animals [3, 8]. There are two main approaches. The first 
analyses the importance of commensal bacteria by comparing the development and metabolism of 
conventional animal with germ-free ones. The second approach is to introduce gut microbiota from 
conventional to germ-free animals and observe what changes the animal undergoes.   
1.2.i.a Nutrition 
The main input of microbiota into nutrition is the enhancement of nutritional value extraction from 
food. Germ-free animals require greater calorie density food to maintain body weight than 
conventional animals [3]. Additionally, humans are not able to digest all the polysaccharides that 
come from the consumption of plants [4]. After screening the genome of gut microbiota it was found 
that at least 81 families of the glycoside hydrolase enzymes are coded in the microbial genome. The 
gut bacteria create a trophic chain which enables the full digestion and energy retrieval from the plant 
polysaccharides and supporting the human organism in the metabolism of arabinose, fructose, 
galactose, glucose, mannose, starch, sucrose and xylose [4]. The gut microbiota play an important role 
in nutrition not only by digestion of sugars but also by producing short chain fatty acids, GABA, 
essential amino acids and vitamins [3, 4, 9]. The analysis of gut microbiome identified a number of 
genes coding the enzymes used for the synthesis of DXP (deoxyxylulose 5-phosphate) and IPP 
(isopenteryl pyrophosphate). DXP is used for the synthesis of thiamine (vitamin B1) and pyridoxal 
phosphate (vitamin B6) which  explains why germ-free animals require certain vitamins (like vitamin 
K and some B vitamins) in their diet in contrast to conventional animals [3]. At the same time, IPP 
has over 25000 derivatives and is found in every known type of cell [4].   
Development of gut microbiota and metabolic changes in preterm babies 
PhD Thesis                                                    Natalia Przysiezna  16 
 
1.2.i.b Gut maturation 
The gut is a large organ with a maximal surface of approximately 8000m
2 
 which makes it the largest 
surface exposed to exterior world [10]. There are many reasons why an infant’s gut changes over the 
time. Firstly, at some point it must adapt itself to a potentially omnivore diet. In infancy the main food 
source is human milk and at this point the gut must be programmed to harvest energy from this lipid-
rich source. During weaning infants receive a more diverse diet that is shifted towards a high 
concentration of carbohydrates [11]. One study on mice found that the structure of intestinal epithelial 
glycans change over time. At the stage of breastfeeding mice have intestinal epithelial glycans 
terminated mainly with sialic acid [12]. Once mice are weaned the expression of intestinal epithelial 
glycans shifts towards fucose terminated [12-14]. This change is triggered by modification of 
expression of glycosyltransferases [13, 14]. What is important is that such change of intestinal 
epithelial glycans is not observed in germ-free mice. However, when adult germ-free mice were 
colonised by microorganisms the intestinal epithelial glycans terminated with sialic acid changed to 
terminated with fucose [13, 14]. This suggests that presence of bacteria is involved in this aspect of 
gut development. It is suggested that perhaps bacteria use fucose as an energy source while colonising 
intestines during weaning [11].  
The studies on germ-free animals have also shown a decreased intestinal weight and surface and 
thinner villi in those animals when compared to conventional ones. Additionally, the caecum has been 
shown to be  up to eight times larger with higher pancreatic protein content in germ-free rodents [8, 
15, 16]. Another important aspect of gut maturation that is related to gut microbiota is the 
development of the villus capillary network. Germ-free mice have poorly developed villus capillaries; 
however colonisation by bacteria results in a rapid angiogenesis of the gut [8, 17].  
1.2.i.c Immunological system development 
Another important change in early life development is the development of the immunological system. 
Soon after birth infants have rather well developed innate immunity while the adaptive immunity is 
facilitated by antibodies received with mother’s milk. In infants that are not breast-fed the 
responsibility for fighting with antigens lies on macrophages, neutrophils and natural killer cells [18]. 
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During weaning the infant must be able to produce their own antibodies in order to fight  potential 
diseases [11].  
One study on mice analysed the influence of gut microbiota on the expression of Angiogenin-4, a 
Paneth cell protein that is believed to participate in epithelial host defence. The expression of this 
protein is developmentally regulated postpartum and increases to the adult level during weaning. In 
germ-free mice levels of Angiogenin-4 were low and never reached levels that are found in 
conventional adults. However, after colonising the germ-free adult mice with gut bacteria the 
expression of Angiogenin-4 increased suggesting that presence of gut microbiota is crucial for the 
expression of this protein [19]. Additionally, other components of the immune system (mucosal 
immunoglobulin A and intraepithelial lymphocytes) are reduced in germ-free animals in comparison 
to conventional ones [20-23]. It is yet unknown  if the host defense reacts to the increasing number of 
bacteria in the gut or is it triggered by ‘beneficial’ bacteria [11]. 
1.2.i.d Eubiosis / dysbiosis balance 
Although the gut bacteria normally habitate the lumen of the gut and should not be able to penetrate 
the deeper layers, there are few pathways for that the microorganisms may use for such transfer. 
Firstly, tight junctions (the intercellular connection that holds cells attached one to another) may be 
used as a gate for pathogens. Secondly, some bacteria can use the trans-cellular transfer in order to 
spead from the lumen of the gut [10]. Such a situation is sometimes referred to as ‘leaky gut’.  
Since preterm infants have immature gut and immune system, the exposure to pathogenic bacteria in 
the gut may lead to a pro-inflammatory and tissue-damaging outcomes [24]. The incidence of 
necrotizing enterocolitis (NEC) and sepsis are not uncommon in the premature neonates thus the 
understanding of the gut colonisation may be crucial in the fight with those clinical outcmes [25-33].  
1.2.i.e Human gene expression alteration 
Due to the fact that there are more bacterial cells in human organism than the host’s ones it is not 
surprising that the number of bacterial genes is also higher than the human genes. It is estimated that 
there are 100-350 times more bacterial genes than human ones and on top of that, there are studies 
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showing  that bacterial metabolites can lead to alterations in  human gene expression [3, 34]. One of 
the examples of human gene expression alteration is related to improvement of extraction of nutritious 
value from food. A series of studies analysing the influence of microbiota on mRNA profiles found 
that there was an increased expression of genes coding proteins involved in metabolism of either 
glucose or fatty acids [3, 34].  
Bacterial gene expression seems to remain stable between humans, which suggests that there may be a 
core set of functions/metabolic pathways that is performed by the microbial community regardles of 
the slight alterations in the  bacterial profile [35]. This is apparent especially during pregnancy as the 
microbial shift from first trimester to third trimester is enormous while the genetic profile of those 
bacteria remains stable and regardless of the dysbiosis of the gut microbiota of pregnant women do 
not develop any serious diseases [35]. Such microbial change may be caused by altered immune 
system during the pregnancy (immune system is less effective in order to minimise the risk of 
attacking the fetus).  
1.2.ii Development of gut microbiota 
There are a number of studies analysing the sequence of bacteria colonising the gut of newborn full-
term infants. One of the studies focused on analysing the development of the gut microbiota with 
correlation to microbial changes in maternal milk. The first bacteria to colonise infant’s gut were 
members of Enterococcus and Streptococcus with E. faecalis and S. salivarius being the most 
abundant species [36]. This occurred within the first day of life. On 10
th
, 30
th
 and 90
th
 day postpartum 
the most abundant genera were bifidobacteria (B. brave, B. bifidum and B. pseudocatenulatum), 
streptococci (S. salivarius, S. vestibularis), lactobacilli (L. gasseri) and enterococci (E. faecalis) 
respectively. Members of Staphylococcus genus were found only on 1
st
 and 10
th
 day postpartum [36]. 
What is important is that vertical transfer of bifidobacterial species was found between mother and 
infant [36]. A Dutch cohort of approximately 1000 infants found that between 3
rd
 and 6
th
 week 
postpartum the most abundant microbial genus was Bifidobacterium. Bacteria belonging to this group 
were found in almost 99% of infants [37]. E. coli and B. fragilis were found in above 80% of infants. 
Clostridium difficile and bacteria belonging to lactobacilli were less commonly found [37].  
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1.2.iii Factors affecting gut colonisation 
There is a number of endogenic and exogenic factors that can affect the microbiota composition of the 
gut. Endogenic factors include genetics, sex, gestational age, postnatal age, maturity of the gut and 
immunity [29, 38]. Exogenic factors also called interventions that can affect gut microbiota are mode 
of delivery, route of feeding and type of diet, exposure to antibiotics and environment [5, 26, 29, 38-
44]. An interesting finding is that identical twins who share the same habitat ant diet can still have 
different gut bacteria [8]. 
There are two types of mechanisms that can control the microbiota composition. The first one is the 
host-bacterial interaction which involves immunological reactions. The other type of control 
mechanism is a bacterial-bacteria interaction. This type of interaction is based on ecological changes 
caused by production of metabolites (short-chained fatty acids, bacteriocins), consumption of oxygen, 
competition over food or epithelial receptors [45]. A change in gut environment can lead to shift of 
the bacterial population.  
In order to get an unbiased insight into the influence of factors affecting gut colonisation on changes 
in microbial profiles in newborn babies, a systematic review was completed. Literature on association 
of early life events and gut microbiota was assessed through PubMed (www.ncbi.nlm.nih.gov) in 
accordance with PRISMA guidelines 5 (all studies that were retrieved after search were screened for 
inclusion and exclusion criteria). The search was conducted on the 1
st
 August 2013, using the 
following Medical subject heading (MeSH) key words, limited to human studies: (gut OR 
gastrointestin* OR enteric OR bowel) AND (biota OR microflora OR bacteria OR microbes OR 
microbiome) AND (neonat* OR infant* OR baby OR babies) AND (development OR colonisation 
OR colonization). Forward citations were traced and authors were contacted where additional data 
were required. Data on study design, location, population, outcome, adjustment variables, method of 
outcome measurement, and potential sources of bias (including recruitment selection and exclusion 
criteria) were extracted for the following factors: 1) mode of delivery, 2) gestational Age, 3) nutrition, 
4) exposure to antibiotics. Studies were excluded if microbiota data were not presented in relation to 
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at least one of these four parameters, babies had NEC/sepsis or if infants were administered probiotics 
and/or prebiotics. 
This literature review located 2179 papers of which 874 studies were excluded as either they were 
reviews or were not analysing gut microbiota in humans. The remaining 1305 papers were screened 
for inclusion and exclusion criteria. Fifty one publications that met inclusion criteria were included 
after abstract screening. Fourteen studies were excluded as they did meet exclusion criteria or they did 
not analyse influence of any of the factors, did not show details of infants’ characteristics and 
presented general data for infants. This left thirty six publications to be discussed in the review. Due 
to the fact that some of the publications were based on the same study and the results were 
complementary, they were merged which gave final number of studies equal thirty three. 
The influence of mode of delivery on gut microbiota was analysed in fourteen publications [46-60]; 
type of diet in twenty three experiments [39, 41, 50, 51, 54, 57, 58, 60-77]; exposure to antibiotics in 
ten [41, 49, 51, 57, 58, 60, 64, 78-81] and gestation age in three publications [61, 64, 79]. Eleven 
studies analysed gut microbiota of preterm infants[39, 41, 46, 48, 50, 51, 61, 64, 71, 79, 80], eleven of 
full-term infants [47, 52-54, 61, 63-65, 69, 72, 76, 79, 81, 82] and in fourteen publications there was 
no information about gestational age of infants [49, 56-59, 62, 63, 66-68, 70, 73-76, 78]. Majority of 
studies did not focus on any particular class of bacteria. Only eight papers had any class/species of 
interest including Clostridium [64, 80], Lactobacilli and Bifidobacteria [51, 52, 67, 68] and 
Enterobacteriaceae [59]. A summary of the studies included for this systematic review is given in 
Table 1. 
Table 1: Studies included in the systematic review 
Author 
Year and 
location of 
sample collection 
Species studies Population details:  
Analytical 
technique 
Parameters 
evaluated 
Blakey JL 
 
[41] 
1979-80 
Australia 
Prevalence of 
bacterial species 
28 preterm infants aged 25-36 weeks GA. 
Samples were collected daily from 1st till 8th day 
of life then twice a week for 6th weeks. Samples 
were analysed immediately. 
Culture, 
Gas-liquid 
chromatography 
Diet: EN, TPN 
Antibiotics 
Stark PL and 
Lee A 
 
[61] 
Prior to 1982  
Australia 
Prevalence and 
counts of bacterial 
species 
11 preterm infants aged 30-35 weeks GA and 15 
full term infants. 3-6 samples per individual 
were collected in 1st week of life then weekly till 
1st month. Samples were stored at -60°C. 
Culture 
Diet: human milk, 
formula milk 
Development of gut microbiota and metabolic changes in preterm babies 
PhD Thesis                                                    Natalia Przysiezna  21 
 
Stark PL and 
Lee A 
 
[62] 
Prior to 1982  
Australia 
Prevalence and 
counts of bacterial 
species 
14 infants of undisclosed GA. 5 samples per 
individual were collected within 1st week of life, 
then at 4th week and every 6 weeks f life 6th 
month of life. Samples were stored at -60°C. 
Culture 
Diet: human milk, 
formula milk 
Yoshioka H 
 
[63] 
Prior to 1983 
Japan 
Prevalence and 
counts of bacterial 
species 
13 infants of undisclosed GA. Samples were 
collected daily for 6 days after 1st month of life 
for 6 days and analysed within 2h.  
Culture 
Diet: human milk, 
formula milk 
Lundequist B  
 
[72] 
Prior to 1985 
Sweden 
Prevalence of 
bacterial species 
22 full-term infants. Samples were collected on 
5th day, 3rd and 8th week of life and analysed 
within 5h. 
Culture 
Diet: human milk, 
formula milk 
Rotimi VO 
 
[46] 
1982-83 
Nigeria 
Prevalence of 
bacterial species 
23 preterm infants aged 24-36 weeks GA. 
Samples were collected on 1st, 2nd, 3rd and 6th day 
of life and analysed within 30min. 
Culture Mode of delivery  
Merida V 
 
[64] 
Prior to1986 
Belgium 
Prevalence of 
Clostridium 
species 
32 preterm infants aged 29-35 weeks GA and 31 
full-term infants. No data was provided on 
sample collection timing. 
Culture 
Diet: human milk, 
formula milk, PN 
Antibiotics 
Neut C  
 
[73] 
Prior to 1987 
France 
Prevalence of 
bacterial species 
15 infants of undisclosed GA. Samples were 
collected at 0h and 6th h then on 1st, 2nd, 4th, 7th 
and 14th day of life and were analysed within 
24h. 
Culture 
Diet: human milk, 
formula milk 
Bezirtzoglou E 
and Romond C 
 
[74]  
Prior to 1990 
France 
Counts of 
bacterial species 
19 infants of undisclosed GA. Samples were 
collected at 0h and 6th h then on 1st, 2nd, 4th, 7th 
and 14th day of life. Then they were analysed 
within few hours. 
Culture 
Diet: human milk, 
formula milk 
Adlerberth I  
 
[49] 
1982-83 
Sweden, Pakistan 
Prevalence of 
bacterial species 
39 infants of undisclosed GA. Samples were 
collected daily till undisclosed time point. No 
data on storage method was provided. 
Culture Mode of delivery 
Bennet R 
 
[78] 
1987-88 
Sweden, Ethiopia 
Prevalence of 
bacterial species 
60 infants of undisclosed GA. Samples were 
collected from 2nd till 8th week of life and 
analysed within 24h. 
Culture Antibiotics 
Kleessen, B 
 
[76] 
Prior to 1995 
Germany 
Prevalence and 
counts of bacterial 
species 
39 full-term infants. Samples were collected on 
7th, 15th, 30th, 60th and 90th day of life and 
analysed immediately.  
Culture 
Diet: human milk, 
formula milk 
Gewolb IH 
 
[39] 
1999 
USA 
Prevalence of 
bacterial species 
29 preterm infants of undisclosed GA. Samples 
were collected on 10th, 20th and 30th day of life 
and analysed immediately. 
Culture 
Diet: human milk, 
formula milk 
Gronlund MM  
 
[47] 
1995-96 
Finland 
Prevalence of 
bacterial species 
64 full-term infants. Samples were collected on 
1st, 10th, 30th, 60th and 180th day of life and stored 
at 4°C for up to 35h. 
Culture Mode of delivery 
Bonang G 
 
[65] 
2000 
Netherlands 
Counts of 
bacterial species 
51 full-term infants. Samples were collected in 
1st week and then in 2nd, 4th and 6th month of life 
and then stored at -20°C. 
Culture 
Diet: human milk, 
formula milk 
Harmsen HJ 
 
[66] 
Prior to 2000 
Netherlands 
Prevalence of 
bacterial species 
12 infants of undisclosed GA. 6 samples per 
individual were collected till 20th day of life and 
stored at 4°C. 
Culture, RAPD, 
qPCR, FISH 
Diet: human milk, 
formula milk 
Favier CF 
 
[81] 
Prior to 2003 
Netherlands 
Counts of 
bacterial species 
5 full-term infants. Samples were collected daily 
for first 2 weeks and then weekly till 160th day of 
life. No data on storage method was provided. 
PCR-DGGE Antibiotics 
Hällström M 
 
[48]  
Prior to 2004 
Finland 
Prevalence of 
bacterial species 
42 preterm infants aged 25-31 weeks GA. 
Samples were collected twice weekly for first 2 
months of life. No data on storage method was 
provided. 
Gas-liquid 
chromatography 
Mode of delivery 
Ahrne S 
 
[67] 
1998-2000  
Sweden 
Prevalence of 
Lactobacillus 
species 
112 infants of undisclosed GA. Samples were 
collected 1st, 2nd, 4th and 8th week and then in 6th, 
12th and 18th month of life stored at 4°C. 
Culture, RAPD, 
qPCR 
Mode of delivery  
Diet: human milk 
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Adlerberth I 
 
[49] 
1998-2000  
Sweden 
Prevalence of 
bacterial species 
117 infants of undisclosed GA. Samples were 
collected in 1st, 2nd, 4th and 8th week and then in 
6th, 12th and 18th month of life stored at 4°C. 
Culture, qPCR 
Mode of delivery 
Antibiotics 
Bezirtzoglou E 
 
[68] 
Prior to 2006 
Greece 
Counts of 
Bifidobacterium 
species 
26 infants of undisclosed GA. Samples were 
collected on 4th day of life. No data on storage 
method was provided. 
FISH 
Diet: human milk, 
formula milk 
Magne F 
 
[40] 
2000-01 
France 
Presence of 
bacterial species 
16 preterm infants aged 27-36 weeks GA. One 
sample per infant was collected between 5th and 
56th day of life and stored at -20°C. 
PCR-TTGE, 
sequencing 
 
Mode of delivery 
Diet: human milk, 
formula milk, 
mixed milk 
Butel MJ 
 
[42] 
2002-05 
France 
Presence of 
Bifidobacterium 
species 
52 preterm infants aged 30-36 weeks GA. 
Samples were collected twice weekly till 34th 
day and stored at -80°C. 
PCR-TTGE 
Mode of delivery 
Diet: formula 
milk, mixed 
Antibiotics 
Chen J  
 
[52] 
2006 
China 
Counts of 
bacterial species 
40 full-term infants. Samples were collected 
daily till 7th day of life.  Samples were stored at 
4°C for several hours then at -80°C. 
qPCR Mode of delivery 
Biasucci G 
 
[53, 55] 
2003 
Italy 
Presence of 
bacterial species 
46 full-term infants. Samples were collected on 
3rd day of life stored at -20°C. 
PCR-DGGE, 
PCR-TTGE 
Mode of delivery 
Mitsou EK 
 
[54] 
Prior to 2008 
Greece 
Prevalence and 
counts of bacterial 
species 
97 full-term infants. Samples were collected on 
4th, 30th and 90th day of life and analysed 
immediately.  
Culture, qPCR 
Mode of delivery 
Diet: formula 
milk, mixed 
Dominguez-
Bello MG 
 
[56] 
Prior to 2010 
Venezuela 
Abundance of 
bacterial species 
10 infants of undisclosed GA. One sample per 
infant was collected within 24h of life and stored 
in liquid nitrogen.  
qPCR Mode of delivery 
Fallani M 
 
[57, 58] 
Prior to 2010 
Sweden, UK, 
Germany, Spain, 
Italy 
Abundance of 
bacterial species 
606 infants of undisclosed GA. Samples were 
collected at 6th week of life and stored at 4°C. 
FISH 
Mode of delivery 
Diet: human milk, 
formula milk, 
mixed milk 
Antibiotics 
Roger LC and 
McCartney AL 
 
[69] 
2005-07 
UK 
Counts of 
bacterial species 
14 full-term infants. Samples were collected 
fortnightly for 10 weeks from 1st month of life. 
Then monthly till 12th month of life, then on 15th 
and 18th month. Samples were stored at -20°C. 
Findings only till 6th month were included in the 
review. 
FISH 
Diet: human milk, 
formula milk 
Bezirtzoglou E 
 
[70] 
Prior to 2011 
Greece 
Abundance of 
bacterial species 
12 infants of undisclosed GA. Samples were 
collected from 11th till 36th day of life and stored 
firstly at 0-4°C and then at -70°C. 
FISH 
Diet: human milk, 
formula milk 
Morowitz MJ 
 
[71] 
Prior to 2011 
USA 
Abundance of 
bacterial species 
1 preterm infant aged 28 weeks GA. Samples 
were collected daily from 5th till 21st day and 
stored at -80°C. 
Sequencing 
Diet: human milk, 
PN supplemented 
with formula 
milk, TPN 
Arboleya S 
 
[79] 
Prior to 2012 
Spain 
Counts of 
bacterial species 
20 preterm infants aged 30-35 weeks GA and 21 
full-term infants. Samples were collected on 2nd, 
10th, 30th and 90th day. Samples were stored at -
20°C and within a week at -80°C. 
qPCR,  
PCR-DGGE 
Antibiotics 
Ferraris L 
 
[80] 
Prior to 2012 
France 
Presence of 
bacterial species 
76 preterm infants aged 24-36 weeks GA. 
Samples were collected weekly until discharge 
and stored at -80°C. 
Culture,  
PCR-TTGE 
Antibiotics 
Schwartz S 
 
[77] 
Prior to 2012 
USA 
Counts of 
bacterial species 
12 infants of undisclosed GA. Samples were 
collected on 3rd month of life. No data on storage 
method was provided. 
Sequencing 
Diet: human milk, 
formula milk 
Azad MB 
 
[60] 
2008-09 
Canada 
Counts of 
bacterial species 
24 full-term infants. One sample per infant was 
collected between 3rd and 4th month of life. No 
data on storage method was provided. 
Sequencing 
Diet: human milk, 
mixed  
Mode of delivery 
Antibiotics 
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1.2.iii.a Mode of delivery 
Thirteen studies from this systematic review reported that mode of delivery has an impact on gut 
microbiota development;  only one study did not find any correlation [39].  
A vast number of studies found a negative correlation between Caesarean delivery and colonization 
by Bacteroides [37, 46-49, 57, 58], Bifidobacterium [27, 37, 46, 47, 49-55], Escherichia coli [44, 48, 
49, 53, 55, 59], Lactobacillus and Lactobacillus-like bacteria [46, 47, 54, 56]. A number of studies 
found that vaginal delivery was negativelly associated with the presence of Clostridium [37, 47-50]. 
No influence of mode of delivery on the Streptococcus population was reported [48, 50, 56-58] and 
findings for other bacteria were contradictory. The findings regarding the diversity and richnes are 
contradictory as well. Three studies reported that Caesarean section leads to increased diversity of gut 
microbiota [48, 59, 83]. Rotimi et al. recorded that vaginally delivered infants had higher diversity of 
species [46] while Hallstrom et al. found that infants delivered by Caesarean section had higher 
number of species but equal number of genera [48]. At the same time Adlerberth et al. reported that 
infants delivered by Caesarean section had higher number of genera [59].  
Additionally, research analysing gut microbiota during pregnancy and the correlation of maternal and 
infant’s gut microbiota found no clear pattern. The results indicate that the infant after birth has 
microbiota of  equal similarity with the microbiota of any mother during the beginning of pregnancy, 
but no similarity with the  microbiota of any mother at the end of pregnancy [35]. That would suggest 
that perhaps maternal microbiota at the moment of birth does not affect infant gut colonisation. At the 
same time it is important to remember that the study analysed full-term infants and that the preterm 
gut may react to maternal microbiota differently. 
1.2.iii.b Type of diet 
Although formula milk aims to resemble the breast milk there are many differences in composition. 
One is  higher content of proteins in formula milk than those  in breast milk [34]. Higher protein 
content can potentially lead to a shift of microbiota towards species that specialise in protein 
fermentation. The process of the protein fermentation itself is known to produce toxic metabolites like 
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amines, ammonia, phenols and sulphides [84]. Untreated human milk (fresh, not pasteurised) has a 
protective role for the infant gut. Apart from having IgA antibodies it also contains a number of 
oligosaccharides of which some are homologous to cell surface pathogen receptors [18]. Thanks to 
this pathogens are less likely to bind to surface of the infant’s gut as they will bind to free 
oligosaccharides coming from maternal milk. Additionally a study analysing the species of 
Bifidobacterium extracted from breast milk of healthy mothers found that some of these species were 
able to inhibit in vitro the growth of such pathogens as Salmonella enterica, Shigella sonnei and 
Cronobacter sakazakii while growth of Clostridium difficile or Staphylococcus aureus  was not 
inhibited [85]. At the same time, it was noticed that some of the tested bifidobacterial strains were in 
fact facilitating adhesion of pathogens to intestinal mucus [85].  
Most of the studies from systematic review found that presence of Bifidobacterium is associated with 
breast milk [54, 57, 58, 61-63, 66, 68-70, 72-76]. At the same time, the following species are more 
common among formula-fed infants: Bacteroides [37, 39, 57, 58, 62, 63, 66, 70, 76], Clostridium [37, 
50, 57, 58, 66, 69, 72-76, 86], Enterobacteriaceae [37, 39, 44, 50, 57, 58, 65, 66, 71, 72, 76] and 
Enterococcus [63, 65, 66, 76]. Findings for the other genera and the diversity of gut microbiota are 
contradictory. One study found that formula-fed infants had higher number of species and genera in 
comparison to breast-fed ones [66]. Other study claims that total bacterial count was slightly higher 
for formula-fed infants within 1
st
 week but after 1
st
 month it was higher for breast-fed ones [63]. Other 
study found diversity (Shannon’s Index) and richness (Chao Index) were much lower after 
administration of breast milk to preterm infants [87]. Other studies found that bacterial colonisation of 
the intestines was faster in breast-fed infants and that total bacterial count was higher during first 3 
months of life [73, 76]. Finally, last study found that guts of infants fed with breast milk were 
colonised by more species than in case of formula fed infants and at the same time, the total bacterial 
count was similar in both groups [39]. 
According to Blakey et al. total parenteral feeding in first 4 days leads to delayed gut colonisation, 
lower bacterial diversity (lower number of species), half the number of Bacteroides and slightly 
higher number of Clostridium [41]. Another study found that both TPN and PN are associated with 
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presence of Pseudomonas and Pseudomonacaceae [71]. Parm et al. found that parenteral nutrition 
decreased chances of colonisation by Klebsiella oxytoca, E. coli and Serratia [44].The decrease of 
microbial diversity as a result of parenteral nutrition was confirmed by Jacquot et al. [83].  
1.2.iii.c Antibiotics 
Exposure to antibiotics seems to affect many different genera. The population of beneficial bacteria 
like Lactobacillus [41, 78] and Bifidobacterium [37, 51, 79, 81] decreases in the presence of 
antibiotics. Two studies found that exposure to antibiotics negatively affect the population of 
Enterococci [78, 81]. Three studies report decreased number of infants colonized with Clostridium 
when they were given antibiotics [41, 49, 64]. A number of studies found that the total bacterial count 
and the diversity of species decrease when the antibiotics were given [39, 41, 42, 87]. However, one 
study found that early neonatal administration of drugs increased the diversity of gut microbiota [83]. 
Nine studies from this systematic review analysed the influence of antibiotics on gut microbiota. The 
findings in studies included in the systematic review are contradictory. This may be because of a 
number of factors. Firstly, different types of antibiotics are prescribed. Secondly, many species 
become resistant over time thus the older papers may have different finding than the modern one. 
Finally, infants that require antibiotics are usually sick and different types of diseases may lead to 
different microbiological profiles of the gut. 
1.2.iii.d Gestational age 
Gestational age affects the gut microbiota because of the immaturity of immune system. Additionally, 
some of the preterm births are linked to uterine infection thus gut microbiota may have an interesting 
link to gestational age [10, 88, 89]. Only three publications from this systematic review compared gut 
microbiota between preterm and full-term infants which was not enough to draw a conclusion [61, 64, 
79]. The comparison of full-term babies with premature ones is not always informative. Preterm 
babies undergo different treatment than full-term ones (hospitalisation, prolonged exposure to 
antibiotics, parenteral nutrition) and as a result gestational age is not the only difference between 
preterm and full-term babies.  
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1.2.iii.e Other factors 
There are number of other, less well reported factors that can potentially affect the gut microbiota. 
Those factors had not been included in the systematic review, but available findings are reported in 
this section. In adults, there had been found differences in the gut microbiota profiles between males 
and females. Men had been reported to have a higher relative abundance of species belonging to 
Clostridia, Bacteroidetes and Proteobateria [38, 90]. The association of gut microbiota patterns with 
the geographical region is often mentioned in various reviews but can usually be explained by the 
difference in diets. Factors such as maternal education, use of probiotics or antibiotics by mother 
during pregnancy, prolonged rupture of membranes, sex, experiencing fever, living on a farm or 
having fury pets were found as possible contributors to gut microbiota profiles [37, 81].  
1.2.iii.f Conclusion on systematic review 
There had been only 11 studies that were conducted on preterm babies and met the criteria of this 
systematic review. Additionally, as seen in the Table 1 the sample collection times and methods used 
for bacterial profilings vary thus the comparison of the studies is dificult and results questionable. A 
large gap in the literature had been identified and this PhD project is contributing towards improving 
the knowledge regarding this issue. 
1.2.iv Association of the gut microbiota with functional clinical outcomes 
Another systematic review to assess what is known regarding the association of bacterial profiles with 
functional clinical outcomes had been conducted on the 1
st
 Oct 2013. The systematic review was as 
well conducted in PubMed and the search term was: (gut OR gastrointestin* OR enteric OR bowel 
OR colon OR intestin*) AND (biota OR microflora OR bacteria OR microbes OR microbiome OR 
microorganisms) AND (neonat* OR infant* OR baby OR babies) AND (disease OR allergy OR 
eczema OR asthma OR atopic OR obesity OR diabetes OR NEC OR necrotizing enterocolitis OR 
necrotising enterocolitis OR sepsis OR sirs). Studies were excluded if no sample was collected prior 
to the 6
th
 month of life, or when pre/probiotics were administered to babies. 
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In total 62 studies had been included: five for sepsis, nine for NEC, four for diabetes, 10 for obesity, 
seven for autism, and 28 for various allergies and asthma. 
1.2.iv.a Sepsis 
Sepsis is a term that covers a number of infections including superficial skin infections, cellulitis, 
necrotizing fasciitis, wound infections, peritonitis, abscesses and septicaemia [7, 91]. Septicaemia 
occurs when bacteraemia  is accompanied  by the symptoms of infection [7]. Septicaemia is usually a 
result of spread of a localised infection and in 95% cases is caused by only one organism [7]. Sepsis 
syndrome is defined as septicaemia associated by an immunological reaction of the organism [7]. 
When the multiple organ failure occurs then the condition is called septic shock [7].  
Sepsis is the most common problem in pediatric intensive care units and neonatal sepsis occurs in 
0.8% of life births and in quarter of cases is associated by meningitis [92]. It is estimated that 25% of 
newborn infants with sepsis die. Early onset of neonatal sepsis occurs within 7 days of life and is 
usually caused by bacteria from the mother’s vagina which can enter via the amnion or during the 
birth [92]. Late onset of sepsis occurs after 7
th
 day  and is believed to be caused by pathogens from the 
environment [92]. Risk factors for newborns to acquire sepsis include prematurity, low birth weight, 
prolonged rupture of membranes, maternal urinary tract infection  and maternal colonization by group 
B Streptococci [92]. The major bacterial contributors of sepsis are group B Streptococci, E. coli, 
Staphylococci, Enterococci, Klebsiella, Haemophilus and Pseudomonas [92-96]. 
After analysing the findings from my systematic review investigating the correlation of gut microbiota 
profiles and sepsis, there were insufficient data to draw a conclusion for any of the genera or species. 
All of the studies found microbial differences between health and sepsis patients [97-101]. It was 
reported that microorganisms responsible for the onset of sepsis matched those obtained from the guts 
of patients. This included species such as E. coli, Enterobacter cloacae and Acinetobacter baumani. 
This would mean that gut microbiota can be a reservoir for the microorganism inducing sepsis. There 
was however no agreement on the influence of the high abundance of Enterobacteriaceae [98, 100]. 
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Sepsis is a complex problem and it seems there is no common pattern of gut microbiota changes that 
could be linked with the higher incidence of sepsis. 
1.2.iv.b Necrotizing enterocolitis 
Necrotizing enterocolitis (NEC) is very important disease that can affect newborn infants. Up to 90% 
of all cases are seen in very low preterm infants. Additionally in more premature babies, NEC occurs 
later after birth [32]. There are studies analysing the contribution of gut microbiota to the 
development of NEC. Early detection of ‘NEC microbial profile’ could help prevent the onset of 
disease not only in premature but also in full term infants.  
In this systematic review the presence of Klebsiella [102-105], C. perfringens [29, 103, 106, 107], 
group D Streptococci [102, 103], and Enterobacter [48, 103, 104] has been found to be associated 
with NEC. The correlation between the presence of C. perfringens and the NEC has also been 
observed in the studies on piglets [29]. The results for other bacteria are contradictory. There was also 
no conclusive answer regarding the incidence of NEC and diversity or richnes fo gut microbiota [83, 
105, 108, 109]. 
Interesting finding was in relation to the relative abunance of Proteobacteria. Healthy infants had 
stable abundance of this phylum while patients that later developed NEC had lower abundance at birth 
and experienced a rapid increase in the abundance prior to onset of NEC [105, 109]. This was also 
observed on twins where only one of the infants developed NEC while the other remained healthy. 
Additionally, Smith et al. found in intestinal tissues surgically removed from NEC patients that 
members of the Proteobacteria phylum represented 49% of all bacteria [110]. It is possible that the 
presence of Proteobacteria at the early stage of life may lead to a proper maturation of the immune 
system resulting in lack of overgrowth of those opportunistic pathogens. 
1.2.iv.c Allergy, atopy and asthma  
Twenty-three studies reported findings for Bifidobacterium and allergy/atopy/eczema/asthma. Most of 
the studies reported a lack of correlation between prevalence [111-118] and total counts of the 
Bifidobacterium genus [113, 118-125] and the future development of allergy. On the other hand four 
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studies reported that the prevalence [119, 121, 126, 127] and the counts [123, 126-130] of 
Bifidobacterium were lower among allergic infants. There was not enough data about the abundance 
of this genus to draw any conclusions. No correlation of the development of the allergy and the 
prevalence of Bacteroides [111, 114, 117, 119, 121, 126, 131], Lactobacillus [111, 113, 114, 116, 
117, 121, 126], Streptococcus [119, 121, 126], Enterococcus [121, 126], Eubacterium [119, 121, 
126], Enterobacteriaceae [118, 121, 126] was found.  
Additionally no correlation between the allergy and change of the bacterial counts of Bacteroides 
[114, 118, 119, 121, 122, 125, 126, 128, 130], Clostridium [113, 114, 118, 119, 121-126], 
Lactobacillus [113, 119, 121-128], Enterococcus [118, 119, 121, 122, 126-128], Staphylococcus [113, 
118, 121, 126, 130], Streptococcus [119, 121, 125, 126], Enterobacteriaceae [118, 121-123, 125, 
126], Eubacterium [121, 126] was observed.  
A number of studies found no difference in the total bacterial counts [27, 123, 126, 128, 129]. Only 
Smehilova et al. reported lower total bacterial counts in the infants with allergic colitis [127]. 
Additionally two studies reported a lower diversity in the infants that developed eczema after sample 
collection [132, 133] while Bisgaard et al. found lower diversity prior to allergy but not prior to 
asthma [134] 
The findings from this systematic review show that there are no known bacteria that are confirmed by 
few independent studies as strongly associated with the presence of NEC.  
1.2.iv.d Obesity 
The systematic review retreived 10 studies that analysed the correlation of gut microbiota with 
obesity. Only two of those studies analysed bacterial profiles before infants got obese or overweight 
[135, 136]. Based on those two studies there seems to be a positive correlation between Bacteroides 
and obesity [135, 136]. However, the number of prospective studies is too low to draw any 
conclusions. There is an obvious gap in the literature regarding the colonisation of gut and future 
weight gain. 
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1.2.iv.e Diabetes 
Only four studies were found to be eligible for the analysis of correlation of diabetes with changes  in 
gut microbiota profiles. Diabetes was reported to be associated with higher counts of Proteobacteria 
and Bacteroides [137, 138] and also higher prevalence of the latter genus [139]. There was also a 
negative correlation with counts of Bifidobacterium [138, 139] and Firmicutes [137, 140]. Findings 
for Clostridium, E. coli and Lactobacillus were contradictory [137, 139, 140]. It is however important 
to remember that the number of included studies was low and only one study analysed microbiota 
prior to diagnosis and thus the conclusion may be biased. What is more important is that Giongio 
focused on type-1 diabetes while other studies analysed type-2. The systematic review had not 
retrieved enough data to draw any meaningful conclusions. 
1.2.iv.f Neurodevelopmental disorders 
The systematic review retrieved only six studies meeting inclusion criteria for the correlation of the 
gut microbiota with autism. None of the studies analysed microbiota prior to diagnosis thus the results 
cannot be treated as a proof of causality.  All of the studies, that provided this data, had groups with a 
similar age of the individuals. Autism was reported to be negatively associated with the abundance of 
Collinsella [141, 142], Verrucomicrobia [142] and some species of Clostridium (C. leptum and C. 
methylpentosum) [141]. At the same time Desulfovibrio was found to be positively linked with autism 
[141]. 
1.2.iv.g Conclusion from the systematic review  
The aspect of association of gut microbiota profiles with the functional clinical outcomes is not well 
investigated. There are very few studies that had looked into this and the results are usually 
inconclusive.  
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1.3 Preterm infants 
1.3.i Definition and epidemiology 
Human infants are usually born after 37 weeks of gestation. Such infants are called full-term [143-
145]. Preterm infants, those born before 37
th
 week of gestation are divided into early preterm and late 
preterm (Figure 1). Early preterm are those that were born before 32
nd
 week of gestation while late 
preterm are those born between 32
nd
 and 37
th
 week [144-147]. Early preterm infant are classified as 
extremely preterm if born before 28
th
 week while those born between 28
th
 and 31
st
 week of pregnancy 
are called very preterm [145] . Late preterm infants can be divided into mild and moderate if they are 
born between 32-33 week and 34-36 week respectively [145]. Late preterm birth occurs more often 
than early  [89, 145, 147]. Approximately 1-1.5% of births in UK take place before the 31
st
 week of 
gestation while worldwide up to 11% of births are preterm [143, 147, 148]. Due to the fact that it is 
difficult to know exact day of conception gestational age (GA) is usually estimated rather than exact 
value given. In some countries like USA gestational age is not used on daily basis. Instead a different 
terminology is used that is related to the weight of the baby. Full-term infants in the UK are usually 
born with a birth weight of around 3.5 kg [149]. If they are born with a weight lower than 2.5kg they 
are termed low birth weight infants. If their weight is lower than 1500g they are called very low birth 
weight and if less than 1000g,  extremely low birth weight. Approximately 6% of live births in UK 
are low birth weight [150].  
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Figure 1: Flowchart presenting subgroups of premature birth. Based on the information from Moutquin 2003 [145] 
 
1.3.ii Types of prematurity 
The majority of preterm births, 21-68%, are idiopathic, which means that they are of an unknown 
aetiology. A common associate of preterm birth (7-58% cases) is  preterm premature rupture of the 
membranes (PPROM). At the same time, on average 25% of preterm deliveries (range from 9% to 
38%) are medically indicated [145-147, 151-153]. It is also believed that the early preterm birth (less 
than 32 weeks GA) is most frequently associated with the infection of the uterus [89, 154]. 
Prematurity is responsible for 75% of morbidity and 70% of mortality among neonates in developed 
countries and each year approximately 1 million infants die worldwide due to preterm complications  
[89, 144-147, 152, 153]. As a result of improvements in  modern medicine  the balance between 
mortality and morbidity has  changed. Infants that survive increase the number of severe morbidity 
[151]. There are several factors that affect mortality and morbidity and they include gestational age 
(higher risk for early preterm infants than for late preterm infants), birth weight (smaller infants are at 
bigger risk) and plurality (higher rate of survival for singletons) [144, 147, 151]. 
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1.3.iii Factors contributing to prematurity 
There are number factors that contribute to the preterm delivery. This includes  maternal age and 
health, occurrence of previous preterm birth, in-vitro fertilisation, low socio-economic status (at the 
same time there is an increase in preterm birth in wealthy communities), genetic factors, repeated 3
rd
 
trimester abortion, lifestyle and low BMI [89, 145, 147, 151, 152]. 
Medically induced preterm birth was found to be associated with intrauterine growth restriction, 
unstable fetal condition, maternal hypertension, in-vitro fertilisation, medical acute illness, obstetrical 
complications, multifoetal pregnancy, diabetes and maternal age above 35 years [145, 151, 152]. 
PPROM is more likely to occur in case of vaginal infection, uterine distension, cervical anomalies and 
in low socio-economic status [145]. Idiopathic preterm birth is related to previous preterm birth, low 
body mass and poor body mass gain, stress, uterine anomalies, smoking, drug abuse and maternal age 
below 18 years [145]. 
It is believed that intrauterine infections can be responsible for up to 40% of preterm labours [89, 147, 
155]. However, it is more likely that the presence of bacteria in the uterus predisposes to the 
premature birth rather than is the main cause.  Bacterial presence deep within the human foetal 
membranes had been observed in 70% elective caesarean sections at term [154]. Additionally, Steel 
observed that all of the intact fetal membranes obtained from preterm fetuses and some from term 
fetuses (included: not in labour, in labour, PPROM) had bacteria and/or inflammatory cells present. 
[154]. Additionally, bacterial presence in the amnion or chorio-amnion was found in up to 80% of 
preterm births and 30% of term births [156].  
There are four main routes for  microorganisms to enter the uterus (Figure 2). The first and the most 
common one is through the vagina and cervix, the second route is a transfer through placenta, the 
third is an accidental infection during an invasive procedure and the last possible route is a transfer of 
microorganisms from abdominal cavity through the fallopian tubes [89, 147, 155]. Additionally, 
bacterial vaginosis (BV) is believed to increase 2-5 times the risk of preterm birth although most 
women with BV deliver at term and most placental inflammation is not related to BV [88, 89, 156]. 
Development of gut microbiota and metabolic changes in preterm babies 
PhD Thesis                                                    Natalia Przysiezna  34 
 
 
Figure 2: Potential sites of bacterial infections in the uterus. Reproduced with permission from Goldenberg et al. 
2000 [89], Copyright Massachusetts Medical Society 
 
Additionally, microorganism can colonise a number of sites in the uterus. They can colonise the 
placenta (villitis), the choriodecidual space (the space separating the fetal and maternal tissues), the 
fetal tissues,  amnion and chorion (choriamnionitis), the amniotic fluid (amnionitis), the umbilical 
cord (funisitis) or the fetus itself (Figure 2) [89]. One of the theories trying to find the link between 
the infection of the uterus and the preterm labour is that the fetal inflammatory response can lead to 
the onset of labour (Figure 3) [147, 154].  
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Figure 3: Potential pathways from chorodecidual bacterial colonisation to occurrence of premature birth. 
Reproduced with permission from Goldenberg et al. 2000 [89], Copyright Massachusetts Medical Society 
 
The most commonly found micro-organisms in the uterus of women delivering  preterm without the 
rupture of membranes are Gardnerela vaginalis, Mycoplasma hominis and Ureoplasma urealyticum 
[89, 147, 156]. In the case of PPROM, the enteric gram-negative bacteria (Enterobacteriaceae) 
represent up to 40% of microorganisms recovered from the amniotic fluid [155]. Other common 
microorganisms that can be found in the womb after the rupture of membranes are E. coli and group B 
streptococci [89]. There is also a number of other species of either oral or vaginal origin that may be 
linked to preterm birth. They are usually members of one of the following genera: Bacteroides, 
Fusobacterium, Gardnerella, Lactobacillus, Peptostreptococcus, Porphyromonas, Prevotela, 
Actinomyces, Campylobacter, Capnocytophaga, Mobiluncus, Leptotrichia [89, 156]. 
1.3.iv Characteristics 
Preterm infants are born immature. Different systems develop at different stages of their growth in the 
womb. For example suck swallow coordination is not fully developed until the 34
th
 week [32]. This 
means that such infants are not able to be breast fed and require tube feeding. Additionally motility 
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and gastric emptying is delayed and quite often feeding intolerance is present [155]. Meconium is 
believed to suggest the maturity of the gut as it is  rarely passed in utero before the 34
th
 week of 
gestation [155]. It is hypothesised that early passage of meconium in the preterm infant may be caused 
by the swallowing of enteropathogenic bacteria from the womb [155]. In infants born before 30
th
 
week GA there is lower oesophageal tone [32]. The  kidneys continue to develop in preterm infants 
after birth thus it is possible that urinary metabolites will show clusters relating to  GA [157]. 
Nephrogenesis is usually finished by 34
th
 to 36
th
 week of gestation. Preterm infants at the 38
th
 week of 
corrected age have smaller kidneys than the full term infants at the same age but when adjusted to the 
body size the kidneys or preterm infants were proportionally bigger [158]. Gut development is 
affected by the weeks post-partum which suggests that gut microbiota and faecal metabolites will be 
related mostly to weeks post-partum but still affected by GA [158]. Many preterm infants have 
problem with maintaining  growth. They are usually lighter than a fetus remaining in the womb and 
once reaching  term equivalent age, they are shorter than full-term infants [159]. A subnormal growth 
of head may indicate problems with neurodevelopment and may lead to lowering of IQ in future life 
[159]. Additionally, teenagers that were  born extremely-low-birth-weight are on average shorter and 
lighter than those born at term [160]. 
1.3.v Mode of delivery 
1.3.v.a Vaginal 
Vaginal delivery is occurs in the majority of mammals (with exceptions of monotremes). Vaginal 
delivery can be divided into three subgroups: spontaneous, assisted, and induced. Spontaneous vaginal 
delivery is defined as following labour that was not induced by drugs or any other techniques, and  
without the use of any instrumentation. Assisted vaginal delivery is when the  use of special 
instrumentation is required to facilitate the birth.When labour does not start spontaneously and is 
induced manually or by drugs it is referred to as induced vaginal delivery. Spontaneous vaginal 
delivery is more likely to occur than Caesarean section in case of idiopathic preterm birth and 
PPROM (~ 65%) [152].  
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1.3.v.b Caesarean section 
Caesarean section is a surgery that involves removal of the fetus/infant from the uterus through an 
incision in the abdomen. Historically Caesarean section has been performed when mother’s or infant’s 
life was put at risk during birth. Nowadays it may be done upon request. Caesarean section may take 
place pre-labour or in labour which often includes rupture of membranes. In medically indicated 
preterm births the most common mode of delivery is Caesarean section (60-90% of such births, 
depending on week of pregnancy) [152].  
1.3.vi Type of diet 
The average growth rate of the fetus is 15g/kg/day. At 24 weeks of gestation the fetus is composed of 
90%  water, 2% lipids and 8.8% protein [161]. At term the composition of the newborn has altered to 
75% water with lipids and protein increased to 11% and 12% respectively [161]. Newborn babies 
have a rapid switch from a high carbohydrate and low fat diet to a high fat and low carbohydrate diet 
[162, 163]. The necessary glucose is obtained from the glycogen stored in the liver [162]. However, 
when  preterm labour occurs, the storage of the glucagon in the liver is quite low and the enzymes 
participating in gluconeogenesis are not fully active yet [162]. Because of that there is a higher risk of 
developing hypoglycaemia in preterm infants than in full-term infants and intravenous administration 
of glucose is often required [162]. Until the third trimester, the fetus does  not accumulating lipids in 
adipose tissue at  levels high enough for survival on this source only [163]. The ability to oxidise  
long chain fatty acids and to produce ketone bodies is low but  increases soon after birth [162]. The 
process of lipogenesis has been observed in preterm infants (28 weeks GA) in the first day of life 
[162].  
1.3.vi.a Enteral nutrition 
There are several types of milks that can be provided as an enteral nutrition (Figure 4). Fresh mother’s 
milk is the  milk of choice however it is not always possible to provide this [164].  In such situation 
either donor milk or formula is given. Donor milk is usually pasteurised which leads to elimination of 
beneficial bacteria and deactivation of the bile-salt-stimulated lipase which is responsible for 
increasing milk fat absorption [163]. Formula  may or may not be supplemented with probiotic 
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bacteria. Levels of beneficial bacteria are different from those in the mother’s milk even when 
probiotics are used. Preterm formula is usually composed in order to satisfy the nutrition requirements 
of a growing fetus. A blinded randomised trial of the influence of mother’s milk vs. the preterm 
formula  found that mother’s milk reduces the number of days on parenteral nutrition and reduces the 
chances of necrotising enterocolitis (NEC) [164].  
 
Figure 4: Types and subtypes of possible enteral nutrition 
 
A proper composition of lipids, carbohydrates and amino acids is necessary for a healthy growth of 
preterm infant [157, 160]. The reason for administration of high-fat formulas is that the percentage of 
fat absorption remains stable regardless of the concentration of fat which means that high-fat formulas 
result in a bigger amount of absorbed and metabolised fat [165]. At the same time, it was considered 
desirable to reduce the concentration of fat and provide a caloric intake from carbohydrates and 
proteins [165]. Although preterm infants require proteins for rapid growth, the high concentration of 
those molecules can have an adverse effect on the infant’s health [160]. High-protein formulas did 
often have high levels of sodium as well. Consumption of such formula results in a rapid weight gain 
due to the water retention which can lead to oedema [165]. Additionally prolonged high-protein diet 
my lead to metabolic acidosis as undeveloped kidneys of preterm infant are not able to cope with the 
metabolism of a non-volatile acid [165].  
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Newborn full-term infants are normally fed orally, however preterm infants are not always mature 
enough to be fed exlusivelly through mouth and need intravenous supplementation which is called a 
parenteral nutrition (PN) [157, 161, 162, 166]. Since the motor ability of suckling is not developed by 
the 34
th
 week of gestation, babies born before are fed through a gastric tube. 
1.3.vi.b Parenteral nutrition 
Due to the immaturity of the gut (food intolerance, risk of necrotising enterocolitis) the majority of 
early preterm infants require some parenteral nutrition (PN) for 15.6 days on average [160, 167-169]. 
The time that an infant will spend on PN is affected by gestational age, body weight and  morbidities 
[167]. A systematic review reported that there is a significant improvement in time to regain weight 
and in the reduction of maximum weight loss when parenteral nutrition is provided early after birth 
[170]. What is more, the same review mentioned that there was a significant reduction in chances of 
sepsis but no influence on the mortality when PN was provided straight after birth [170]. Energy 
requirements are higher for infants of small gestational age than for those born at term thus in order to 
maintain  growth rate in preterm infants, a proper composition of nutrients must be provided [160, 
161]. Resting energy is largelly unaffected by the gestational age and is approximately 50 kcal/kg/day 
[160]. However, the energy needed for the development of new tissues is 4.5-4.9 kcal per gram of 
tissue [161]. The recommended daily caloric intake for preterm infants is 110-120 kcal/kg [161, 167]  
of which 20-25 kcal/kg/day should be from protein. In order to avoid growth faltering, enough energy 
of non-protein origin must be provided. In case of a disease more energy may be required [160].  
When administering amino acid solutions, a daily intake of 1-1.5g/kg per day (g×day×kg
-1
) is needed 
to prevent catabolism of proteins [166]. It is suggested that early administration of amino acids can 
have beneficial effect on head and brain growth and neurodevelopment and improves  nitrogen 
balance,  electrolyte balance and blood glucose control [167]. There are contradictory results whether 
rapid increase of amino acid concentration sustains optimum  protein catabolism/anabolism balance 
[161, 166]. There is currently  no gold standard of what should be the growth rate for preterm infants. 
It is assumed that the best option may  be to maintain natural fetal growth [166] but this has not been 
established. 
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It was decided in the 1960s that parenteral administration of lipid emulsion may improve energy 
intake [171]. The presence of a lipid emulsion protects amino acids from being used as an energy fuel 
thus they can be used as protein building molecules [165, 172, 173]. Additionally, essential fatty acid 
deficiency may be prevented by the administration of lipids [173]. A common lipid emulsion provided 
intravenously is Intralipid which is composed of long chain triglycerides (LCT) from soybean oil and 
phospholipids from egg yolk [171]. The components of Intralipid are arranged into chylomicrons with 
phospholipids on the surface and triglycerides in the centre [172]. Soybean lipids are metabolised 
differently when they are given intravenously compared to oral nutrition [174]. Prolonged parental 
nutrition with Intralipid can lead to serious side effects like parental nutrition-associated liver disease 
(PNALD) [160, 175, 176]. It is suggested that the liver may not be able to metabolise artificial 
chylomicrons in the same manner as would it metabolise natural chylomicrons (created after digestion 
of fat) [174]. This is caused by the fact that vegetable oil-based lipid emulsions can lead to cholestasis 
and hepatostasis [160, 173, 175, 176]. Soyabean oil is rich in omega-6-acids which can be 
proinflammatory and is often contaminated with phytosterols which are linked to liver damage [160, 
171, 177]. Phytosterols are plant molecules that are analogus of cholesterol in animals [177]. Those 
molecules are not dangerous when administered orally, however when provided intravenously they 
are found to be toxic to the liver cells [177]. Additionally it was reported that administration of 
linoleic acid in high concentration can result in inhibition of macrophage and neutrophil activity 
[172]. An alternative source of lipids may be a solution to PNALD [160, 171, 175]. There is an 
alternative option to the Intralipid which is SMOFlipid,  a lipid emulsion composed of soybean oil, 
medium-chained triglycerides, olive oil and fish oil.  
Due to the fact that the major role of the introduction of the lipid emulsion is to preserve the amino 
acids from being used as an energy source, an interesting finding was that fish oil was associated with 
higher levels of branched-chained amino acids catabolites such as 2-methylbutyroylcarnitine, 
isovalerylcartinine, hydroxyisovaleroyl carnitine, tiglyl carnitine, methylglutaroylcarnitine, compared 
to the soybean oil [173]. Fish oil is composed of long-chained fatty acids but is rich in omega-3-fatty 
acids which have more beneficial effect on the human body than omega-6-fatty acids that can be 
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found in soybean oil [173, 178]. Animal studies reported that fish oil based lipid emulsion does not 
impair  bile flow, prevents the development of steatosis and can improve the health of PNALD 
patients [160, 173, 177, 178]. Metabolic analysis of the livers from mice fed either soybean oil or fish 
oil found that the latter led to a reduction of omega-6-fatty acids, arachidonic acid and 
hydroxyeicosatetraenoic acids (commonly produced during the inflammation) [173]. On the other 
hand eicosapentaenoic acid, which can be found in the fish oil, needs further testing on its safety in 
preterm babies [163].  
Olive oil is believed to have a beneficial impact on health as some of its components like oleic acid, 
phytosterols, α-tocopherol, triterpenes, oleocanthal and phenolic compounds have been found to have 
anti-inflammatory and antioxidant abilities [171]. Additionally, in vitro and animal studies have found 
that olive oil based lipids, in contrast to soy-based lipids, did not lead to suppression of the T-
lymphocyte activation and proliferation, delayed bacterial clearance, [157, 171, 179]. It was also 
reported that intravenous administration of olive oil lipids does not stimulate gluconeogenesis in 
contrast to administration of Intralipid [180]. 
Essential lipids for a newborn baby include linoleic, linolenic, arachidonic and docosahexaenoic acids 
[162]. All these lipids are included in the parenteral formula. Triglycerides are metabolised into fatty 
acids which then can enter ketogenesis. Ketones are considered to be a useful energy source in 
seriously ill patients thus administration of lipids that could be easily utilised into ketones is an 
important aspect of parenteral nutrition [181]. In the case of long chain fatty acids a molecule called 
carnitine is required for transportation into mitochondria. Seriously ill patients may have low levels of 
carnitine and thus a better energy source than long chain triglycerides was needed. Medium chain 
fatty acids can simply diffuse through mitochondrial wall without assistance of carnitine [172, 181]. 
Medium chain fatty acids are product of digestion of medium chain triglycerides (MCT). MCT are 
composed of three saturated fatty acids that have 6 to 12 carbon atoms. They are metabolised  and 
absorbed two fold quicker than LCT due to the fact that they are 100 times more soluble in water than 
LCT and do not need attendance of pancreatic lipase or bile acids [172]. After parenteral 
administration MCT are neither accumulated in the liver nor stored in adipose tissue [165, 172, 182]. 
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What is more, medium chain triglycerides do not participate in production of free radicals [172]. 
However, MCT are not advised for patients with ketosis problems [172]. The study performed by 
Denison et al. in the mid 80’s found that administration of an emulsion composed of both long chain 
and medium chain triglycerides was metabolised more rapidly than an emulsion composed of only 
long chain triglycerides [181]. The finding was also confirmed by another study [183]. There were no 
side effects observed in adult men after 10 days of administration of emulsion composed of both long 
chain and medium chain triglycerides [181]. Long chain triglycerides cannot be totally removed from 
the lipid emulsion as they provide essential fatty acids which are crucial for proper visual and brain 
development [161, 172]. Fish oil is an interesting component of SMOF lipid which is not present in 
the Intralipid [175, 184]. Supplementation with fish oil lipid emulsion was found to decrease levels of 
pro-inflammatory cytokines, TNF-α and IFN-γ which are high in patients fed parenterally [168, 175, 
185]. Furthermore, administration of fish oil lipid emulsion led to reversal of parental nutrition-
associated liver disease symptoms [175]. A randomised double-blinded study analysing differences 
between lipid emulsions administered to preterm infants found that infusion of SMOF lipid led to 
decrease of total bilirubin and direct bilirubin when compared with infants fed with Intralipid [184]. 
At the same time there is  not enough evidence that these hybrid lipids could improve the treatment of 
PNALD [178]. Additionally, animal studies have reported that supplementing PN with lipid emulsion 
reduces the levels of inflammatory markers Ccl2 and Apcs (which are much higher in animals on PN 
without a lipid emultion compared to control group) but does not affect the levels of inflammatory 
factors TNFf and Il1β [186]. 
Carbohydrates are necessary for neurodevelopment as at early gestational ages the brain largely 
consumes  glucose. The levels of glucose needed in preterm infant can be twice as high as in full-term 
infant [161]. The concentration of administered glucose must be balanced in order to avoid both hypo- 
and hyperglycaemia [168, 187]. Additionally, too high concentration of carbohydrates may lead to 
steatosis (abnormal retention of the fat in cells) [160]. Using exogenous insulin to obtain higher 
glucose delivery rates is not recommended as it can lead to reduction of protein synthesis [187]. 
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Finally, electrolytes, vitamins and minerals are necessary for proper development of preterm infant. 
They should be provided at the same level as in utero. Phosphorus, magnesium and calcium are 
important to maintain function and structures of tissues [161]. When it comes to vitamins both fat-
soluble and water-soluble must be provided with the latter one being administered on regular basis as 
humans are lacking abilities to effectively store them in their bodies [161].  
Although the parenteral nutrition is required for survival of most of preterm infants, there may be 
some complications related to this mode of feeding. Firstly, there may be disorders related to the 
intravenous administration and this may include both thromboembolism and sepsis [93, 160, 161, 177, 
188, 189] . Infection associated with catheters involves usually Candida, Staphylococcus aureus and 
coagulase-negative Staphylococci [93, 161]. Secondly, there may be an excess or deficit of 
administered nutrients. Preterm infants at discharge often have higher body fat composition than full-
term infants [185]. This is why the proportion of molecules in emulsions is so important. Next, growth 
impairment or metabolic bone disease may be caused by parenteral nutrition as a result of improper 
calcium and phosphorus levels and aluminium contamination [161]. As previously mentioned 
PNALD is one of the biggest complications related to PN [160, 161, 177, 189] and it has a 100% 
mortality rate within the first year since the diagnosis if the transplantation is not available [160]. PN 
is only one of the risk factors for the development of PNALD. The other factors include young age, 
low birth weight, preterm birth, lack of EN, disruption of bile acids circulation, bile duct obstruction, 
nutrition excess or deficiency (especially taurine and choline) and sepsis [160, 177, 178]. Finally, 
there are reports suggesting that the origin of sepsis may not be the catheter but the gut microbiota 
that overgrows as a result of affected biliary flow and motility of gut [93, 160]. 
1.3.vi.c Total parenteral nutrition 
Total parenteral nutrition (TPN) indicates that no oral food supplementation is given [185]. This form 
of diet is usually administered to very sick, very small or very preterm infants [185]. Oral 
consumption of food stimulates the secretion of gastrointestinal hormones like gastrin, peptide YY 
and cholecystokinin [177]. Lack of those enzymes may lead to reduced secretion of bile acids, 
intestinal stasis and consequently sepsis [177]. Prolonged administration of TPN to a number of 
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species (rats, pigs, humans) was found to increase body fat percentage [168, 185, 188, 190]. A study 
performed in rats found that animals on total parental nutrition for 21 days had altered organ weights 
when compared to their baseline characteristics. In particular they had lighter guts, and heavier 
kidneys, heart and lungs [188]. Additionally, TPN resulted in lower levels of haematocrit, 
haemoglobin and glucose [188]. A study in pigs found that administration of TPN results in insulin 
resistance and glucose intolerance [168]. It is believed that lack of EN plays a major role in the 
development of PN related complications [178]. 
1.4 Conclusions 
Preterm babies differ in early life care practices from the full-term ones, it is therefore possible that 
the gut microbiota development will occur differently for full-term babies and preterm ones. The 
development and changes of the pattern of gut microbiota colonisation in premature babies had not 
been properly investigated and there is a large gap in the literature regarding the impact of early life 
interventions on the gut microbiota. This PhD has investigated how postnatal age, gestational age, 
mode of delivery, route of nutrition, type of milk, and sex of the baby is linked to gut microbial and 
metabolic profiles in preterm babies. 
 
 
 
 
 
 
 
 
 
Development of gut microbiota and metabolic changes in preterm babies 
PhD Thesis                                                    Natalia Przysiezna  45 
 
Chapter 2 – Materials and Methods 
2.1 Study design 
2.1.i NEON study 
The NEON study stands for amino acid regimen and intravenous lipid composition in preterm 
parenteral nutrition: a randomised controlled trial of Nutritional Evaluation and Optimisation in 
Neonates. The NEON study was a randomised 2x2 factorial double blinded controlled trial which was 
funded by MRC/NIHR EME programme. The inclusion criteria for the NEON study were the 
prematurity (<31 weeks of gestation) and need of nutritional support in form of the PN and the 
exclusion criteria were life threatening anomalies. Infants were randomised within 12 h of life and 
assigned to one of 4 feeding mode groups. Factors variable in feeding mode are: concentration of 
amino acids (immediate recommended daily intake concentration vs. incremental concentration 
leading toward recommended daily intake) and lipid content (20% Intralipid vs. 20% SMOFlipid). 
The structure of the NEON study randomisation is presented in the Figure 5. 
Additionally, infants differ in mode of delivery (vaginal delivery vs. elected caesarean section vs. 
emergency caesarean section) and antibiotic exposure. Full daily health record data were collected on 
the enrolled infants and this data is available for interrogation in the final analysis. This data included: 
gestation age, sex, mode of delivery (vaginal, Caesarean section), route of nutrition (parenteral, 
enteral), type of milk (formula, breast milk). Stool and urine samples were collected on weekly basis. 
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Figure 5: Study flowchart representing the four randomised groups. 
 
The main aim of the NEON study is to demonstrate efficacy and confirm safety of introduction of 
SMOF lipid and immediate recommended daily intake concentration of amino acids to decrease non-
adipose body mass deficit. Additionally the NEON study provides the opportunity to look at the effect 
of the three factors of interest (mode of delivery, parenteral feeding and type of milk) on development 
of gut microbiota in preterm infant’s gut.  
2.1.ii Sample collection 
Stool and urine samples were collected on weekly basis since birth till discharge.  
2.1.iii Sample analysis strategy 
The analysis strategy of the biofluids obtained from the NEON study is presented in the Figure 6. The 
metabolic profiles of both stool and urine were designed to be obtained by the 
1
H Nuclear Magnetic 
Resonance spectroscopy. The metataxonomic analyses were designed to be performed by a 
combination of bacterial identification by 16S rRNA gene sequencing.  
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Figure 6: Flowchart presenting the sample analysis strategy 
2.2 Metabonomics 
Metabolomics is a branch of science that focuses on analysing the metabolic profile of biological 
samples. There are several techniques that can be used with the two most popular ones being Nuclear 
Magnetic Resonance (NMR) spectroscopy and Mass Spectrometry (MS). For the purposes of this 
study NMR was selected as the method of choice as it allows the global profiling, while MS is much 
more useful for the targeted analysis [191, 192]. 
2.2.i NMR spectroscopy  
Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful tool used for the identification of 
molecules and quantifying their relative concentration in the sample [193]. This method is especially 
good for untargeted global profiling of the samples as it is highly reproducible and does not destroy 
the sample [191, 192]. The high reproducibility of the NMR means that the comparison between the 
results obtained on different machines is reliable.  
2.2.i.a Theory 
Nuclear Magnetic Resonance spectroscopy is based on the principle that a nucleus has a magnetic 
momentum and an angular momentum (also known as spin) [194]. Many nuclei (those with an odd 
number of protons + neutrons) have a non-zero spin, which results in them creating a small magnetic 
field while spinning. When a magnetic field is applied, nuclei behave just like bar magnets in a 
magnetic field and they align themselves with or against the field, with a small energy difference 
existing between the several possible orientations (proton has two possible orientations) [192, 193]. In 
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order to excite nuclei in an external magnetic field, a 90º radio frequency pulse is applied. After the 
radio frequency is switched off, the nuclei relax and return to their preferred position in the applied 
magnetic field (Figure 7). This leads to a release of energy, which can be detected [191-194]. The 
exact resonance frequency produced when the nucleus returns to its natural position depends on the 
chemical and electromagnetic environment.  For example, other nuclei and their electrons can shield 
nucleus from the effects of the magnetic field [191, 192]. These local differences in energy can be 
used to identify different chemical structures within a molecule. Typically the resonance frequency 
for each nucleus is transformed into parts per million (ppm) unit, with the use of the reference 
molecule – such as TSP (trimethylsilyl propionate) which is set at 0ppm [191, 192]. The NMR signals 
can provide further knowledge about the chemical structure and the absolute concentration of the 
molecule. The absolute concentration can be calculated from the area under the peak. When 
comparing the area to the control electromagnetic signal introduced in the run, it is possible to 
estimate the number of protons in the particular fragment of the molecule. If the chemical structure is 
known, then the total number of protons calculated from the area under the peaks belonging to the 
molecule is divided by the number of protons (
+
H) in the chemical structure of the molecule. The 
structure is analysed based on the peak shape. Nuclei which are close to each other interact with what 
is called J-coupling. In the NMR spectroscopy, this interaction leads to J-splitting of the signal 
resulting in multiplet peaks. Apart from the shape of the peaks, an important information in the 
metabolite identification is the previously mentioned chemical shift given in parts per million (ppm). 
Each chemical compound has its own unique NMR fingerprint. For a detailed explanation of NMR 
properties refer to “Basic One- and Two-Dimensional NMR Spectroscopy” by Friebolin H. [191, 192, 
194-197]. 
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Figure 7: Principles of NMR. The segment A shows how the nuclei align themselves when the external magnetic field 
is applied. The segment B shows how the radio frequency ‘pushes’ the magnetic field of the nuclei. 
 
In case of the biological samples the nuclei usually analysed are 
1
H (protons) and 
13
C as they are most 
common atoms in the organic molecules. However, occasionally other atoms are analysed – 15N, 19F, 
23
Na and 
31
P [191-193]. 
2.2.i.b One-dimensional NMR spectroscopy 
The one dimensional (1D) 
1
H-NMR spectra were acquired on a Bruker DRX-600 spectrometer 
(Bruker Biospin, Karlsruhe, Germany) using the water presaturation pulse sequence [relaxation delay-
90°-t1-90°-tm-90°-acquire free induction decay (FID)]. The relaxation delay was 2 seconds; with 90° 
relating to the 90° radio frequency pulse applied, t1, referring to the interpulse delay, which was set to 
3µs, while tm is the mixing time of 100ms. The probe was operating at 600.29 MHz at a temperature 
of 300 K and was matched and tuned automatically to the proton transmitter resonance frequency at 
the beginning of the run. The water signal has reduced its intensity by the presaturation technique. 
This is done with the use of long low power radio frequency pulse in order to selectively saturate the 
frequency at which the water is found during the relaxation delay. This is also referred to as the O1 
parameter. Sixty-four scans were collected for each sample, composing of 64 thousand data points, 
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giving a total spectral width over 20 ppm (parts per million). The acquisition time was 2.73s. The 
signal to noise ratio was improved by applying an exponential weight function corresponding to a line 
broadening of 0.3Hz to each FID (free induction delay) prior to Fourier transformation. The 
parameters used for the standard pulse sequence of the faecal water sample were: P1=11.47µs, 
Pl1=12.50-dBW, Pl9=46.96dB and O1=2830Hz. For urine these were: P1=10.54µs, Pl1=11.10-dBW, 
Pl9=48.44dB and O1=2820.74Hz. 
2.2.i.c Two-dimensional NMR spectroscopy 
Two-dimensional NMR spectroscopy can help with identification of compounds in more complex 
samples [194, 195, 198]. The J-resolved (JRES) spectroscopy unravels the hidden peaks and releases 
information on peak structure for split peaks (e.g.: allows identification of whether a split peak is a 
doublet or two singlets) [195, 196]. Another type of two-dimensional pulse sequence is correlation 
spectroscopy (COSY), which gives information about the correlation/coupling of the neighbouring 
nuclei [197, 198]. TOSCY is total correlation spectroscopy and it shows couplings between the nuclei 
from the same molecule but which are further apart, typically up to 6 bonds distance [194, 199]. 
HSQC also known as heteronuclear single-quantum correlation spectroscopy, as the name suggests, 
shows the correlations between two neighbouring heterogenous atoms (e.g. 
1
H and 
13
C). In order to 
analyse the heterogenous atoms which are further apart there is a heteronuclear multiple-bond 
correlation spectroscopy (HMBC) [194, 197, 199].  
2.2.ii Sample preparation for NMR analysis 
The majority of samples were collected prior to the PhD as part of the NEON study and sample 
collection finished in the 19
th
 month of the PhD. Samples were frozen straight after collection at -20ºC 
and transferred within few days to a -80ºC freezer. In order to avoid introducing batch effects in 
spectroscopic acquisition, samples were randomized by randomly assigning a number from 1 to ‘n’ 
where ‘n’ was the number of obtained containers with samples. This labeling was performed on dry 
ice to avoid any freeze-drying cycles. 
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2.2.ii.a Urine 
Out of 1117 urine samples collected for the NEON study, 33 containers were empty or had volume of 
less than the required 540µl. The total working set therefore included 1086 samples, which were 
randomised and aliquoted for NMR analysis. An aliquot of 540µl of urine sample was mixed with 
60µl of Phosphate buffer (containing 0.01% sodium 3-(trimethylsilyl)propionate-2,2,3,3-d4 – used as 
a chemical shift reference) and transferred to a 5mm (outer diameter) NMR tube. After sealing the 
tubes with caps, they were inverted several times in order to mix the sample with buffer. Samples 
were left for few hours in 4ºC to equilibrate. A quality control sample was prepared from pooled urine 
samples. 
High concentration of antibiotics and other drugs, skewed baseline and line broadening across the 
spectrum were found in 44 samples, which were subsequently excluded from the analysis, leaving. 
1042 NEON urine samples and 110 quality controls (QCs). Mislabelling or a mismatch of available 
metadata led to exclusion of 129 samples and the remaining 913 samples were modelled using 
multivariate and univariate statisticall analysis. 
2.2.ii.b Stool 
Faecal water was extracted following the protocol explained in the Method Development chapter. 
Briefly: 100mg of stool sample was mixed with 250µl of solvent (25% Acetonitrile in UPLC grade 
water) and homogenised by bead beating (1mm zirconium beads for 10 seconds). After centrifugation 
at >16,000×g for 20 min, 540µl of faecal water were transferred to a glass vial which was left for an 
hour for evaporation of solvent. The dehydrated powder was resuspended in 540 µl of D2O used as a 
field frequency lock for the spectrometer) and mixed with 60µl of Phosphate buffer (containing 0.01% 
sodium 3-(trimethylsilyl)propionate-2,2,3,3-d4 – used as a chemical shift reference) and transferred to 
a 5mm (outer diameter) NMR tube. Tubes were closed with caps and inverted several times in order 
to mix the sample with buffer. Samples were left for few hours in 4ºC to equilibrate. 
Although 1187 stool samples were collected for the NEON study, 31 of the containers were empty. 
Sixty-nine duplicates were created to check the repeatability of the extraction method. A quality 
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control sample was prepared from pooled faecal water samples that were extracted from a random 
subset of leftover NEON stools. The working set of NEON stool samples equaled 1225. Sixty samples 
did not produce enough faecal water due to high concentration of lipids (which accounted for up to 
90% of mass of the sample). Additionally 141 samples did not meet the criteria for shim and had to be 
removed from the modeling which left a total of 1024 samples for modeling. 
2.2.iii Pre-processing of 1H-NMR spectra 
The spectra were pre-processed in the TopSpin 2.1 software where the baseline was corrected and the 
TSP peak was calibrated to 0.00ppm. Further pre-processing continued in the Matlab software with 
the use of in house created scripts. Spectra were aligned, normalised (probabilistic normalisation), 
scaled (uni-variance) and modelled using the quality controls (pooled sample of all samples in any 
given study). Due to the dynamic range of the molecules visualised within a typical biofluid spectrum, 
scaling to unit variance was used to allow the lower concentration metabolites to receive equal 
weighting to the high concentration metabolites such as creatinine, which would otherwise dominate 
the analysis without necessarily being biologically relevant. 
2.2.iv Multivariate statistical analysis 
Multivariate statistical analysis is a method of choice for the analysis of datasets rich in information, 
such as metabolic profiles, particularly where there are more variables than samples. This statistical 
approach helps to extract the latent variables and reduce the dimensionality of the dataset and 
facilitates the detection of which regions of spectra are discriminant, thus are significantly differ 
between the two analysed groups [200]. There are two broad approaches to multivariate statistical 
analysis: unsupervised and supervised. It is advisable to create both of the models as each of them 
carries different information which when combined gives a larger image of the metabolic changes 
between the analysed groups [200].  
2.2.iv.a Unsupervised multivariate statistical analysis 
Principal Component Analysis (PCA) is the unsupervised model used in this thesis for multivariate 
statistical analysis. The model has no knowledge regarding the classification of samples and performs 
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distribution of the samples only based on the NMR spectra and hence chemical similarities / 
dissimilarities between samples [200, 201]. Principal components are a set of values which were 
created by orthogonally transforming the observations of possibly correlated variables [200, 201]. 
There can be as many PCs as there are variables in the dataset but they contain progressively less 
information such that the last PC in a model will contain only noise and no useful information. Thus 
PCA is a dimension reduction technique that can show the information in the form of scores and 
loadings. Scores show the separation of samples based on their variability, while loadings indicates 
which characteristics causes the variability. Additionally, the model informs about the natural 
variation of the sample set by providing the R
2
 for each PC (in a form of percentage of variation 
explained by this feature) [200, 201]. If PC1 has low R
2
 this means that the samples present a very 
complex variation, a situation, which is very common in the human metabolic analysis. In this thesis, 
PCA models had been created in Matlab software using in house scripts.  
2.2.iv.b Supervised multivariate statistical analysis 
After performing the unsupervised analysis (the PCA models) the next natural step is to compare two 
or more groups of interest using a supervised modelling technique where information as to the class of 
each sample is used to maximize the distance between two or more classes in the data [200, 201]. 
Orthogonal Partial Least Squares Analysis (O-PLS) compares two (or more) groups of samples 
according to their class and reports any differences in the loadings plot. The regions of spectra are 
coloured according to the discriminance. The O-PLS model provides very important information in 
the form of R
2
Y and Q
2
Y. Quoting Triba et al. “R2Y measures the goodness of fit while Q2Y 
measures the predictive ability of the model.” [202]. This means that if the R2Y equals 1 it would 
indicate that model perfectly describes the data and if the Q
2
Y equals 1 then it means the model is 
100% predictive [200-202]. In order to test the robustness of the model, permutation analyses were 
performed. The model was repeated automatically 100 times against random permutations and the 
number of times the Q
2
Y value for the permutations analysis was larger than the Q
2
Y value for the 
true unpermutated model was considered the p-value. In order for the model to be considered robust 
the p-value had to be ≥ 0.05 which corresponds to 5%. 
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2.2.v Metabolite identification 
There are two main methods to identify metabolites. First method is the visual inspection of the 
spectra and referencing them to any 2D datasets. Statistical methods can also be used to identify 
correlated information in the NMR spectra and hence to extract structural information. After 
identifying a discriminant region of the spectrum, a Matlab script called STORM was used to search 
for the correlation between the chosen region of the spectrum and the correlated parts. Because NMR 
is quantitative all the protons within a molecule should covary. STORM (subset optimization by 
reference matching) identifies which peaks are increasing in concentration with the peak of interest 
(Figure 8) [203]. Obtaining such information can provide the NMR fingerprint of a discriminant 
molecule. Metabolic databases are then searched to find a matching compound. However, it is not 
always possible to identify the molecule from the database. In case of uncertainty, the standards (pure 
solutions of a compound) are spiked into a sample to see how the metabolic profile changes. 
Additionally, the quality control samples had been given for the MS analysis in order to identify as 
many low concentration molecules as possible and try to match the findings from MS with the 
unknown metabolites.  
 
Figure 8: The result of the STORM analysis of the unknown peak of the chemical shift of 2.04ppm. The colour of the 
peaks indicates the level of correlation while the direction if the correlation is positive or negative. The above 
spectrum shows the 1H NMR fingerprint of lactose. 
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2.3 Gut microbiota profiling 
2.3.i Theory 
Due to the fact that 99% of the known bacterial species are uncultivable it was necessary to find a new 
culture-independent technique to identify microbial profiles [204-209]. The potential biomarker used 
for the identification must have been present in all the bacteria yet present variability between the 
species [210]. The molecule perfect for the task seemed to be 16S rRNA gene.  
2.3.i.a What is 16S rRNA 
The 16S rRNA gene is a DNA molecule that codes the 16S rRNA, which is a part of small subunit 
(30S) of the prokaryotic ribosome [210, 211] (Figure 9). It is a molecule homologous to the 
eukaryotic 18S rRNA. Due to the invention of the polymerase chain reaction (PCR) and sequencing, it 
was possible to multiply and the sequence the 16S rRNA genes. The structure of the 16S rRNA is 
extremely useful as the conserved regions (identical among all the bacteria) are mixed with the 
variable regions carrying species-specific mutations (Figure 10). 
 
 
Figure 9: The simplified structure of the prokaryotic (70S) ribosome 
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Work done on the analysis of the mutations among the variable regions of the 16S rRNA gene led to 
the creation of the first phylogenetic tree [211]. This was later spread on other kingdoms like Archea 
and Eukaryota as analysis of the eukaryotic analogue of the 16S rRNA gene – the 18S rRNA gene, 
allowed the evolutionary assessment of the living organism [211]. The usage of the 16S rRNA gene in 
the microbial identification had found its application not only in the evolutionary research but also in 
environmental and clinical microbiology [210, 211]. 
 
Figure 10: The simplified structure of the 16S rRNA gene with conserved regions dark shaded, and the variable 
regions light shaded 
 
2.3.i.b Comparison of the analytical techniques 
The discovery of the 16S rRNA gene created a shift in the microbial diagnostics from culture-based to 
culture-independent [210]. There are many techniques available, including: terminal restriction 
enzyme fragment polymorphism (T-RFLP), degradation gradient gel electrophoresis (DGGE), 
temporal temperature gradient gel electrophoresis (TGGE), Sagner’s sequencing, pyrosequencing 
(a.k.a. 454 Roche sequencing platform), and MiSeq (Illumina platform). The detailed comparison of 
those techniques is given in the Table 3.  
2.3.ii DNA extraction from stool samples 
The stool samples had been chosen for the DNA extraction provided that there had been available: 
1. NMR spectrum for the same sample  
2. NMR spectrum for the matching urine sample (collected on the same day) 
3. At least two more samples (meeting the above criteria) for the same baby 
4. At least one sample (meeting the above criteria) for the same baby that was collected within 
the first 10 days of life 
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The DNA was extracted from the remaining stool pellets (after the extraction and removal of the 
faecal water) using the PowerSoil DNA extraction kit (MoBio Laboratories) according to standard 
protocol [212].  
2.3.iii Quantitative Polymerase Chain Reaction (qPCR) analysis 
The qPCR was performed to obtain the total bacterial count. Universal set of primers for the variable 
region V3 was chosen (515F, 806R). The primers and PCR grade water were purchased from MoBio 
Laboratories, while Maxima SYBR Green/ROX qPCR Master Mix was bought from Life 
Technologies. The reagent recipe for the master mix is given in the Table 2. 
 
Table 2: The complete reagent recipe (master mix) for 1X PCR reaction 
PCR Grade H2O 10.5 µL 
Forward primer (10µM) 0.5 µL 
Reverse primer (10µM) 0.5 µL 
Template DNA 1 µL 
Maxima SYBR green master mix 12.5 µL 
Total 25 µL 
 
The qPCR was performed in the 96 well plate thermocycler. The conditions were as follow: 
1. 94°C 3 minutes 
2. 94°C 45 seconds 
3. 50°C 60 seconds 
4. 72°C 90 seconds 
Steps 2-4 repeated 35 times 
5. 72°C 10 minutes 
6. 4°C infinity 
The calibration curve was done using five 10 fold dilutions of E. coli DNA at a concentration of 
500µg/mL in triplicates. Additionally, each run had a positive and a negative control.  
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Table 3: Comparison of the analytical tool for the bacterial identification 
Analytical 
method 
Culturing 
Sequence-specific separation tools Sequencing 
T-RFLP DGGE/TGGE Sanger’s sequencing Pyrosequencing MiSeq sequencing 
Mechanism 
Plating samples on 
various selective 
media, microscopic 
observations and 
biochemical tests 
PCR products are digested with 
restriction enzymes to produce 
labelled terminal restriction enzyme 
fragments (TRFs). T-RFs are 
denatured, and the obtained single 
stranded DNA is separated by 
electrophoresis under denaturing 
conditions.  
Molecules are separated in either: 
a) the gradient of the denaturant 
gel 
b) in constant concentration of 
denaturant in gel and in 
increasing temperature over the 
time 
Single-stranded DNA is placed 
in a mixture. Fluorescently-
labelled nucleotides are added 
(one by one), if they are 
incorporated into the daughter 
DNA strand – the fluorescence 
occurs. 
Single-stranded DNA is attached to 
beads and then added to the matrix 
(each bead goes into a hole in the 
plate). Nucleotides are added 
separately and if they get 
incorporated into the daughter DNA 
strand – the luminescence occurs. 
Single-stranded DNA molecule is 
attached to the matrix and amplified 
which results in a cluster of DNA 
molecules. Fluorescently-labelled 
nucleotides are added (one by one), if 
they are incorporated into the daughter 
DNA strand – the fluorescence occurs. 
Identification 
made upon 
Bacterial colonies 16S rRNA gene 16S rRNA gene 
Result Colonies Bands on gel electrophoresis = fingerprint DNA sequence 
Strengths 
 Cheap 
 Easy 
 Little preparation 
 
 Quick 
 Can be automated 
 Sensitive (LLD = 1%) 
 Labelling with a different 
fluorochrome, allows accurate 
sizing of the fragments to within ± 
1 nucleotide. 
 Cheap 
 Sensitive even to single 
mutation 
 64 samples per run 
 Run lasts 16h 
 Chemical denaturing gradient 
not needed 
 The most sensitive 
 Sequences can be classified according to taxonomy and function 
 Results from different studies can be compared 
 First ever sequencing 
technique 
 Up to 800bp 
 Cheaper than regular sequencing 
 Up to 700bp 
 Analysis time 10h 
 No clone libraries required 
 Cheaper than pyrosequencing 
 Up to 600bp 
 Analysis time – 4-16h per sample 
Weaknesses 
 50-90% of gut 
microbiota are not 
cultivable 
 Growing bacteria 
takes days 
 Microbes of different species often 
share one T-RF 
 Digestion with up to three different 
restriction enzymes is usually 
necessary  
 Difficulties with gradient 
creation 
 Specially synthesized GC 
clamped primers needed 
 
 Expensive 
 One DNA strand at a time 
 Requires clone libraries – 
risk for bias 
 More expansive than separation 
methods 
 Requires DNA libraries 
 Need of using barcode reading to 
avoid multiplex results (specific 
primers or labelling the correct 
sentence) 
 Need of using barcode reading to avoid 
multiplex results (specific primers or 
labelling the correct sentence) 
References [213-218] [219-224] [204-207, 221, 225-230] [208, 221, 231-237] 
[208, 209, 215, 221, 225, 232, 
233, 235, 238-244] 
[213, 221, 235, 238, 241, 243-253] 
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2.3.iv Pre-processing of the sequenced data 
The sequencing was performed using the MiSeq (Illumina) platform by the Research and Testing 
Laboratory (USA) [245, 249]. Since the results from the sequencing were provided as two reads per 
each sequence (two halves with an overlapping region), they had to be combined into one structure. In 
order to do so, a program Mothur was used and a standard script was followed [254]. The cut-off of 
2000 reads was used when processing the samples, which means that all the samples that had less than 
2000 reads had been removed. Keeping those samples in would lead to big complications later on 
when the Mothur calculates the number of OTUs (operational taxonomic units a.k.a. bacterial species) 
as this is done by keeping only the OTUs which are in the 25
th
 or above percentile. Keeping large 
numbers of samples with low number of sequences would reduce the percentile for all the OTUs and 
thus reduce how detailed the outcome could be [245, 249, 254]. In order to match the species from the 
company’s database with the 16S rRNA gene sequences a command that calculates the uncorrected 
pairwise distances between the aligned DNA sequences was used, followed by the Bayesian classifier. 
The outcome files from the Mothur program were merged to create one final matrix of taxonomic 
information and number of reads in each sample. 
2.3.v Analysing the microbial profiles 
After obtaining the files from the Mothur and preparing the metadata file, the analysis of the microbial 
profiles was done using the STAMP software [255]. In order to avoid obtaining false results, a plan 
for statistical analysis had been prepared in advance (Figure 11). Since the data was not normally 
distributed the non-parametric tests were used. For comparison of two groups the two-sided (two-
tailed) White’s non-parametric t-test was used as this was the available non-parametric test [256]. 
There were two parametric tests available as T-test was designed for situation when both groups had 
similar variation (or standard deviation (SD) squared) while Welch’s t-test was for analysis when the 
variations of groups were not similar [257]. Due to the fact that the dataset contains information about 
all the identified bacteria, the statistical tests in fact perform the multiple tests comparing all the 
bacteria types. In order to avoid the random false positive results, the Benjamini-Hochberg correction 
was applied [258].  
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Figure 11: Flowchart presenting the statistical analysis options. The approach used for our analysis is presented in 
the thick-outlined boxes 
 
For the analysis of > 2 groups the available non-parametric test was Kruskal-Wallis H-test [259]. Due 
to the fact that the Post-hoc analysis can produce type 1 error and give false positive results it was 
decided not to look at the Post-hoc results. Instead the statistical approach presented in the Figure 12 
was followed. 
 
Figure 12: Flowchart presenting the statistical approach when working with comparing > 2 groups 
 
When significant differences were found between the 3 groups it was investigated further which 
groups were significantly different from each other and this was pre planned to compare with the gold 
standard. For route of nutrition it was exclusive enteral nutrition (EN) and for type of milk it was 
exclusive breast milk (BM). The statistical approach to analyse the multiple groups that represent the 
continuous variable (like postnatal age or gestational age) is to do test for trend. Unfortunately this 
software did not offer such option therefore the best available option was chosen – description of any 
potential patterns of changes. The richness of gut microbiota had been calculated using the Chao 
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index while the diversity was calculated with the Shannon’s index with the highest values 
corresponding to the highest richness/diversity [260].  
2.4 Regression of metabolites against gut microbiota  
In order to investigate the metabolic activity of gut microbiota, the taxa of interest were be regressed 
against the NMR spectra. Two approaches were taken. The first was the O-PLS regression of NMR 
spectra according to ‘classes’ which in fact will be the presence or lack of particular group of bacteria.  
The second type of analysis was done using an algorithm in the R platform created by my colleague 
Daniel Homola. Features were selected using the Boruta feature selection method. Then spearman 
rank correlation and Benjamini-Hochberg correction for multiple testing were applied. The results 
were shown as heat maps of the regions of NMR spectrum (in ppm) and bacteria. 
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Chapter 3 - Method development 
3.1 Introduction 
Faecal water extraction protocols have been optimised for extraction from adult stool samples or full-
term newborn’s stools [261-264]. The preterm stool has a different composition than the one from 
full-term infant therefore the extraction method requires further development. Apart from the fact that 
the gut of preterm infants is not fully developed, these infants often receive parenteral nutrition 
instead of oral which can lead to lower bacterial yield in the intestine. Additionally, newborn stool 
often has higher levels of lipids than adult stool which results in accumulation of a lipid layer above 
the faecal water during the extraction protocol. A new protocol was developed to work with preterm 
infant’s stool samples.  
Other important consideration for method development is that preterm stool samples usually have 
small volume, which means that it is not possible to perform faecal water extraction and bacterial 
DNA extraction separately. Thus the new protocol was prepared in a manner that allowed using the 
same sample fraction for both NMR/MS analysis of faecal water and DNA extraction from stool 
microbiota. Each stage of faecal water extraction was tested for its influence on gut microbial DNA 
yield. 
3.2 Faecal water extraction 
In order to develop a method for faecal water extraction a number of factors had to be validated. This 
included: 1) solvent, 2) mass of the stool sample, 3) type of homogenisation, 4) solvent evaporation 
and 5) filtration. The final step is the lipid layer preparation for lipidomics. 
3.2.i Solvents 
A number of solvents were proposed for extraction of faecal water for NMR analysis. This included 
deionised water 18MΩ (dH2O), 0.01M phosphate buffered saline (PBS), heavy water (D2O) and 
phosphate buffer (2.84% w/v Na2HPO4, 0.48% w/v NaH2PO4, 0.02% w/v NaN3, 0.017% w/v TSP (3-
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(trimethyl-silyl)propionic acid-d4), in D2O). The first two solvents are commonly used for faecal 
water extraction while the latter two are commonly used for samples analysed by nuclear magnetic 
resonance (NMR) spectroscopy. Water was deionised (18MΩ) while D2O, tablets for PBS preparation 
and all substrates for phosphate buffer preparation were sourced from Sigma.  
A series of experiments comparing the previously mentioned solvents was performed. All of the 
solvents were not compared in the same experiment but in a series of experiments thus the results for 
each comparison will be presented separately with a final conclusion.  
Stool sample ranging from 200mg to 500mg (depending on experiment) were mixed with twice the 
volume (ratio 1g of stool : 2ml of solvent) of either dH2O (18MΩ), PBS (0.01M), D2O or phosphate 
buffer (2.84% w/v Na2HPO4, 0.48% w/v NaH2PO4, 0.02% w/v NaN3, 0.017% w/v TSP, in D2O). 
Samples were homogenised either by vortexing for 2 min or by bead beating twice for 5 sec on 
Precellys 24-duo bead beater. Then samples were centrifuged for 20 min at >13,000×g. Supernatant 
was transferred to new microcentifuge tube, topped up with D2O or phosphate buffer (depending on 
solvent) to a total volume of 550µl.  
Standard one-dimensional 
1
H NMR spectra were acquired on Bruker DRX 600 MHz spectrometer 
(Rheinstetten, Germany) with a 5mm TXI probe operating at 600.13 MHz. A relaxation delay-90°-t1-
90°-tm-90°-acquire free induction decay (FID) sequence was used to obtain 1-dimensional NMR 
spectra. The 90° pulse length varied from 9.75 μs to 11.25 μs depending on sample type and 
condition. The total number of scans varied from 64 to 128 was saved as 32k data points with a 
spectral width of 20 ppm. The same settings (apart from the pulse length and the number of scans) 
were used for all other NMR analysis.  
The first experiment comparing extraction of stool of full-term newborn found no significant 
difference between the PBS and D2O solvents. Figure 13 shows that none of the peaks corresponding 
to recovered metabolites was lost and the general ratio of peaks was unaltered (with small differences 
for few peaks). An interesting observation was that when extracted in PBS, the lipid layer was much 
smaller and the faecal water was less clear than when extracted in D2O.  
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Figure 13: Comparison of CPMG one-dimensional 1H NMR spectra of faecal water extracted in D2O or PBS 
 
 
The second experiment compared extraction of faecal water from fresh adult stool sample with D2O, 
PBS or phosphate buffer. Results show that PBS was more effective in metabolite retrieval than D2O 
(Figure 14). What is more, samples extracted in phosphate buffer were more difficult to shim than 
samples extracted in the other solvents indicating that there was a chemical interaction that occurred 
in phosphate buffer. Although the number of peaks or metabolites retrieved from each solvent was 
comparable, the ratio of peaks varied according to solvent.  
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Figure 14: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted in D2O, PBS or 
phosphate buffer. Spectra expanded from 0.5 ppm to 2.3 ppm 
 
 
 
Figure 15: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted in D2O and H2O. 
Spectra are scaled to TSP and region from 0.0 ppm to 4.0 ppm is expanded 
 
 
The final experiment comparing solvents for faecal water extraction was performed on a stool sample 
of a one year-old infant. Comparison was made between dH2O and D2O. Results presented in Figure 
15 show that the biggest difference was the shimming quality. Due to better shimming two peaks 
2.41ppm (succinate) and 1.92 ppm (acetate) were higher when extracted in D2O.  
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Succinate 
D2O 
PBS 
Phosphate buffer 
Acetate 
Propionate 
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Due to the fact, that bile acid profiling by mass spectrometry (MS) was proposed as a part of this 
study, a new extraction method that would improve bile acid retrieval had to be created. It was 
proposed to use 25% acetonitrile solution in dH2O (18MΩ) to extract faecal water. The faecal water 
was planned to be separated into two fractions of which one would be used for MS and the other one 
for NMR. The fraction for NMR would be speed vacuumed and the pellet would be resuspended in 
phosphate buffer. It was decided to check how extraction in 25% acetonitrile would affect NMR 
spectra. Extraction in dH2O (18MΩ) was used as a control. 
Three stool samples were divided into four fractions each. Two fractions were extracted in 25% 
acetonitrile while the other two in dH2O (18MΩ). Samples were bead beaten with 1mm zirconium 
beads and centrifuged for 20 min at 16,000×g. The faecal water was transferred to new 
microcentrifuge tube and samples were speed vacuumed for 3h at 45°C. The powder was resuspended 
in 400µl of D2O and 200µl of phosphate buffer was added. Samples were then vortexed for 1 min, 
sonicated for 5 min and vortexed again for 1 min. After that samples were centrifuged for 10 min at 
top speed at 4°C to precipitate any left proteins. Supernatant was transferred to NMR tubes and 
standard one-dimensional 
1
H NMR spectra were acquired on Bruker DRX 600 MHz spectrometer 
(Rheinstetten, Germany) with a 5mm TXI probe operating at 600.13 MHz. A relaxation delay-90°-t1-
90°-tm-90°-acquire free induction decay (FID) sequence was used to obtain 1-dimensional NMR 
spectra. The 90° pulse length varied from 15.00 μs to 20.00 μs depending on sample type. The total 
number of scans equalled 256 and was saved as 32k data points with a spectral width of 20 ppm. 
The results showed that there was no difference between extraction in 25% acetonitrile and in dH2O 
(18MΩ) (Figure 16).  This means that 25% acetonitrile in dH2O can be used to retrieve metabolites 
from stool for later NMR analysis (provided that acetonitrile will be evaporated and sample will be 
resuspended in phosphate buffer). 
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Figure 16: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted by two different 
modes of bead beating (presented in duplicates). Figure showing an expanded fragment from 0.8ppm to 1.8ppm. 
 
3.2.ii Stool sample mass 
When using a centrifuge of speed below 16,000×g the mass of stool sample 
used for faecal water extraction occurred to be an important issue. It was 
observed that in some samples there was ‘a wave effect’ (stool was shaped as 
wave) and often the top of the ‘wave’ collapsed into the sample trapping 
some fractions of faecal water (Figure 17) 
Figure 17: Shape of stool 
pellet after extracting 
faecal water from 500mg 
of faeces 
 
An experiment to compare optimal mass of stool was performed. Experiment was performed in 
duplicates and sample mass equalled 0.1g, 0.25g and 0.52g. The volume of added solvent was 200µl, 
500µl and 1ml respectively. Samples were vortexed for 2 min and centrifuged for 20 min at speed 
36,000×g. Supernatant was collected and samples were again centrifuged this time for 10 min. 
Supernatant was again collected and samples again centrifuged for 10 min. After that, samples were 
centrifuged again, this time for 5 min only. Table 4 presents results for this experiment. 
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Acetonitrile 
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Table 4: Results showing the influence of mass of stool sample and the shape of pellet and volume of retrieved faecal 
water when centrifuged at < 16,000×g 
Sample 
ID 
Mass 
used 
Volume 
of solvent 
Volume of obtained faecal water and shape of pellet 
After initial 
 20 min 
After next  
10 min 
After next  
10 min 
After next  
5 min 
Total 
(% of solvent) 
1 & 2 0.11g 200µl 
150µl 
 
50µl 
 
0µl 
 
– 
200µl 
(100%) 
3 & 4 0.25g 500µl 
300µl 
 
200µl 
 
20µl 
 
5µl 
 
525µl 
(104%) 
5 & 6 0.52g 1000µl 
800µl 
 
200µl 
 
50µl 
 
7µl 
 
1057µl 
(105%) 
 
It was obvious that more than 20 min of centrifuging is needed if using a centrifuge slower than 
16,000×g. Additionally, increasing the time of centrifugation leads to retrieval not only of 100% of 
used volume of solvent but also of additional water from the stool sample. 
The next experiment was set to analyse how many sets of centrifugation should be performed. Three 
fractions of the same stool were weighted (0.26g) and mixed by vortexing with 500µl of D2O. The 
first fraction was centrifuged once for 60 min, the second fraction – once for 40 min and the third 
fraction was centrifuged two times, each time for 20 min with supernatant being collected after each 
centrifugation. Table 5 presents results for this experiment. 
 
Table 5: Results showing the correlation of volume of retrieved faecal water and the time of centrifuging at the speed 
13,000×g 
Sample 
ID 
Mass used 
Volume of 
solvent  
Mode of 
centrifuging 
Volume of obtained 
faecal water  
Pellet shape 
1 0.26g 500µl 1 x 60 min 340µl 
 
2 0.26g 500µl 1 x 40 min 300µl 
 
3 0.25g 500µl 2 x 20 min 450µl 
 &  
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Conclusion from those two experiments was that if a centrifuge of speed below 16,000×g will be 
used, it is necessary to make sure stool sample is not heavier than 0.25g and that sample is centrifuged 
twice for 20 min. This will provide the highest retrieval of faecal water.  
Due to these observations centrifuge with speed above 16,000×g was obtained. This meant that time 
of centrifuging could be adjusted to 20 min. 
3.2.iii Type of homogenisation 
In order to extract the highest possible concentration of metabolites the most effective homogenisation 
method must be chosen. At the same time it was important to make sure that this step of faecal water 
extraction will not harm the bacterial cells as this would lead to a drop in bacterial DNA yield.  
Two types of homogenisation have been compared – bead beating and vortexing. Firstly, the 
experiment was performed on stool obtained from full-term infant. Stool was divided into four 
fractions each weighting 250mg (experiment was performed in duplicates). 500µl of solvent was 
added and samples were homogenised by either 1 min of vortexing at top speed or by bead beating 
twice for 5 sec with 5sec break between beats at lowest possible speed which equalled 5000 rpm 
(Precellys 24-duo bead beater). The size of beads was used based on chances of accidental rupture of 
bacterial cells. It was decided that 250mg of 1mm zirconium beads should not cause a significant 
change in bacterial DNA yield (this was later confirmed and is explained in section 2.1.ii.b). Samples 
were centrifuged for 20 min at 16,000×g and supernatant was transferred to NMR tube. 
CPMG and standard one-dimensional 
1
H NMR spectra were acquired on Bruker DRX 600 MHz 
spectrometer (Rheinstetten, Germany) with a 5mm TXI probe operating at 600.13 MHz. A relaxation 
delay-90°-t1-90°-tm-90°-acquire free induction decay (FID) sequence was used to obtain one-
dimensional NMR spectra. The 90° pulse length varied from 9.75 μs to 11.25 μs depending on sample 
type and condition. The total number equalled 64 and was saved as 32k data points with a spectral 
width of 20 ppm. The same settings (apart from the pulse length and the number of scans) were used 
for all other NMR analysis. The results presented in Figure 18 show that both methods present similar 
information recovery. There has been visible difference in intensity of peaks. 
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Figure 18: Comparison of CPMG one-dimensional 1H NMR spectra of faecal water extracted by bead beating and 
vortexing  
 
Due to the fact that bead beating is a high throughput technique it was selected for homogenisation. 
Another aspect of validation was to decide on time and speed of bead beating. The previously 
described bead beating was compared with the one from a different protocol (5500 rpm) bead beaten 
three times 40 sec with 5 sec breaks). Three preterm stool samples were divided into four fractions 
each (experiment run in duplicates). Approximately 100mg of stool was mixed with 200µl of H2O 
(0.02% NaN3 w/v) and 250mg of 1mm zirconium beads and bead beaten. Samples were centrifuged 
for 20 min at 16,000×g, frozen and then they followed different protocol. After defrosting, 500µl of 
H2O was added and samples were centrifuged for 20 min at 16,000×g. 400µl of supernatant was 
transferred to a new microcentrifuge tube with 200µl of phosphate buffer (2.84% w/v Na2HPO4, 
0.48% w/v NaH2PO4, 0.02% w/v NaN3, 0.017% w/v TSP, in D2O) and vortexed for 10 sec. 550µl 
were transferred to an NMR tube. The 90° pulse length varied from 12.00 μs to 13.25 μs depending 
on sample type and condition. The total number of scans equalled 128 and was saved as 32k data 
points with a spectral width of 20 ppm. 
There was no difference between the spectra of faecal water samples obtained by the different types 
of bead beating (Figure 19). The influence of bead beating on DNA yield is described in Method 
Development chapter section 3.1.i.b. The choice of homogenisation method was made based on time 
and the shorter bead beating mode was chosen. 
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Figure 19: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted by two different 
modes of bead beating (presented in duplicates). Segment A presents the whole spectra while segment B an expanded 
fragment from 2.1ppm to 2.9ppm. 
 
Due to the fact that new, higher throughput bead beater had been purchased by the lab, another 
experiment comparing two bead beaters was performed. Three stool samples were divided into four 
fractions each (experiment in duplicates). Stool was mixed with H2O containing 0.02% sodium azide 
(w/v) in a ratio of 1g to 2ml. 0.25g of 1mm zirconium beads were added to all fractions. Two 
fractions were bead beaten twice for 5 sec on Precellys 24 bead beater with speed of 5000 rpm while 
the other two fractions were set for 10 sec on Mini beadbeater with speed of 36 oscillations per 1 sec. 
5500-3x40-005 
5000-2x05-005 
5000-2x05-005 
5500-3x40-005 
Duplicat 1 
A 
5500-3x40-005 
5500-3x40-005 
5000-2x05-005 
5000-2x05-005 
 
 
B 
γ-amino-N-butyrate 
p-Hydroxyphenyllacate 
Tyramine 
Succinate 
Development of gut microbiota and metabolic changes in preterm babies 
 
PhD Thesis                                                    Natalia Przysiezna 72 
 
The supernatants of duplicates were pulled and phosphate buffer was added to final volume of 550µl. 
After vortexing the samples were transferred to NMR tubes and standard one-dimensional 
1
H NMR 
spectra were acquired on Bruker DRX 600 MHz spectrometer with a 5mm TXI probe operating at 
600.13 MHz. Due to the variable sample nature the value for the 90° pulse length which varied from 
12.00 μs to 30.00 μs depending on sample type and condition. The total number of scans equalled 256 
and was saved as 32k data points with a spectral width of 20 ppm. Only two stool samples were 
analysed by NMR as consistency of the third sample was emulsion like. Comparison of spectra 
(Figure 20) found no difference in information retrieval. This means that both beat beaters (Precellys 
24 and Mini beadbeater) can be used for faecal water extraction.  
 
Figure 20: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted by two different bead 
beaters (Precellys 24 and Mini beadbeater). Region from 0.8ppm to 4.0ppm was expanded. 
 
3.2.iv Solvent evaporation 
As previously mentioned, speed vacuuming step had to be incorporated into protocol in order to 
remove the acetonitrile and H2O from sample before analysing on NMR. In order to asses if the 
process of speed vacuuming does not result in a loss of metabolites, three stool samples were divided 
into two fractions which followed regular protocol of faecal water extraction in H2O. Then phosphate 
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buffer with TSP was added and standard one-dimensional, CPMG and diffusion edited spectra were 
obtained. Samples were then removed from the NMR tubes, transferred into microcentrifuge tubes, 
speed vacuumed for 3 hours and resuspended in either D2O with TSP or phosphate buffer. Samples 
were then run on NMR to obtain spectra. There are flaws in the experiment which include removing 
samples from NMR tubes and higher final concentration of TSP in sample. Spectra were scaled to 
alanine (1.48ppm). The results presented in Figure 21 show that speed vacuuming led to reduction of 
acetate (1.92ppm), fumarate (5.63ppm) and a doublet at 8.43ppm shift which probably is formamide.  
 
                                          
Figure 21: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted before and after 
speed vacuuming. Segment A presents the whole spectra of selected sample while segment B is an expanded fragment 
of all spectra showing region from 8.25ppm to 8.50ppm. 
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To check the batch effect of speed vacuuming another experiment was performed. One stool sample 
was divided into two fractions which were extracted in dH2O with use of bead beating. Faecal water 
for each fraction was then aliquoted (400µl) into two microcentrifuge tubes each. One set of the 
duplicates was speed vacuumed for 3h at 45°C while the other remained in the room temperature. All 
samples had sodium azide added during that time. After evaporation of dH2O samples were 
resuspended in 400µl of dH2O in order to maintain the same concentration of metabolites as in 
duplicates that were not speed vacuumed. After adding 200µl of phosphate buffer to every aliquot 
samples were vortexed and transferred into NMR tubes. Standard one-dimensional 
1
H NMR spectra 
were acquired on Bruker DRX 600 MHz spectrometer with a 5mm TXI probe operating at 600.13 
MHz. The 90° pulse length which varied from 15.00 μs to 20.00 μs depending on sample type and 
condition. The total number of scans equalled 256 and was saved as 32k data points with a spectral 
width of 20 ppm. 
The results show that singlet at chemical shift 1.25ppm was introduced during speed vacuuming 
(Figure 22). The identification of this peak was not successful, however there are reports of “common 
impurity” presented as a singlet at the same chemical shift. At the same time singlets at chemical 
shifts 3.36ppm (methanol) and 4.42ppm (dihydroxyacetone) disappeared (Figure 23).  
 
 
Figure 22: Comparison of standard one-dimensional 1H NMR spectra of faecal water extracted before and after 
speed vacuuming 
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Figure 23: Comparison of standard one-dimensional 1H NMR spectra presenting the influence of speed vacuuming of 
faecal water on the metabolic profile. Segment A presents fragment from 3.30ppm to 3.37ppm while segment B 
presents region from 4.41ppm to 4.48ppm. 
 
 
Because the faecal water will be obtained with use of 25% acetonitrile it is necessary to evaporate this 
solvent and resuspend in D2O prior to the NMR analysis. Speed vacuuming cannot be used for that 
purpose as it introduces the impurities. The other possibilities to remove the acetonitrile from faecal 
water are freeze-drying and Nitrogen flow. 
Three sets of faecal waters that were extracted in D2O or H2O were divided into four fractions. Two of 
the fractions from each set were freeze-dried and later resuspended in D2O while the other two 
fractions were used as a control. The results showed that freeze-drying did not introduce any 
impurities but at the same time caused decrease in the concentration of certain volatiles (Figure 24). 
The metabolites that were affected by freeze-drying included ethanol (triplet at 1.18ppm), acetate 
(singlet at 1.92ppm), citrate (doublets at 2.54ppm and 2.66ppm), methanol (singlet at 3.36ppm), α-
hydroxyhippurate (singlet at 5.56ppm) and the unidentified singlet at chemical shift 2.23ppm (marked 
with a small black arrow on Figure 24). 
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Figure 24: Comparison of standard one-dimensional 1H NMR spectra presenting the influence of freeze-drying of 
faecal water on the metabolic profile  
 
 
Unfortunately the available freeze-drier was operating only up to -50°C which meant that no samples 
containing acetonitrile could be used. The freezing point for acetonitrile is ~ -50°C which means that 
there was a risk that this solvent would escape the ice trap and damage the oil in the pump. In order to 
use freeze-drying as a method of acetonitrile removal, a new machine operating up to -100°C would 
have to be bought. Due to high costs of such machine, another potential method – the Nitrogen flow, 
was tested. The outline of the experiment to test the effect of Nitrogen flow on the quality of spectra 
was the same as for the previously described experiment testing the freeze-drying. The results 
showed, that similarly to the freeze-drying, the Nitrogen flow did not introduce any impurities but 
removed some of the volatile metabolites (Figure 25). The difference was observed for ethanol (triplet 
at 1.18ppm), a doublet at chemical shift 1.36 and a singlet at a chemical shift 2.23ppm. 
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Figure 25: Comparison of standard one-dimensional 1H NMR spectra presenting the influence of drying samples with 
Nitrogen flow on the metabolic profile  
 
Using the Nitrogen flow was very fast (<1h needed for 50µl) and did not require using water bath thus 
samples were kept at room temperature to avoid the degradation. Additionally in the Turbovap 
apparatus, up to 50 samples could be dried at the same time which made the method robust. The final 
decision was to use the Nitrogen flow (Turbovap) to remove the acetonitrile from the faecal water 
samples. In order to meet the Brukers criteria, samples were resuspended in 600µl D2O and 60µl of 
phosphorus buffer (1.5M KH2PO4, 2mM NaN3, 0.1% TSP (3-(trimethyl-silyl)propionic acid-d4) was 
added.  
3.2.v Filtration 
One of the proposed steps in protocol was to filter faecal water through Costar’s Spin-x centrifuge 
tube filters (Sigma CLS8160). At the very beginning of the method development filters were tested 
for their purity with use of both D2O (Sigma, USA, 151882) and 0.01M PBS (Sigma, P4417) which 
was prepared from tablets according to manufacturer’s instructions. 500µl of solvent (the experiment 
was done for both 0.01M PBS and D2O) was transferred to Costar’s Spin-x centrifuge tube filter and 
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to Eppendorf 2ml minicentrifuge tube. The Eppendorf tube was used as a blank for solvent’s contact 
with plastic. Both centrifuge tube filters and to Eppendorf minicentrifuge tubes were centrifuged at 
top speed for 10 min. Samples were transferred to NMR tubes and 50µl of D2O was added in order to 
obtain final volume of 550µl. The 90° pulse length varied from 10 μs to 10.5 μs depending on sample 
type and condition. The total number of scans equalled 512 was saved as 32k data points with a 
spectral width of 20 ppm. 
The results showed that both D2O and 0.01M PBS absorbed elements of column which led to 
presence of impurities in NMR spectra (Figure 26). What is more important is that metabolites 
removed from column included acetate which is an important bacterial metabolite and is one our main 
focus while analysing spectra. 
 
 
 
Figure 26: Standard one-dimensional 1H NMR spectra presenting the influence of filtration of solvent through Spin-x 
centrifuge tube filters. Segment A compares filtered and not filtered D2O while segment B compares filtered and not 
filtered PBS. 
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The experiment was later repeated for 25% acetonitrile solution. Costar’s Spin-x centrifuge tube filter 
(Sigma CLS8160) was washed four times with new fractions of solvent. All fractions were collected 
and unfiltered 25% acetonitrile solution was treated as a control. Samples had been evaporated and 
stored in -20°C. Metabolites were resuspended in 550µl D2O (Sigma, USA, 151882) with 0.017% 
TSP (Sigma). Samples were then vortexed for 1 min, sonicated for 5 min and again vortexed for 1 
min. After that samples were centrifuged for 10 min at top speed at 4°C to precipitate any left 
proteins. Supernatant was transferred to NMR tubes and standard one-dimensional 
1
H NMR spectra 
were acquired on Bruker DRX 400 MHz spectrometer (Rheinstetten, Germany) with a 5mm TXI 
probe operating at 400.13 MHz. A relaxation delay-90°-t1-90°-tm-90°-acquire free induction decay 
(FID) sequence was used to obtain 1-dimensional NMR spectra. The 90° pulse length varied from 
12.00 μs to 12.50 μs depending on sample type. The total number of scans varied from 128 to 256 and 
was saved as 32k data points with a spectral width of 20 ppm. The results show that 25% acetonitrile 
solution does not retrieve impurities from Costar’s Spin-x centrifuge tube filters. This means that 
filters can be used if faecal water was extracted with this solution (which may be a case if stool 
sample should be used also for mass spectrometry). Figure 27 illustrates that there are no impurities 
coming of the filters if 25% acetonitrile (in H2O) is used as the solvent. 
 
   
Figure 27: Standard one-dimensional 1H NMR spectra presenting the influence of filtration of 25% acetonitrile 
solution through Spin-x centrifuge tube filter (256 scans on 400 MHz) 
 
3.2.vi Preparation of lipid layer for lipidomics 
The process of faecal water extraction was effective enough for the lipid layer separation from the 
faecal water that no organic solvent extraction was necessary. Faecal water was tested for the 
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presence of lipids in order to confirm the effectiveness of the method. There were no peaks visible on 
chromatogram. The whole lipid layer was collected and resuspended in 230µl of 
isopropanol/acetonitrile/water solution in a ratio 2:1:1. Three 1mm zirconium beads were added and 
sample was bead beaten for 10 seconds, centrifuged for 10 mins at 16,000 × g. 100µl of supernatant 
was transferred to glass vial and sealed. 
3.2.vii Final protocol 
 
Figure 28: Flowchart presenting the final protocol for faecal water extraction 
3.3 DNA extraction from stool pellet 
Stool pellet from faecal water extraction was used for metataxonomic analysis of gut microbiota. In 
order to obtain accurate data it was important to asses if any of the faecal water extraction steps led to 
loss of DNA yield and/or quality. For the method development QIAamp Stool Tubes Pathogen 
Detection protocol and the QIAamp DNA Stool Mini Kit was used. 
The whole pellet from faecal water extraction was placed in a sterile 2ml bead-beating tube that was 
prefilled with approximately 0.3g of 0.1mm glass beads. The sample was topped up with 1.5ml of 
100mg stool + 250µl 25% acetonitrile 
Bead beating for 10 sec with 0.05g of 1mm zirconium beads 
Centrifuging for 20 min at >16,000×g 
Faecal water 
Filtration and aliquoting 
20µl for QC 50µl into 
glass vial 
Turbovap 
for for 1h 
Resuspend in potasium buffer, vortex 
for 30s, sonicate for 5 min 
NMR analysis 
150µl into 
well plate 
MS 
Lipid layer 
MS (lipidomic) 
analysis  
Stool pellet 
DNA extraction 
qPCR 
Illumina 
Development of gut microbiota and metabolic changes in preterm babies 
 
PhD Thesis                                                    Natalia Przysiezna 81 
 
ASL buffer. There was left free space in the tube in order to obtain a more efficient bead beating. 
Sample was beaten 3 times for 30 sec with 5 sec intervals at 6500 rpm (Precellys 24 bead beater) and 
incubated for 5 min at 95°C in a heat block. After that the sample was centrifuged for 1 min 40 sec at 
16,000×g (the protocol states that the sample should be centrifuged for 1 min at >20,000×g but it is 
advised that if the top speed of the centrifuge is lower, then the time must be proportionally 
elongated). After centrifuging 1.2ml of supernatant was transferred into a sterile 2ml Eppendorf 
microcentrifuge tube and the InhibitEX tablet was added. Immediately after that, the sample was 
vortexed for 1 min, incubated at room temperature for another 1 min and centrifuged at 16,000×g for 
4 min. 200µl of supernatant was then transferred into a new sterile 1.5ml microcentrifuge tube 
prefilled with 15µl of proteinase K. 200µl of buffer AL were added into the sample making sure that 
proteinase K was not mixed with buffer AL before the supernatant was added. Sample was then 
vortexed for 15 sec and incubated for 10 min at 70°C in heat block. Next, 200µl of EtOH (96-100%) 
was added to the lysate and vortexed. The lysate was then transferred into QIAamp spin column, that 
was placed in 2ml microcentrifuge tube, and centrifuged at 16,000×g for 1 min 40 sec. QIAamp spin 
column was then transferred into a new 2ml microcentrifuge tube, 500µl of buffer AW1 was added 
and centrifuged at 16,000×g for 1 min 40 sec. QIAamp spin column was again transferred into a new 
2ml microcentrifuge tube, 500µl of buffer AW2 was added and centrifuged at 16,000×g for 4 min. 
QIAamp spin column was finally transferred into a new 1.5ml microcentrifuge tube, 200µl of buffer 
AE was added, incubated for 1 min at room temperature and centrifuged at 16,000×g for 1 min 40 sec. 
Eluted DNA was stored in -20°C until further analysis. 
Quantity of the DNA was measured with Nano-drop Spectrometer ND-1000. 2µl of the sample were 
applied and the absorbance at various wavelengths was measured. Buffer TE which was used for the 
elution of DNA from the column was used as blank. Apart from retrieving the value for DNA 
concentration per 1µl of solvent also the information about the purity of DNA were obtained. This 
included the ratio of absorbance 260/280nm and 260/230nm. The concentration of DNA is calculated 
with the use of the Lamberts-Beer law         , where ‘A’ stands for absorbance, ‘e’ for 
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absorption coefficient, ‘l’ for length that light has to travel and ‘c’ for concentration. The absorption 
coefficient ‘e’ is characteristic for a particular compound. 
According to QIAamp protocol, the typical DNA concentration extracted from adult stool sample 
varies from 75 to 300 ng/µl. In order to make the validation process easier I used DNA concentration 
per 1g of stool. The concentration of DNA was recalculated using Equation 1 formulas.  
 
Equation 1: DNA concentration recalculation  
                       =                        /µ  ×                  [µ ] 
                     [  /1 ] =                        /           [g] 
                     [µ /1 ] =                      [  /1 ] × 1000 
 
3.3.i Untreated stool vs. faecal pellet  
The first important experiment was to establish if it is possible to use stool pellet from faecal water 
extraction for effective DNA extraction. The efficiency was compared to this from untreated stool.  
Four stool samples (two from preterm infants 5 weeks post-partum, one from full-term infant 1 week 
post-partum and one from 1-year-old infant) were divided each into three fractions of equal masses. 
Two fractions were used for faecal water extraction and one was left untreated for the DNA 
extraction. The DNA extraction followed the protocol described in Method Development chapter 
section 3.2.ii. The results presented in Table 6 show that pellet from faecal water extraction can be 
effectively used for DNA extraction. Surprisingly both the DNA concentration per 1µl of elution 
buffer and the purity of samples are improved. In depth analysis of the sample purity are explained in 
the Method Development chapter section 3.2.ii.g.  
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Table 6: Comparison of DNA yields after extraction from untreated stool and stool pellet obtained from faecal water 
extraction. Results for pellets are presented as mean value of duplicates and range is provided in the brackets. 
Sample 
ID 
Type of 
sample 
DNA concentration in 
ng/µl of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
Untreated 2.9 0.96 1.45 
Pellet 
19.0 
(16.2-21.8) 
1.88 
(1.85-1.90) 
1.85 
(1.56-2.13) 
B 
Untreated 1.9 1.03 0.46 
Pellet 
3.1 
(2.8-3.3) 
1.47 
(1.18-1.75) 
0.48 
(0.40-0.56) 
C 
Untreated 4.7 1.69 0.79 
Pellet 
4.9 
(4.5-5.3) 
1.82 
(1.50-2.13) 
0.81 
(0.78-0.83) 
D 
Untreated 63.8 2.22 1.96 
Pellet 
83.4 
(83.0-83.8) 
2.15 
(2.13-2.17) 
2.11 
(2.07-2.15) 
 
3.3.ii Type of homogenisation  
Type of homogenisation was one of the most important factors that could affect the DNA yield. There 
was a risk that bead beating with 1mm zirconium beads could rupture bacterial cells. What is worse, 
in such case it would not be clear if the percentage of loss was proportional (random loss) or if some 
species were more predisposed to damage. In order to assess the influence of bead beating on bacterial 
survival, pellets obtained by bead beating (twice for 5 sec at 5000 rpm on Percellys 24 bead beater) 
were compared with those that were obtained by vortexing. The DNA extraction followed protocol 
described in the Method Development chapter section 3.2.ii. As shown in the Table 7 vortexing of 
faecal water reduced the DNA yield of stool pellet. This means that bead beating with 1mm zirconium 
beads is a better method of stool sample homogenisation. 
 
 
 
 
 
 
Development of gut microbiota and metabolic changes in preterm babies 
 
PhD Thesis                                                    Natalia Przysiezna 84 
 
Table 7: Comparison of DNA yield from pellets that were bead beaten and those that were vortexed.  
Sample ID Homogenisation method 
DNA concentration in 
µg/g of stool  
Purity of DNA 
260/280 nm 260/230 nm 
A 
Bead beating 5000-2x05 4.6 2.13 0.78 
Vortexing 3.38 1.50 0.83 
B 
Bead beating 5000-2x05 21.8 1.90 1.56 
Vortexing 16.2 1.85 2.13 
C 
Bead beating 5000-2x05 2.7 1.18 0.56 
Vortexing 2.4 1.75 0.40 
 
 
Next step was to decide which program of bead beating will give the best results for both metabolite 
profiles and DNA yield. Samples that have been bead beaten twice for 5 sec at 5000 rpm were 
compared with those that have been bead beaten three times for 40 sec at 5500 rpm (Percellys 24). 
The results shown in the Table 8, present that there is no clear pattern in influence of type of bead 
beating on DNA yield. It is more likely caused by the fact that stool itself is not homogenous and 
different fractions may contain more or less of bacterial cells. That is why it was decided to vortex 
stool sample for 1 min prior to separation of fraction for the faecal water extraction. What is more, 
sample “C” was meconium which explains low DNA concentration.   
 
Table 8: Comparison of DNA yield from pellets that were bead beaten for different time. 
Sample ID Bead beating program 
DNA concentration in 
µg/g of stool 
Purity of DNA 
260/280 nm 260/230 nm 
A 
5500-3x40-005 
8.2 
(7.0-9.3) 
2.67 
(2.18-3.15) 
0.27 
(0.18-0.35) 
5000-2x05-005 
15.7 
(14.1-17.3) 
3.18 
(2.85-3.50) 
0.39 
(0.30-0.48) 
B 
5500-3x40-005 
11.3 
(10.5-12.0) 
2.24 
(1.98-2.49) 
0.40 
(0.39-0.40) 
5000-2x05-005 
10.0 
(8.7-11.2) 
2.35 
(2.32-2.38) 
0.27 
(0.26-0.27) 
C 
5500-3x40-005 
1.1 
(0.6-1.5) 
1.98 
(0.69-3.26) 
0.15 
(0.05-0.24) 
5000-2x05-005 
1.3 
(0.0-2.6) 
0.59 
(0.00-1.17) 
0.10 
(0.01-0.18) 
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As explained in the Method Development chapter section 3.2.i.b, it was necessary to perform another 
experiment comparing bead beating on Percellys 24 (twice for 5 sec at 5000 rpm) and Mini Bead 
beater (10 sec at 36 oscillations per 1 sec). Pellets from this experiment were extracted according to 
previously mentioned protocol (Method Development chapter section 3.2.ii). The results, presented in 
Table 9, show that there seems to be higher DNA yield when samples are homogenised at Mini Bead 
beater for 10 sec at 36 oscillations per 1 sec.  
Table 9: Comparison of DNA yield from pellets that were bead beaten with different programs  
Sample ID Bead beating program DNA [ug/1g] 
Purity of DNA 
260/280 nm 260/230 nm 
A 
10 sec at 36 osc per 1 sec 
23.1 
(21.8-24.4) 
2.24 
(2.18-2.29) 
1.48 
(1.37-1.58) 
twice for 5 sec at 5000 rpm 
34.4 
(32.8-36.0) 
1.98 
(1.96-1.99) 
1.06 
(1.02-1.10) 
B 
10 sec at 36 osc per 1 sec 
29.6 
(29.4-29.7) 
2.13 
(2.08-2.17) 
1.87 
(1.86-1.87) 
twice for 5 sec at 5000 rpm 
26.9 
(26.5-27.3) 
2.04 
(2.02-2.05) 
1.65 
(1.54-1.76) 
C 
10 sec at 36 osc per 1 sec 
67.2 
(53.0-81.4) 
1.89 
(1.81-1.97) 
1.49 
(1.14-1.83) 
twice for 5 sec at 5000 rpm 
58.7 
(51.0-66.4) 
1.99 
(1.98-2.00) 
2.00 
(1.99-2.00) 
 
 
3.3.iii Solvents 
As previously described in the Method Development chapter section 3.2.i.a, a number of solvents 
have been tested for faecal water extraction. The influence of those solvents on bacterial cell survival 
has been examined in additional experiments. The majority of the results (Table 10) suggest that there 
is no significant difference in DNA yield obtained from stool pellets that were extracted with use of 
different solvents. The only significant difference is visible for sample ‘A’ however due to lack of 
duplicates it is possible that those results are not representative and are caused by lack of homogeneity 
in the stool sample. When it comes to the issue of DNA purity all samples show that faecal water 
extraction in phosphate buffer leads to the best 260/280nm and 260/230nm ratios, followed by D2O 
with PBS giving the lowest purity. The aspects of DNA purity are described in detail in the Method 
Development chapter section 3.2.ii.h. This finding suggests that faecal water extraction in phosphate 
buffer should provide good quality DNA sample.  
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Table 10: Comparison of DNA yield from pellets extracted either in D2O, H2O, PBS or phosphate buffer. Results are 
presented as mean value of duplicates and range is provided in the brackets. 
Sample ID Solvent 
DNA concentration in 
ng/µl of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
D2O 18.6 2.09 1.27 
PBS 27.3 1.69 0.71 
Phosphate buffer 68.3 1.84 1.42 
B 
D2O 
4.9 
(4.5-5.3) 
1.82 
(1.50-2.13) 
0.81 
(0.78-0.83) 
PBS 
5.0 
(1.8-8.1) 
1.52 
(1.45-1.58) 
0.43 
(0.27-0.59) 
C 
D2O 
83.4 
(83.0-83.8) 
2.15 
(2.13-2.17) 
2.11 
(2.07-2.15) 
H2O 
70.0 
(61.0-79.0) 
2.17 
(2.14-2.19) 
2.13 
(2.11-2.14) 
D 
D2O 
57.0 
 (31.7-84.2) 
1.86 
(1.75-1.96) 
1.09 
(0.84-1.33) 
Phosphate buffer 
52.1 
(51.1-52.6) 
1.81 
(1.72-1.90) 
1.23 
(0.94-1.52) 
 
 
As previously described in the Method Development chapter section 3.2.i.d, another experiment 
comparing faecal water extraction in 25% acetonitrile in dH2O (18MΩ) with extraction in dH2O 
(18MΩ) was performed. DNA extraction of the stool pellets was performed according to previously 
described DNA extraction protocol (Method Development chapter section 3.2.ii). The results of this 
experiment suggest that faecal water extraction in 25% acetonitrile in dH2O (18MΩ) does not 
significantly affect the DNA yield (Table 11). Even though the mean value of DNA concentration 
may imply that faecal water extraction in water may produce better results, the range shows that there 
is a big variation among the sample and what is more, important the range values for acetonitrile and 
H2O overlap. There is also no clear pattern of purity improvement or decrease.  
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Table 11: Comparison of DNA yield from pellets extracted either in 25% acetonitrile or H2O. Results are presented 
as mean value of duplicates and range is provided in the brackets. 
Sample ID Solvent 
DNA concentration in 
µg/g of stool 
Purity of DNA 
260/280 nm 260/230 nm 
A 
H2O 
65.1 
(36.6-93.6) 
1.98 
(1.82-2.13) 
0.82 
(0.77-0.87) 
Acetonitrile 
117.6 
(89.6-145.6) 
2.08 
(1.99-2.17) 
0.95 
(0.91-0.99) 
B 
H2O 
22.1  
(15.7-28.5) 
1.67 
(1.57-1.76) 
0.92 
(0.63-1.11) 
Acetonitrile 
16.9 
(10.5-23.4) 
1.94 
(1.90-1.97) 
1.12 
(1.10-1.13) 
C 
H2O 
35.6 
(16.7-54.6) 
1.91 
(1.79-2.02) 
1.23 
(1.15-1.30) 
Acetonitrile 
31.7 
(24.1-39.4) 
1.81 
(1.69-1.93) 
1.02 
(0.92-1.11) 
 
 
3.3.iv Presence of sodium azide  
In order to assure no bacterial metabolism in faecal water, 0.02% sodium azide (NaN3) is commonly 
used as a preservative. The influence of sodium azide on bacterial cell survival is unknown and the 
aim of this experiment was to test if there is any significant drop in DNA yield after extracting in the 
presence of sodium azide. Four stool samples were divided into four fractions each and one stool 
sample was divided into two fractions. Two of the fractions where extracted in D2O with no sodium 
azide and the other two fractions were extracted in phosphate buffer with 0.02% sodium azide. In the 
case of the fifth stool sample, which was divided only into two fractions, the experiment was not done 
in duplicates.  In all the samples there was visible a slight drop in DNA yield when faecal water was 
extracted in phosphate buffer with 0.02% sodium azide, compared to D2O (Table 12).  
 
Figure 29: Gel electrophoresis of PCR products of 16S rRNA gene extracted from stool samples. Ladder is marked as 
L, positive control as + and negative control as –. Number refers to stool sample, PB refers to faecal water extraction 
in phosphate buffer (with 0.02% sodium azide) while D2O refers to faecal water extraction in D2O. 
 
    L         1DO     2PB      3PB      3DO     2DO     1DO        L           +           –          L 
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Table 12: Comparison of DNA yield from pellets extracted either in phosphate buffer or D2O. Results are presented 
as mean value of duplicates and range is provided in the brackets. 
Sample ID 
Solvent (presence of 
sodium azide) 
DNA concentration in 
ng/µl of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
Phosphate buffer with NaN3 
35.1 
(34.6-35.6) 
1.76 
(1.73-1.79) 
1.08 
(1.05-1.20) 
D2O without NaN3 
41.45 
(34.6-48.3) 
1.93 
(1.92-1.93) 
1.20 
(1.04-1.43) 
B 
Phosphate buffer with NaN3 
20.4 
(20.3-20.5) 
1.63 
(1.59-1.66) 
0.83 
(0.80-0.86) 
D2O without NaN3 
21.3 
(20.0-22.6) 
1.76 
(1.68-1.83) 
0.81 
(0.74-0.88) 
C 
Phosphate buffer with NaN3 
17.6 
(16.8-18.4) 
1.70 
(1.68-1.71) 
0.87 
(0.87-0.87) 
D2O without NaN3 
22.5 
(22.3-22.6) 
1.61 
(1.61-1.61) 
0.82 
(0.74-0.91) 
D 
Phosphate buffer with NaN3 
52.1 
(51.1-52.6) 
1.81 
(1.72-1.90) 
1.23 
(0.94-1.52) 
D2O without NaN3 
57.0 
 (31.7-84.2) 
1.86 
(1.75-1.96) 
1.09 
(0.84-1.33) 
E 
Phosphate buffer with NaN3 2.2 1.70 0.49 
D2O without NaN3 4.0 1.51 0.74 
 
 
The quality of DNA was tested by Dr Julian Marchesi. PCR was done with use of the universal 
primers for 16S rRNA gene – 27F and 1492R. The PCR results (Figure 29) show that the quality of 
DNA was not affected by the presence of sodium azide during faecal water extraction. Due to the fact 
that the drop in DNA yield was not significant and may have been related to lack of homogeneousness 
in the stool itself, it was decided to use sodium azide. Presence of sodium azide in faecal water is very 
important as it stops any unwanted metabolism of the metabolites and provides representative spectra. 
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3.3.v Presence of the lipid layer 
After analysing stool samples from different sources it was observed 
that newborn infants are more likely to have steatorrhoea which is 
an excess of fat in stool. This fat was forming a lipid layer which 
was floating above faecal water thus blocking the access (Figure 
30). Due to the fact that the influence of presence of lipids on DNA 
extraction was unknown, it was decided to test it. As presented in 
Table 1Table 13, presence of lipid layer may affect the DNA 
extraction. It was decided to remove the lipid layer with metal 
spatula prior to removal of faecal water 
Figure 30: Picture of faecal water 
presenting the lipid layer floating 
on top of faecal water. 
 
 
 
 
Table 13: Comparison of DNA yields after extraction from stool pellet with and without lipid layer. Results for stool 
pellets without lipid layer are presented as mean value of duplicates and range is provided in the brackets. 
Sample ID Lipid layer 
DNA concentration in 
ng/µl of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
Present 2.9 0.96 1.45 
Lack 
19.0 
(16.2-21.8) 
1.88 
(1.85-1.90) 
1.85 
(1.56-2.13) 
B 
Present 1.9 1.03 0.46 
Lack 
3.1 
(2.8-3.3) 
1.47 
(1.18-1.75) 
0.48 
(0.40-0.56) 
C 
Present 4.7 1.69 0.79 
Lack 
4.9 
(4.5-5.3) 
1.82 
(1.50-2.13) 
0.81 
(0.78-0.83) 
D 
Present 63.8 2.22 1.96 
Lack 
83.4 
(83.0-83.8) 
2.15 
(2.13-2.17) 
2.11 
(2.07-2.15) 
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3.3.vi DNA yield variation in preterm, full-term and adult stool samples  
Results from all the experiments were pulled together in order to analyse the range of DNA 
concentration in each age group: preterm newborns, full-term newborns, 1-year-old babies and adults. 
Although the results suggest that preterm stool has higher concentration of DNA it is important to 
remember that stool from full-term infants available for analysis is usually from 1
st
 week of life while 
samples from preterm infants were collected for few months after birth. In the method development, 
apart from 1
st
 week stool samples from full-term infants also one set of stool from 7-week-old full-
term infant was used (Table 14). The age postpartum range of preterm infants was 1-7 weeks. At the 
age of 1 year the adult microbiota starts to develop and by the 2
nd
 year of life it is usually fully 
developed [26]. After few weeks of life newborn infants start to have higher yield of DNA that is 
within the adult range.  
 
Table 14: Comparison of DNA yields from different types of stool samples including: preterm, full-term, 1-year-old 
and adult. Results are presented as mean value of duplicates and range is provided in the brackets. 
Source of sample DNA concentration in µg/1g of stool 
Purity of DNA 
260/280 nm 260/230 nm 
Preterm baby 
(n=44) 
17.2 
(0.0-74.3) 
1.79 
(0.00-3.50) 
0.69 
(0.01-2.13) 
Full-term baby  
(n=9) 
14.6 
(1.7-36.0) 
1.89 
(1.50-2.29) 
0.97 
(0.49-1.58) 
1-year old baby 
(n=5) 
71.1 
(61-79-8) 
2.17 
(2.13-2.22) 
2.09 
(1.96-2.15) 
Adult 
(n=12) 
49.9 
(26.5-81.4) 
2.18 
(1.72-2.29) 
1.76 
(0.94-2.00) 
 
 
Due to the fact that samples collected in the first weeks of life are usually low in DNA yield, it was 
important to examine what DNA concentration is a threshold for PCR. Dr Julian Marchesi performed 
PCR with use of universal primers for 16S rRNA gene – 27F and 1492R. DNA concentration lower 
than 1.9ng/µl was not enough to give strong PCR product (Figure 31), concentration of 1.3ng/µl gave 
weak band after gel electrophoresis while <1ng/µl gave no PCR product. This means that at least 
2ng/µl of DNA is required for metataxonomic analysis. It was decided to try concentrating DNA 
samples to avoid risk of losing some of the valuable samples.  
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Figure 31: Gel electrophoresis of PCR products of 16S rRNA gene extracted from stool samples. Ladder is marked as 
L, positive control as + and negative control as –. Values represent the DNA concentration in ng per 1µl of elution 
buffer. 
 
3.3.vii Concentration of DNA  
In order to concentrate the DNA samples, the DNA extraction protocol got modified. In the original 
protocol the final step of DNA elution from the column (protocol described in detail in the Method 
Development chapter section 3.2.ii) consists of incubating 200µl of elution buffer for 1 min and then 
washing the column during centrifuging. The proposed change included using twice 100µl of elution 
buffer. 100µl of elution buffer was incubated on top of column for 1 min then centrifuged only to be 
collected and placed again on top of column for 1 min and then centrifuged. This not only introduced 
lower volume of solvent which should automatically concentrate the DNA two fold, but also 
elongated the incubation time which could result in washing of column higher amount of DNA. Those 
two variations of DNA elution from column were compared on four preterm stool samples collected 
4-7 weeks post-partum. One of the stool samples had to be withdrawn from the experiment as the 
mass of the stool pellets after faecal water extraction was significantly higher in one of the duplicates. 
The results of this experiment (Table 15) show that proposed changes to the protocol result in higher 
concentration of DNA. This should lead to reduction in the number of stool samples with DNA 
concentration not meeting the threshold for the metataxonomic analysis.  
Table 15: The association of DNA yield with the elution buffer volume and number of elutions 
Sample ID 
Time of elution and volume of 
elution buffer 
DNA concentration in ng/µl 
of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
1x with 200µl 16.8 2.09 1.00 
2x with 100µl 51.8 1.66 0.91 
B 
1x with 200µl 12.8 2.09 0.87 
2x with 100µl 30.0 1.79 0.78 
C 
1x with 200µl 14.0 1.85 0.99 
2x with 100µl 80.0 1.71 0.86 
 
 L      2.9    21.8    16.2    1.9     3.3     2.8     1.3     0.7     0.6     12.2    2.9     2.8       –        +        L 
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The only worrying result was that the purity of samples seemed to have dropped. As a result, an 
experiment to improve the DNA purity was planned. 
3.3.viii Purity improvement 
The ratio 260/280nm (the ratio of absorbance) should be approximately 1.8 but values above 1.6 are 
acceptable. This ratio is mostly affected by presence of phenol (> 2.0) and proteins (< 1.8). The other 
reasons why the value may be different includes the composition of DNA and pH of the sample. The 
260/280nm ratio for Guanine is 1.15, for Cytosine 1.51, for Thymine 1.47, for Adenine 4.50 and for 
Uracil 4.00. This means that DNA rich in A-U pairs would have higher 260/280nm ratio than DNA 
rich in G-C. Acidity plays an important role when comparing the 260/280nm ratio between regular 
spectrometer and nano-drop. If sample is in acidic pH environment the value obtained on nano-drop 
will be drop by 0.3 compared to results from standard spectrometer. In case of basic pH the value will 
rise by 0.3 [265]. The 260/230nm ratio should be between 2.0 and 2.2 however it is accepted if is 
above 1.5. It can be affected by EDTA, phenol, carbohydrates, guanidine hydrochloride which is a 
common compound in DNA extraction kits.   
Two newborn stool samples from 1
st
 and 3
rd
 week of life were divided into four fractions each. Stool 
pellet was obtained after faecal water extraction with phosphate buffer. Two of the fractions were 
extracted accordingly to the DNA extraction protocol described in Method Development chapter 
section 3.2.ii and the other two had slightly modified protocol. Those modifications included 
additional 4 min centrifuging at 16,000×g of supernatant obtained after adding InhibitEX tablet. The 
other modification was removing from column any leftover AW2 buffer by centrifuging for 1 min 40 
sec at 16,000×g. Although impurities and leftover AW2 buffer were removed from the samples, there 
was no clear improvement of total purity visible (Table 16). The mean values for 260/230nm ratio did 
seem to improve after modification of the DNA extraction protocol but the ranges of values did 
overlie thus those findings are not significant. On the other hand there is visible a drop in the 
260/280nm ratio. The proposed modifications of the DNA extraction protocol will not be introduced 
to the final protocol.  
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Table 16: The association of DNA purity with the improvements of DNA extraction protocol 
Sample ID DNA extraction protocol 
DNA concentration in 
ng/µl of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
Original protocol 
12.0 
(8.7-15.2) 
1.72 
(1.61-1.83) 
0.44 
(0.26-0.61) 
Additional centrifuging steps 
10.4 
(10.2-10.6) 
1.37 
(1.36-1.37) 
0.56 
(0.54-0.57) 
B 
Original protocol 
6.8 
(6.8-6.8) 
1.53 
(1.27-1.79) 
0.34 
(0.23-0.44) 
Additional centrifuging steps 
5.8 
(3.6-7.9) 
1.28 
(1.15-1.41) 
0.43 
(0.37-0.48) 
 
The low ratio of 260/230nm was visible only in newborn stool samples which means that it is 
probably unavoidable obstacle. Dr Julian Marchesi performed an experiment to test if the impurities 
causing low 260/230nm ratio inhibit the PCR reaction. DNA extracts with low 260/230nm ratio were 
diluted before PCR reaction to see if there will be any improvement in the results. Dilution caused 
drop of DNA concentration below the threshold for PCR. However, the PCR reaction led to 
successful amplification of the DNA from samples that had the DNA concentration above the 
previously mentioned threshold and with the 260/230nm ratio as low as 0.35. The conclusion from 
this experiment was that low 260/230nm ratio does not inhibit the PCR reaction thus should not affect 
metataxonomic analysis. In order to check if low values for purity were not caused by low DNA 
concentration, four DNA extracts (two from preterm sample, one from 1-year-old infant and one from 
adult) were diluted two fold, fivefold and tenfold. Samples were analysed on nano-drop to see if there 
is any correlation between the DNA concentration and purity (Table 17).  
The association of 260/280nm ratio value and DNA concentration is presented on the Figure 32, 
where the increasing DNA dilution corresponds to the decreasing DNA concentration. The graph 
clearly shows that there is underlying unknown factor that affects the 260/280nm ratio. Three out of 
four samples presented trend of 260/280nm ratio value decrease with decrease of DNA concentration 
(increase of sample dilution). However this is not visible for the DNA extracted from the adult stool 
sample.  
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Table 17: The association of DNA concentration with the DNA purity. 
Sample ID Dilution 
DNA concentration in  
ng/µl of elution buffer 
Purity of DNA 
260/280 nm 260/230 nm 
A 
0 83.9 2.19 2.03 
2x 43.6 2.23 2.01 
5x 17.9 2.18 2.79 
10x 9.2 2.10 2.16 
B 
0 26.8 2.11 1.74 
2x 12.7 2.31 1.72 
5x 4.8 2.00 1.35 
10x 3.2 1.70 1.25 
C 
0 28.0 1.97 1.31 
2x 16.1 1.82 1.40 
5x 6.0 2.25 1.44 
10x 3.8 1.60 1.34 
D 
0 50.0 1.97 1.12 
2x 27.7 2.06 1.14 
5x 11.4 2.08 1.19 
10x 4.1 2.48 0.98 
 
 
 
Figure 32: Graph showing correlation of 260/280nm ratio and DNA concentration. Red line represents the 
recommended value of 260/280nm ratio while yellow line represents the acceptable value of 260/280nm ratio. Squares 
represent results for preterm samples, triangles results for 1-year-old infant samples and circles – adults. 
 
The 260/230nm ratio value seems to be more associated with the DNA concentration. As presented on 
Figure 33, there is a trend towards lower 260/230nm ratio in more diluted samples.  
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Figure 33: Graph showing correlation of 260/230nm ratio and DNA concentration (sample dilution). Red line 
represents the recommended value of 260/230nm ratio while yellow line represents the acceptable value of 260/230nm 
ratio. Squares represent results for preterm samples, triangles results for 1-year-old infant samples and circles – 
adults. 
The purity of DNA extracted from preterm stool samples seems to be a complex issue and may be 
related to the nature of the sample. Classic methods of the purity improvement did not succeed. Due 
to the fact that metataxonomic analysis can be carried out on samples with low 260/230nm ratio, it 
was decided to accept the complex nature of preterm samples and continue with the experiments 
without improving the purity.  
3.3.ix Final improvements to QIAamp DNA Stool Mini Kit 
Whole pellet from faecal water extraction was weighted and placed in a sterile 2ml microcentrifuge 
tube with a screw cap that was prefilled with approximately 0.3g of 0.1mm glass beads. The sample 
was topped up with 1.5ml of ASL buffer (this should leave free space for a more efficient bead 
beating). Sample was beaten 3 times for 30sec with 5sec intervals at 6500 rpm (Precellys 24-duo bead 
beater) and incubated for 5 min at 95°C in a heat block. After that the sample was centrifuged for 1 
min 40 sec at 16,000×g and 1.2ml of supernatant was transferred into a sterile 2ml Eppendorf 
microcentrifuge tube containing the InhibitEX tablet. Immediately after, the sample was vortexed for 
1 min and incubated at room temperature for another 1 min. Sample was centrifuged at 16,000×g for 4 
min, 200µl of supernatant was transferred into a new sterile 1.5ml microcentrifuge tube prefilled with 
15µl of proteinase K. 200µl of buffer AL were added into the sample making sure that proteinase K is 
not mixed buffer AL before adding the supernatant. Sample was then vortexed for 15 sec and 
incubated for 10 min at 70°C in the heat block. Next, 200µl of EtOH (96-100%) was added to the 
lysate and vortexed. The lysate was then transferred into QIAamp spin column placed in 2ml 
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microcentrifuge tube and centrifuged at 16,000×g for 1 min 40 sec. QIAamp spin column was then 
transferred into a new 2ml microcentrifuge tube, 500µl of buffer AW1 was added and centrifuged at 
16,000×g for 1 min 40 sec. QIAamp spin column was again transferred into a new 2ml 
microcentrifuge tube, 500µl of buffer AW2 was added and centrifuged at 16,000×g for 4 min. 
QIAamp spin column was finally transferred into a new 1.5ml microcentrifuge tube, 100µl of buffer 
AE was added, incubated for 1 min at room temperature and centrifuged at 16,000×g for 1 min 40 sec. 
Eluted buffer was transferred again on the column, incubated for 1 min at room temperature and 
centrifuged at 16,000×g for 1 min 40 sec. Eluted DNA was stored in -80°C until further analysis. 
3.3.x Final DNA extraction protocol 
Due to the fact that Qiagen stopped the production of the kit used for the method development, a new 
kit was used after a careful analysis of the extraction protocols. The protocol which seemed most 
similar to the proposed by my improvements was for the MOBIO PowerFaeces DNA extraction kit. 
The only changes introduced to this protocol were centrifuging at 16,000×g for 1 min 40 sec instead 
of centrifuging at 13,000×g for 1 min.  
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Chapter 4 – The urinary metabonome of the preterm baby 
 
4.1 Introduction 
The human organism has a very complex system of metabolic pathways which are usually maintained 
in a state of equilibrium [266, 267]. This balance is partially achieved by excretion of waste products 
in the urine. The urine composition can reflect the reaction of an organism to various changes in 
environmental factors that take place (stress, change in health status or exposure to various chemical 
substances) [266-268]. Analysing the multi-component composition of the urine is a useful tool for 
quick assessment of an individual’s health. Healthy adult kidneys have an efficient filtration system 
that typically does not allow certain metabolites to leave the system [267]. Therefore, any drastic 
metabolic profile alteration, which cannot be explained by diet, is an indicator of change in 
metabolism or filtration effectiveness. Urine is considered the sample specimen of choice for most 
biomarker studies, mostly because it is easily accessible and can be obtained in a non-invasive manner 
[267, 268]. Moreover, since it is composed of waste metabolites, there are few ethical issues in 
collecting it. 
Various population studies have found that the variation of the urinary metabolic profiles is high not 
only between individuals but also changes within the same individual over time [266]. There are 
number of factors that can contribute to this variation. Since urine represents the waste products of the 
metabolism, the changes in the biochemical profile are most likely to be caused by diet and 
administration of drugs [269, 270]. It is also known that post puberty, males tend to have different 
metabolic profiles than females and at least 12 statistically significant differential metabolites had 
been identified including creatine, creatinine and citrate [266, 271]. Other factors affecting urinary 
metabolic profile are age, BMI, and even the time of day when the sample was collected [271]. There 
are a vast number of metabolic profiling studies of urine conducted in adults but far fewer in children, 
particularly in premature babies [268]. However, one study reported that gestational age and postnatal 
age can affect the changes in urinary metabolic profile (increase in the concentration of glycine and 
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threonine had been observed in relation to increasing postnatal age) [272]. Studies comparing urinary 
metabonome of preterm and full-term babies found that premature babies had lower concentration of 
formate, hippurate, betaine, tryptophan, phenylalanine, malate, tyrosine, hydroxybutyrate, N-acetyl-
glutamate [267], proline and taurine [267, 268]. At the same time bile acids were found to decrease in 
concentration with increasing gestational age [273, 274]. 
Post-menstrual age (PMA) is a combination of gestational age (GA) with postnatal age (PNA) and can 
be explained by the formula: PMA = GA + PNA – 1. Knowing the post-menstrual age is essential for 
the urinary metabonome analysis as the development of kidneys is programmed genetically and they 
are mature at the 36
th
 week of gestation [158, 275]. The development of kidneys has been shown to 
continue after premature birth resulting in larger volume of kidneys (after correcting for the body 
weight) than the term babies when compared at the same PMA [158]. In this chapter the dynamic 
metabolic changes in urine associated with development of the preterm infant are characterised taking 
PMA, GA, PNA and feeding strategy into account. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Flowchart presenting the analysis pipeline for urine samples obtained from premature babies 
characterising changes in the urinary metabonome associated with postnatal age (PNA). 
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4.2 Experimental design  
4.2.i Urine sample preparation 
In total 913 urine samples were eligible for the modeling. Please see the Materials and Methods 
chapter for the detailed sample preparation.  
4.2.ii Nuclear Magnetic Resonance spectra acquisition 
The acquisition of all the urine samples took approximately a month due to a large sample set and 
several issues with the NMR machine. For the detailed information on the acquisition of NMR spectra 
please see the Materials and Methods chapter. The parameters used for the standard pulse sequence of 
the urine sample were: P1=10.54µs, Pl1=11.10-dBW, Pl9=48.44dB and O1=2820.74Hz. 
4.2.iii Sample pre-processing  
Spectra for the NEON urine samples were preprocessed and modeled in Matlab. Initially a model was 
build using all spectra and the quality controls (QCs) in order to ascertain if there was any 
instrumental batch effect. The Principal Component Analysis (PCA) scores plot for the model was 
calculated using 3 principal components returning a cumulative R
2
X of 18.9%. The quality control 
samples were clustering in the centre of the PCA scores plot suggesting that appropriate method of 
normalization had been chosen and that the method was reproducible (Figure 35). It was important to 
confirm that the prolonged acquisition time (over a month) did not lead to a batch effect in the sample 
set. Subsequent stages of analysis were undertaken after removal of the QCs from the model. The 
global model for all samples (including multiple time points) that is presented in the results section 
(section 4.3) was calculated using 3 principal components (PC) giving a cumulative R
2
 of 19.1%. 
Since the cumulative variance for three components only reached 18.9%, this indicated that the 
dataset contained a high degree of chemical variance. The PCA scores plots presented in this chapter 
for the whole data set were created based on this model. 
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Figure 35: Scores scatter plot of the principal component analysis (PCA) model of urine NMR spectral data 
generated from samples collected at multiple time points (whole data set). Quality control samples are coloured red. 
 
The first step of the analysis was to check if the randomized groups had different metabolic profiles, if 
not then the samples could be merged into further exploratory analysis. Initially, in order to get an 
overview of the dataset and to identify any biological outliers, for the exploratory analysis all spectra 
corresponding to multiple time points for 160 babies were modeled together. The unsupervised 
models for multiple time points was coloured according to classes obtained from the NEON metadata 
to identify the factors contributing to the main source of the variation in the scores plot. Those 
variables include: a) postnatal age, b) gestational age at birth, c) mode of delivery, d) presence of 
labour, e) sex, f) route of nutrition (parenteral or enteral), and g) type of enteral nutrition (formula 
milk or human milk). Another step in the preliminary analysis was to carry out a supervised analysis – 
Orthogonal Partial Least Squares model (O-PLS). This approach allowed finding discriminant 
metabolites associated with chosen classes of samples. The preliminary analysis helped to understand 
which of the known factors need to be controlled or accounted for while assessing the influence of the 
other factors. Several models exploring these class variables were undertaken in smaller subsets 
(Figure 34). 
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4.3 Results 
4.3.i Metabolic profiles associated with randomised PN feeding group 
The analysis on randomised groups was done after subtracting samples from the whole data set. Three 
time points were chosen: (a) 2
nd
 to 9
th
 day of life (babies exposed to parenteral nutrition), (b) 15
th
 to 
22
nd
 day of life (babies off the trial parenteral nutrition), and (c) last sample collected provided it was 
after the 32
nd
 week of life. If there was more than one sample available in particular time frame for a 
baby then the one collected earlier was included. All three models were calculated using 3 principal 
components and the cumulative R
2
 equalled: (a) 24.2% (b) 20.8% and (c) 20.6%.  
4.3.i.a Intralipid vs. SMOF lipid 
The PCA scores plots showed no separation according to the type of lipid solution that the babies had 
been given intravenously (Appendix: Figure 78, Figure 79 and Figure 80). The O-PLS models for the 
three previously selected time points confirmed the lack of difference between the groups as the Q
2
Y 
values were negative (Figure 36). 
 
 
Figure 36: The O-PLS models for urine samples comparing the types of lipids. The R2Y and Q2Y values for the O-
PLS of urinary metabolic profiles representing samples collected (A) between 2nd-9th day of life, (B) between 15th-21st 
day of life, and (C) the last sample prior to discharge.  The dark blue bar presents Q2Y while the light blue – R2Y. 
The bars on the right of each figure show the change after introduction of the orthogonal component. 
Development of gut microbiota and metabolic changes in preterm babies 
 
PhD Thesis                                                    Natalia Przysiezna 102 
 
4.3.i.b Recommended daily intake (RDI) vs. increasing concentration of amino acid 
When analysing the concentration of amino acids, the PCA model showed no separation (Appendix: 
Figure 81, Figure 82 and Figure 83). Additionally the O-PLS models created for each of the 
preselected time points returned a negative Q
2
Y values. This means that there is no significant 
difference between the groups randomised according to the concentration of amino acids (Figure 37). 
 
Figure 37: The O-PLS models for urine samples comparing the concentrations of amino acids. The R2Y and Q2Y 
values for (A) whole sample set; samples collected (B) at 1st week of life, (C) 3rd week of life, (D) from babies born at 
24th week of GA, (E) from babies born at 28th week of GA. The dark blue bar presents Q2Y while the light blue - R2Y. 
The bars on the right of each figure show the change after introduction of the orthogonal component.  
 
4.3.ii Metabolic profiles associated with gestational age (GA) 
The Principal Component Analysis scores plot for components PC1 vs. PC2 represented the most 
evidence of clustering according to GA (Figure 38) with earlier GA showing a tendency to cluster to 
the right hand side of the plot and older GA groups clustering on the left. 
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Figure 38: PCA Scores Scatter Plot of whole data set of NMR urine spectra. Samples coloured according to 
gestational age (in weeks)    
 
A supervised model (O-PLS) was built with two orthogonal components resulting in a R
2
Y value of 
47% and a Q
2
Y value of 36%. The O-PLS score plot shows the results for the increasing GA from the 
bottom to the top (Figure 39). Metabolites associated with higher GA included creatinine (3.05ppm s, 
4.06ppm s), myo-inositol (3.29ppm t, 3.52ppm dd, 3.61ppm t, 4.05ppm t), unidentifiable molecule 
(3.62ppm d, 3.64ppm t, 3.74ppm s), hydroxyproline (2.16ppm multi, 2.43ppm multi, 3.37ppm dt, 
3.47ppm dd 4.35ppm dd) and fumarate (6.52ppm s). Bile acids (0.84ppm s) were associated with 
lower GA (Figure 39). The permutation tests to validate the significance of the Q
2
Y showed that the 
model was not robust as the p-value = 0.91. 
The influence of postnatal age was removed by creating models on subsets of samples that were 
collected at the same time points. The choice of the postnatal age time point was made based on the 
number of available samples. The first analysed time point included samples collected between the 2
nd
 
and the 9
th
 day of life (126 samples). The second time point comprised the samples collected between 
the 15
th
 and the 22
nd
 day of life (104 samples). Those time points will be referred to as 1
st
 and 3
rd
 week 
of postnatal age, respectively.   
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Figure 39: Orthogonal Partial Least Squares (O-PLS) loadings plot of urine metabolic profiles coming from samples collected at multiple time points and created in relation to the 
gestational age. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with (increasing – up or decreasing – down) gestational age. Annotated 
metabolites: 1. bile acids, 2. hydroxyproline, 3. methylhydantoin, 4. creatinine, 5. malonate, 6. myo-inositol, 7. fumarate, and 8. 4-hydroxyphenylacetate. The insert bottom right: R2Y 
(light blue bar) and Q2Y (dark blue bar) values showing 47% and 36% respectively. P-value for the Q2Y is 0.91. 
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The PCA scores plot for the samples collected in the 1
st
 week of life was calculated using three 
principal components giving a cumulative R
2
X of 24.2%. The PCA scores plot showed no clustering 
based on the GA (Appendix: Figure 84). The supervised O-PLS model conducted for the continuous 
variable (gestational age in weeks) showed that the reliability of the model (Q
2
Y) increased from 28% 
to 41% after the introduction of the orthogonal component. The p-value for the Q2Y was 0.49 which 
means that the model was not robust. The O-PLS loadings plot showed that methylhydantoin 
(2.93ppm s) and creatinine (3.05ppm s, 4.06ppm s) were associated with the higher gestational age. At 
the same time the oligosaccharide region (3.70ppm-3.90ppm s) was found to be associated with the 
lower GA.  
The PCA scores plot for the samples collected on the 3
rd
 week of life was also calculated from 3 
principal components and the cumulative R
2
X equaled 25.8%. There was no clustering visible in the 
PCA scores plot (Appendix: Figure 85) and the Q
2
Y (37%) for the O-PLS dropped after introduction 
of the orthogonal component, indicating that the model was not stable. The PLS model was robust as 
the p-value from the permutation tests was 0.01. The loadings plot showed that creatinine (3.05ppm s, 
4.06ppm s), malonate (3.12ppm s) and 4-hydroxyphenylacetate (3.45ppm s, 6.87ppm d, 7.17ppm d) 
were associated with the higher GA. No metabolites were found to be associated with the lower GA.  
4.3.iii Metabolic profiles associated with postnatal age (PNA) 
Both PCA score plots (for PC1 vs. PC2, and for PC1 vs. PC3) showed clustering according to 
postnatal age (PNA) presented in weeks. The Figure 40 shows the PCA scores plot for PC1 vs. PC2.  
The O-PLS model was calculated using four orthogonal components which indicate a very high 
variability between the samples as the orthogonal components remove the systematic differences 
caused by the natural variability, but not related to the class of interest (Figure 41). The final R
2
Y and 
Q
2
Y values equaled 82% and 72% respectively. The model was robust as the p-value from the 
permutation tests was 0.01. The O-PLS loadings plot showed that metabolites associated with 
increasing PNA were: pantothenate – vit B5 (0.90ppm s, 0.94 ppm s). There were no metabolites 
associated with lower PNA (Figure 41). 
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Figure 40: PCA Scores Scatter Plot of whole data set of NMR urine spectra. Samples coloured according to postnatal 
age (in weeks) 
 
In order to remove the potential bias of the variable GA, the analysis was continued in stratified 
subgroups as presented in Figure 34. Both PCA scores plot for the 24
th
 GA and for 28
th
 GA were 
calculated using 3 principal components giving cumulative R
2
X values of 24% and 26.9% 
respectively. A clear separation of samples (related to PNA) was visible on PC1 in both cases 
(Appendix: Figure 86 and Figure 87). The O-PLS model for the samples collected from babies born 
on the 24
th
 week of GA was built with 2 orthogonal components and final R
2
Y and Q
2
Y values 
equaled 95% and 82% respectively. The O-PLS model for the samples collected from babies born on 
the 28
th
 week of GA was built with only one orthogonal component and the R
2
Y equaled 77% while 
Q
2
Y 63%.  
After removing the GA variable, the O-PLS scores plots confirmed the findings for pantothenate – vit 
B5 (0.90ppm s, 0.94 ppm s). Additionally acetyl carnitine (2.13ppm s, 2.50ppm dd, 3.18ppm s, 
3.62ppm d, 3.83ppm dd), unidentifiable chemical compound (2.33ppm dd), unidentifiable chemical 
compound (0.91ppm t, 2.78ppm multi), trimethylamine (2.90ppm s) and malonate (3.12ppm s) were 
associated with increasing PNA. At the same time mixture of sugars (3.33ppm multi, 3.38ppm s, 
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3.44ppm s, 3.49ppm s, 3.67ppm d, 3.69ppm t, 3.75ppm multi, 3.83ppm d, 3.85ppm d, 4.04ppm t, 
4.14ppm d, 4.20ppm s, 4.24ppm s, 4.51ppm s, 4.96ppm t, 5.03ppm d, 5.11ppm s, 5.24ppm multi, 
5.37ppm s, 5.40ppm s, 6.49ppm d) had been identified as associated with lower PNA. 
Due to the fact that nutrition is known to have a potential impact on the metabolic profile of urine, 
samples were stratified based on the type of enteral nutrition (exclusively fed by human milk, and 
exclusively formula fed) (Figure 34). This gave two models, both of which were calculated with 3 
principal components. The first model (samples collected only from exclusively human milk fed 
babies) gave cumulative R
2
X of 20.1%.  
The PCA scores plots showed clear separation based on PNA and the O-PLS was build using 5 
orthogonal components and gave final R
2
Y of 90% and final Q
2
Y of 71%.The second model was built 
for samples collected from exclusively formula-fed infants and gave cumulative R
2
X values of 21.2%. 
The PCA scores plots did not show a strong separation based on PNA in formula-fed infants.  The O-
PLS model was build using 4 orthogonal components and the final R
2
Y and Q
2
Y values equaled 95% 
and 62% respectively. 
After removing the variability of diet the O-PLS scores plots showed that higher PNA was associated 
with pantothenate – vit B5 (0.90ppm s, 0.94 ppm s) and acetyl carnitine (2.13ppm s, 2.50ppm dd, 
3.18ppm s, 3.62ppm d, 3.83ppm dd). Findings for the time mixture of sugars (3.33ppm multi, 
3.38ppm s, 3.44ppm s, 3.49ppm s, 3.67ppm d, 3.69ppm t, 3.75ppm multi, 3.83ppm d, 3.85ppm d, 
4.04ppm t, 4.14ppm d, 4.20ppm s, 4.24ppm s, 4.51ppm s, 4.96ppm t, 5.03ppm d, 5.11ppm s, 5.24ppm 
multi, 5.37ppm s, 5.40ppm s, 6.49ppm d) had been confirmed. Additionally unidentifiable chemical 
compound (2.04ppm s, 3.60ppm t, 3.92ppm s, 3.95ppm s, 3.96ppm s, 3.98ppm t, 7.91ppm s) was 
correlated with lower PNA.  
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Figure 41: Orthogonal Partial Least Squares (O-PLS) loadings plot of urine metabolic profiles coming from samples collected at multiple time points and created in accordance to the postnatal age. The X 
axis shows chemical shift in ppm, while the Y axis represents metabolites associated with (increasing – up or decreasing – down) postnatal age. Annotated metabolites: 1. pantothenate, 2. acetyl carnitine, 3 
trimethylamine, 4 malonate. The insert bottom right: R2Y (light blue bar) and Q2Y (dark blue bar) values showing 82% and 72% respectively. The permutation tests for Q2Y retrieved p-value = 0.01. 
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4.3.iv Metabolic profiles associated with postmenstrual age (PMA) 
The PCA score plots showed clustering according to PMA presented in weeks. This was especially 
visible in the plot of PC1 vs. PC2 (Figure 42). The O-PLS model was built using 4 orthogonal 
components and final R
2
Y and Q
2
Y values equaled 80% and 67% respectively (Figure 43). The model 
was robust as the p-value from the permutation tests was 0.01.The O-PLS scores plot showed that 
metabolites associated with increasing PMA were the same as for increasing PNA:  pantothenate – vit 
B5 (0.90ppm s, 0.94 ppm s) (Figure 43). There were no metabolites associated with decreasing PMA. 
 
Figure 42: PCA Scores Scatter Plot of whole data set of NMR urine spectra. Samples coloured according to 
postmenstrual age (in weeks). 
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Figure 43: Orthogonal Partial Least Squares (O-PLS) loadings plot of urine metabolic profiles coming from samples collected at multiple time points and created in accordance to the 
postmenstrual age.The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with (increasing – up or decreasing – down) postmenstrual age. 
Annotated metabolites: 1. pantothenate. The insert bottom right: R2Y (light blue bar) and Q2Y (dark blue bar) values showing 80% and 67% respectively. The permutation tests for 
Q2Y retrieved p-value = 0.01. 
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4.3.v Metabolic profiles associated with sex 
The PCA scores plot showed no clustering according to the sex of the baby (Appendix: Figure 88). 
Additionally, the Q
2
Y in the O-PLS analysis was below the threshold of 5% (Figure 46). After 
working on each postnatal age separately, no difference between no difference about male and female 
urinary metabonomes was observed as the Q
2
Y value was negative. The same was observed when 
analysing the samples collected only from babies born in the 24
th
 week of GA, and from babies born 
only on the 28
th
 week of GA (Figure 46). 
 
Figure 44: The O-PLS models for urine samples comparing sex of baby. The R2Y and Q2Y values for the O-PLS of 
urinary metabolic profiles for (A) whole sample set; samples collected (B) at 1st week of life, (C) 3rd week of life, (D) 
from babies born at 24th week of GA, (E) from babies born at 28th week of GA. The dark blue bar presents Q2Y while 
the light blue - R2Y. The bars on the right of each figure show the change after introduction of the orthogonal 
component.  
 
4.3.vi Metabolic profiles associated with mode of delivery 
The NEON dataset provided a detailed information about mode of delivery which was divided into: a) 
vaginal - natural, b) vaginal – with use of forceps, c) Caesarean elected – in labour, d) Caesarean 
elected – not in labour, e) Caesarean emergency – in labour and f) Caesarean emergency – not in 
labour. However in order to simplify analysis and have a reasonable number of babies in each 
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analysed groups, the analysis were done for vaginal delivery vs. Caesarean section, and in labour vs. 
not in labour.  
The PCA model for the whole sample set showed no separation based on either mode of delivery or 
occurrence of labour (Appendix: Figure 89 and Figure 90). The supervised O-PLS model analysing 
the differences between the modes of delivery was created using one orthogonal component and the 
final R
2
Y value was 23% while Q
2
Y value was 13% (Figure 47). Although the Q
2
Y value was above 
the threshold of 5%, the predictability of the model was very low indicating that the variance 
attributable to mode of delivery was much less, for example, than that attributed to GA.  
Before identifying the discriminant metabolites, further OPLS analysis were performed on the subsets 
of samples collected: a) in the 1
st
 week of life, b) in the 3
rd
 week of life, c) from babies born in the 24
th
 
week of GA, and d) from babies born at the 28
th
 week of GA. The results for all of the four subgroup 
analysis showed that there is no difference in metabolic composition between the vaginal delivery and 
Caesarean section as the Q
2
Y values were either negative or below the threshold of 5% (Figure 47).  
 
Figure 45: The O-PLS models for urine samples comparing mode of delivery. The R2Y and Q2Y values for the O-
PLS of urinary metabolic profiles for (A) whole sample set; samples collected (B) at 1st week of life, (C) 3rd week of 
life, (D) from babies born at 24th week of GA, (E) from babies born at 28th week of GA. The dark blue bar presents 
Q2Y while the light blue - R2Y. The bars on the right of each figure show the change after introduction of the 
orthogonal component.  
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Similar results were observed for the O-PLS models comparing the samples collected from babies 
born while the mother was in labour with those born while the mother was not in labour. The Q
2
Y 
values for the whole sample set and four subgroups were negative or below 5% (Figure 48). 
 
Figure 46: The O-PLS models of urine samples created for presence of labour. The R2Y and Q2Y values for the O-
PLS of urinary metabolic profiles for (A) whole sample set; samples collected (B) at 1st week of life, (C) 3rd week of 
life, (D) from babies born at 24th week of GA, (E) from babies born at 28th week of GA. The dark blue bar presents 
Q2Y while the light blue - R2Y. The bars on the right of each figure show the change after introduction of the 
orthogonal component.  
 
These findings suggest that the mode of delivery or presence of labour does not affect the urinary 
metabolic profile, although when the whole data set was used then some evidence of effect on mode 
of delivery was seen. Since this effect is very subtle, it would require validation with a much larger 
test set of samples. 
4.3.vii Metabolic profiles associated with diet 
Due to the complex nature of the feeding regimes for the premature babies, there are number of 
factors that need to be accounted for. The first step undertaken was the comparison of samples 
collected while the baby was on parenteral nutrition (PN) with those collected while the baby was on 
enteral nutrition (EN).  
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As previously mentioned parenteral nutrition is an intravenous injection of nutrients. This route leads 
to the distribution of the macroelements to the tissues without reaching the lumen of the gut. At the 
same time, the liver of the baby on parenteral nutrition is affected differently than when baby is fed 
orally. Enteral nutrition on the other hand, is the food given orally therefore the nutrients must be 
absorbed through the digestive tract.  
Second diet analysis included comparison between two types of enteral nutrition – human milk and 
formula milk. The composition of the human milk and the formula milk which is based on cow’s milk 
differs. One of such examples is the presence of human milk oligosaccharides in the breast milk. 
Those molecules are known to support the growth of beneficial bacteria and reduce the chances of the 
adhesion of pathogenic bacteria to the lumen of the gut. Additionally, human milk, when not 
pasteurised, is a source of important beneficial bacteria. Those factors have a potential to contribute to 
the metabolic profile of the faecal water 
4.3.vii.a Parenteral nutrition vs. enteral nutrition 
The PCA scores plot showed clustering of samples according to the route of nutrition (Figure 47). 
TPN (1) corresponds to total parenteral nutrition which is simply a parenteral nutrition without any 
enteral supplementation. PN + EN (2) are a mixture of parenteral nutrition and enteral nutrition while 
EN (3) is an exclusive enteral nutrition. Clear metabolic differences were apparent relating to the 
route of nutrition and were still retained after removing the potential bias from such variables as PNA 
or GA. 
Due to the fact that there was no information on the ratio of EN to PN, the analysis were simplified by 
classifying samples as collected either when no PN was given (thus purely enteral nutrition) or when 
baby was on support in form of PN (includes TPN and PN+EN).  
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Figure 47: PCA Scores Scatter Plot of whole sample set of NMR urine spectra. Samples are coloured according to 
feeding route. Dark blue (1) represents total parenteral nutrition (TPN), light blue (2) is a mixture of parenteral 
nutrition (PN) with enteral nutrition (EN) and yellow (3) is enteral nutrition (EN). 
 
The O-PLS model was build using 2 orthogonal components with the final R
2
Y and Q
2
Y values being 
68% and 60% respectively. The model was robust as the p-value from the permutation tests was 0.01. 
There were no metabolites associated with exclusive enteral nutrition. However, the presence of 
parenteral nutrition was associated with: myo-inositol (3.27ppm s, 3.29ppm t, 3.54ppm dd, 3.62ppm t, 
4.06ppm t) and a mixture of sugars (3.22ppm s, 3.33ppm multi, 3.38ppm s, 3.42ppm s 3.44ppm s, 
3.49ppm s, 3.51ppm s, 3.67ppm d, 3.69ppm t, 3.72ppm s, 3.75ppm multi, 3.83ppm d, 3.85ppm d, 
3.89ppm s, 3.91ppm s, 4.04ppm t, 4.14ppm d, 4.20ppm s, 4.24ppm s, 4.51ppm s, 4.65ppm d, 4.96ppm 
t, 5.03ppm d, 5.11ppm s, 5.24ppm multi, 5.37ppm s, 5.40ppm s, 6.49ppm d) (Figure 58).  
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Figure 48: Orthogonal Partial Least Squares (O-PLS) loadings plot of urine metabolic profiles coming from samples collected at multiple time points and created in accordance to the 
route of nutrition. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with enteral nutrition (up) or parenteral nutrition (down). Annotated 
metabolites: 1. myo-inositol, 2. sugars. The insert bottom right: R2Y (light blue bar) and Q2Y (dark blue bar) values showing 68% and 60% respectively. The permutation tests for Q2Y 
retrieved p-value = 0.01. 
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4.3.vii.b Human milk vs. formula milk 
The analysis focused on the influence of human milk thus samples were classified as either a) human 
milk given (includes exclusive and mixed feeding) or b) formula milk given. The PCA model showed 
a slight separation of samples based on the type of milk (Figure 49).  
 
 
Figure 49: PCA Scores Scatter Plots of whole sample set of NMR urine spectra (principal component 3 vs. principal 
component 1) coloured according to whether human milk was given (dark blue) or formula milk was given (light 
blue). 
 
The O-PLS model was done using one orthogonal component and the R
2
Y and Q
2
Y values equalled 
43% and 33% respectively.  The model was robust as the p-value from the permutation tests was 0.01. 
Introduction of formula milk is associated with an unidentifiable chemical compound 1 (0.90ppm t, 
1.70ppm multi, 1.78ppm s, 2.33ppm dd, 4.00ppm dd), and chemical compound 2 (1.87ppm multiplet, 
2.33ppm dd, 2.38ppm d, 3.10ppm t, 6.51ppm d, 6.54ppm d). There were no metabolites associated 
exclusively with human milk (Figure 50). 
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Figure 50: Orthogonal Partial Least Squares (O-PLS) loadings plot of urine metabolic profiles coming from samples collected at multiple time points and created in accordance to the 
type of milk. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with human milk (up) or formula milk (down). The insert bottom right: R2Y 
(light blue bar) and Q2Y (dark blue bar) values showing 43% and 33% respectively. The permutation tests for Q2Y retrieved p-value = 0.01. 
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Table 18: The summary of the models created for the analysis of the changes between the urinary metabolic profiles 
Corrected for Samples PNA GA Sex Mode of delivery Labour 
Human milk 
vs. formula PN vs. EN 
N/A Whole data set Y (4) Y (2) Y (0) Y (1) Y (1) Y (1) Y (1) 
Gestational age 
24
th
 week GA Y (2) X Y (0) N N X X 
28
th
 week GA Y (1) X N N N X X 
Postnatal age 
2
nd
-9
th
 day of life Y (1) Y (1) N N N X X 
15
th
-22
nd
 day of life N Y (0) N Y (0) N X X 
Last day of sample 
collection N N N N N X X 
Postmenstrual age 37
th
 week PMA N X N N N X X 
Type of enteral 
nutrition 
Formula milk Y (4) Y (4) N N N X Y (0) 
Human milk Y (5) Y (3) Y (0) Y (1) N X Y (1) 
Key: 
Y – difference between the classes, positive Q2Y above the threshold value of 0.05 
N – no difference between the classes, negative Q2Y or below the threshold value of 0.05  
(2) – the value in the brackets indicates the number of orthogonal components used in the model 
X – no data as the analysis was not performed
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Table 19: The list of discriminant urinary metabolites identified to be associated with each analysed factor.  
Key: GA – gestational age, PMA – postmenstrual age, PNA – postnatal age. 
Factor Association Metabolite Chemical shift 
PNA 
Increasing  
pantothenate  0.90ppm s, 0.94 ppm s 
acetyl carnitine 2.13ppm s, 2.50ppm dd, 3.18ppm s, 3.62ppm d, 3.83ppm dd 
unknown 2.33ppm dd 
unknown 0.91ppm t, 2.78ppm m 
trimethylamine 2.90ppm s 
malonate 3.12ppm s 
Decreasing sugars 
3.33ppm m, 3.38ppm s, 3.44ppm s, 3.49ppm s, 3.67ppm d, 3.69ppm t, 3.75ppm 
m, 3.83ppm d, 3.85ppm d, 4.04ppm t, 4.14ppm d, 4.20ppm s, 4.24ppm s, 
4.51ppm s, 4.96ppm t, 5.03ppm d, 5.11ppm s, 5.24ppm m, 5.37ppm s, 5.40ppm 
s, 6.49ppm d 
PMA Increasing pantothenate  0.90ppm s, 0.94 ppm s 
GA 
Increasing 
creatinine 3.05ppm s, 4.06ppm s 
myo-inositol 3.29ppm t, 3.52ppm dd, 3.61ppm t, 4.05ppm t 
unknown 3.62ppm d, 3.64ppm t, 3.74ppm s 
hydroxyproline 2.16ppm m, 2.43ppm m, 3.37ppm dt, 3.47ppm dd 4.35ppm dd 
fumarate 6.52ppm s 
malonate 3.12ppm s 
4-hydroxyphenylacetate 3.45ppm s, 6.87ppm d, 7.17ppm d 
methylhydantoin 2.93ppm s 
Decreasing 
bile acids 0.84ppm s 
oligosaccharides 3.70ppm-3.90ppm s 
Parenteral nutrition 
myo-inositol 3.27ppm s, 3.29ppm t, 3.54ppm dd, 3.62ppm t, 4.06ppm t 
sugars 
3.22ppm s, 3.33ppm m, 3.31ppm s, 3.38ppm s, 3.42ppm s 3.44ppm s, 3.49ppm 
s, 3.51ppm s, 3.67ppm d, 3.69ppm t, 3.72ppm s, 3.75ppm m, 3.83ppm d, 
3.85ppm d, 3.89ppm s, 3.91ppm s, 4.04ppm t, 4.14ppm d, 4.20ppm s, 4.24ppm 
s, 4.51ppm s, 4.65ppm d, 4.96ppm t, 5.03ppm d, 5.11ppm s, 5.24ppm m, 
5.37ppm s, 5.40ppm s, 6.49ppm d 
Formula milk 
unknown 0.90ppm t, 1.70ppm m, 1.78ppm s, 2.33ppm dd, 4.00ppm dd 
unknown 
1.87ppm m, 2.33ppm dd, 2.38ppm d, 3.10ppm t, 6.51ppm d, 6.54ppm d 
4.4 Discussion 
The randomised feeding groups (SMOF lipid vs. Intralipid, and incremental vs. RDI concentration of 
amino acids) presented no difference when it came to the urinary metabolic profile suggesting that 
there is no difference in the production of the waste metabolites. The urinary metabonome of preterm 
babies is strongly affected by the postnatal age and gestational age. In case of diet, not only the route 
of nutrition but also the type of milk caused metabolic differences. There were no associations visible 
between the mode of delivery, presence of labour during delivery, sex of the baby and the urine 
metabonome. 
The association of increasing postnatal age with increasing concentration 
of pantothenate (vitamin B5) is not surprising. Pantothenate is known to 
be synthesised by various bacteria including those colonising human gut 
[3, 276-280]. Additionally, animals cannot synthesise vitamin B5 and rely solely on dietary 
consumption or from gut microbial biosynthesis [277, 279, 281]. It seems logical that the older the 
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baby the more likely it is to be colonised by bacteria capable of producing this vitamin. Furthermore, 
it is also known that the concentration of the vitamin B5 increases in the breast milk with duration of 
the lactation and this was reported for both mothers of full-term and preterm babies [282, 283].  
Therefore it is possible that the increase in the concentration of the vitamin B5 is caused by two 
factors simultaneously – the increase of bacterial biosynthesis, and the increase in concentration in 
mother’s milk. Pantothenate is an essential molecule for all living organisms as it is a precursor for 
Coenzyme A (CoA) [276-278, 281, 284, 285] and it was reported before that, since pantothenate is a 
water soluble vitamin, it can be excreted with urine and the excreted concentration correlates to the 
consumption levels [286].  
Another metabolite associated with increasing postnatal age was acetyl 
carnitine. Presence of this chemical compound in urine is not surprising as it 
has been reported before [264, 287-289]. It is created in the human body from 
carnitine and acetyl-CoA [285]. Carnitine is responsible for the transfer of free fatty acids across the 
membranes of mitochondria where they can be utilised [264, 285, 288, 289]. In newborn babies 
carnitine is removed from the organism in the form of acetyl carnitine via the urine [264, 288-290]. It 
had been reported before that the concentration of the acetyl carnitine in blood significantly increases 
after first day of postnatal age [290]. Additionally, carnitine can be found in breast milk and since the 
volume of breast milk given to preterm babies increases over time this could support the observed 
increase in the concentration of acetyl carnitine with age [291]. An interesting observation is that the 
concentration of carnitine in the amniotic fluid drops significantly after the 33
rd
 week of gestation 
which means that babies born before 33
rd
 week of GA are exposed prior to birth to a much higher 
concentration of this molecule than the full-term babies [290]. How this affects the preterm babies is 
yet unknown [290].  
Trimethylamine, which I found to be positively associated with postnatal age, is 
mostly known as a product of decomposition that possesses an unpleasant smell 
[288, 292, 293]. The molecule can be excreted in urine if there was a high 
concentration of carnitine due to the fact that it is a product of bacterial carnitine degradation [264, 
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288, 292, 294, 295]. Since it was already reported that concentration of carnitine increases with 
postnatal age it is possible that the products of its degradation increase in concentration as well. 
Trimethylamine can be also produced as a product of the degradation of choline – it is therefore 
unsure which of the metabolites has contributed as the source for the trimethylmine production [296-
298]. Additionally, women that went into premature labour had lower levels of urinary 
trimethylamine in their first trimester [299]. 
Another compound associated with postnatal age is malonate. It reacts with acetyl-
CoA to form a malonyl-CoA which is an important molecule in biosynthesis of 
fatty acids. It is normal to see a low concentration of malonate excreted in urine 
[300]. It has been reported that diet rich in medium chain fatty acids can result in increased urinary 
excretion of malonate [301]. One possible explanation could be that medium chain fatty acids from 
milk lead to increased concentration of urinary malonate when compared to babies that are mostly on 
parenteral nutrition. Since the shift from fully parenteral to exclusively enteral nutrition is related to 
age and occurs quicker in more mature babies, this could explain why malonate is more concentrated 
in older (higher PNA) and more mature (higher GA) babies. The higher the postnatal age the more 
likely the baby is to be on enteral nutrition. Also the higher the gestational age at birth, the more 
mature the baby is thus again more likely to be fed orally on earlier stage than less mature babies. 
However, malonate was not observed to be associated with any particular route of nutrition.  
It was not possible within the timeframe of this PhD to properly identify the sugars that were 
associated with lower postnatal age since targeted spectroscopic characterisation of sugars is 
challenging. The presence of sugar in urine can be indicative of diabetes. However, premature babies 
have underdeveloped kidneys which do not function properly. The kidneys continue to mature after 
the premature birth and it is logical that the older the baby gets, the more mature the kidneys will be. 
The presence of sugars in the urine may however reflect malfunctioning sugar reabsorption.  
The association of creatinine with an increasing gestational age is a predictable result. The levels of 
creatinine are related to the muscle mass and babies born later in gestation are usually larger than 
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those more premature [302-305]. However, there may be at least two reasons for 
the creatinine levels being associated with gestational age. It is known that in 
healthy well-functioning kidneys there is no reabsorption of creatinine back to 
blood [302-306]. However, premature babies do not have properly functioning kidneys and it has 
been reported that higher gestational age is associated with lower creatinine levels in serum which 
indicates that urinary excretion was higher [302, 305, 307, 308]. It is however important to mention 
that newborn babies have urinary creatinine levels that are initially the same as their mothers due to 
creatinine transfer through placenta [302, 307, 309]. Subsequently the creatinine level drastically 
drops to an infant’s own level and rises again in correspondence with the infant’s growth and gain in 
muscle mass. Therefore, if not enough timed samples have been collected or the time-points fall in the 
time-frame too close to birth, it is possible to observe the opposite result – with creatinine levels 
dropping with postnatal age. 
Myo-inositol, a compound found to be associated with gestational age, is a most 
important stereoisomer of inositol [285, 310]. Inositol is produced in the human 
body from glucose and is used as a building block of many cellular secondary 
messengers [285, 310, 311] and a number of clinical trials had found that inositol helps to cure 
various psychiatric conditions [310-312]. There are reports of increased levels of inositol in the urine 
of babies with inappropriate size for gestational age (both for too small and too large babies) [313-
315]. The most likely explanation why myo-inositol was found to be associated with higher 
gestational age is that breast milk contains this compound and, as previously described, more mature 
babies are more likely to be put on exclusive enteral nutrition earlier [316, 317]. In contrast to above 
hypothesis, it was observed that myo-inositol in urine was associated with parenteral nutrition which 
is consistent with the fact that myo-inositol should be fully reabsorbed to blood and only diabetics or 
people with renal disorders generally have this compound present in their urine [318]. Babies on 
parenteral nutrition are usually younger (postnatal age) than those on full enteral nutrition thus it 
would be logical for their kidneys to be unable to reabsorb the myo-inositol. The above hypothesis is 
also supported by our finding that other sugars are also found at higher levels in the urine of babies on 
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parenteral nutrition (compared to those fed orally). To my knowledge, there is no evidence in the 
literature as to why babies born at later gestational age have more myo-inositol in their urine thus this 
issue requires further investigation. The model which reported this association, even though being 
predictable and representative for the sample set – was not robust. 
As previously reported by Atzori et al. proline has been found to have a 
decreased concentration in premature babies compared with full term ones 
[267]. Therefore, it is not surprising that it was observed an association of 
hydroxyproline (a hydroxylated proline) with gestational age. Proline and hydroxyproline are 
important components of collagen and are necessary for maintenance of a healthy skin. The reported 
association came from a not robust model. 
Fumarate is a product of both citric acid and urea cycles thus it is possible to 
find it in urine [319-321]. The excretion of citric acid cycle metabolites is said 
to be a form of acid-base equilibrium management [321]. It was previously 
reported that babies fed orally have higher concentration of fumaric acid in their urine compared to 
parenterally fed ones [320]. However, this study did not account for potential bias from postnatal age. 
However, if the findings from this study are considered to be correct, the results can be interpreted as 
an association between higher concentration of fumarate and higher gestational age and could be 
explained by the fact that more mature babies are more likely to switch from parenteral nutrition to 
enteral nutrition earlier than those less mature. Another explanation for positive association of 
fumarate with higher gestational age may be due to better functioning kidneys in the more mature 
babies thus more efficient filtration and management of the acid-base balance. Another hypothesis is 
that perhaps the urea cycle, which takes place in the liver, is more effective in more mature babies 
whose liver is less overloaded with effects of parenteral nutrition. Yet again, there may be multiple 
reasons that contribute to the observed difference in the fumarate concentration.  
A singlet at δ2.93 consistent with the chemical shift of methylhydantoin has 
been found as associated with the gestational age. The other singlet expected 
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from this molecule (δ4.07) had not been observed possibly because the urinary concentration of the 
compound is very low (barely detectable by the 
1
H NMR spectroscopy). Methylhydantoin is a product 
of bacterial degradation of creatinine [322, 323] which was observed in Pseudomonas, Bacillus, 
Corynobacterium, Flavobacterium, Escherichia, Proteus and Clostridium species [322-327]. It would 
be a very interesting finding as it would support the findings from the studies that reported presence of 
creatinine degrading bacteria in human stool and urine [324-329]. Additionally, since levels of 
creatinine in urine are associated with gestational age, it would make sense that the product of its 
degradation would be associated as well. The reported association came from a not robust model. 
Finding for 4-hydroxyphenylacetate being associated with the 
gestational age is interesting as this molecule can be found in olive oil 
which is one of the components of the SMOF lipid that is given 
intravenously to babies [330, 331]. However, this source of the metabolite is probably not important 
as no difference between the randomized feeding groups was observed and if the 4-
hydroxyphenylacetate was coming solely from the olive oil from the SMOF lipid the separation of 
samples based on the type of lipid the babies were receiving intravenously would be observed. 
Therefore, it is far more likely that the source of 4-hydroxyphenylacetate was the gut microbial 
catabolism of amino acids [320, 332-336]. Following the more possible hypothesis, if the source of 4-
hydroxyphenylacetate is from the catabolism of amino acids, then perhaps the reason why this occurs 
more often in more mature babies is probably due to the fact that they are less deprived of amino acids 
than the more preterm babies. This issue would require further 
investigation. 
Bile acids were the only group of metabolites found to be associated with 
lower gestational age. Such an association has been reported previously 
[273, 274]. Cholic acid and chenodeoxycholic acid are primary bile acids which are produced in the 
liver from cholesterol and are excreted to facilitate the lipid absorption [5, 33, 337]. In humans bile 
acids are conjugated to glycine and are transferred from ileum to the liver [33]. Some bacterial species 
can deconjugate those bile acids which results in shortage of their reabsorption to the liver and leads 
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to production of secondary bile acids [33]. Additionally, if the liver is dysfunctional the bile acids can 
be excreted in the urine [274, 337-339]. Premature babies do not have fully functional livers and 
additionally they can be affected by the hepatotoxic effects of parenteral nutrition [340]. One possible 
explanation as to the reason that urinary excretion of bile acids is associated with lower gestational 
age, therefore, is probably due to not fully functioning liver. Altering the bile acid balance can lead to 
obesity and insulin resistance [33]. 
The sex of the baby did not appear to have any influence on the metabolic profile of urine. Perhaps at 
this stage of life there are no metabolic differences between boys and girls that would be observable in 
the urine. Additionally, neither mode of delivery nor presence of labour had an effect on the urinary 
metabolism of the babies. It is possible that it is too early to observe any metabolic changes between 
babies born via two different delivery routes. When it comes to diet, the route of nutrition (parenteral 
vs. enteral) has a strong influence on the urinary metabolic profile of the preterm babies. It is however 
very difficult to discuss the results as the switch from parenteral to enteral nutrition is strongly linked 
with increasing postnatal age. Therefore, it is not possible to determine which of those factors (or if 
both simultaneously) affect those metabolic changes. There was visibly a clear separation between 
samples based on the type of milk they were given but the identification of chemical compounds 
responsible for this difference was not possible.  
4.5 Conclusion 
Metabolites found to be associated with increasing postnatal age were either related to bacterial 
activity or to the introduction of enteral nutrition. The presence of sugars in the earlier postnatal age 
indicates underdeveloped kidneys, which with time improve their functionality and reabsorptive 
capacity for sugars. It seems that the most important factors contributing to metabolic changes 
presented in the urine are postnatal age and diet (both the route of nutrition and the type of milk). Not 
all of the discriminant metabolites were identified, thus further research should be undertaken to fully 
answer the question how exactly diet affect the metabolic changes in premature babies. 
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Chapter 5 – The stool metabonome of the preterm baby 
5.1 Introduction 
Stool is mostly composed of water, undigested food, bacteria and their metabolites and its 
composition can hold information relating to the nutritional, pathologic and physiological 
environment of an individual [341].  A number of studies have been performed to assess the metabolic 
profile (metabonome) of adult stool [261-264, 342-347]. It is known that diet and bacterial 
composition are the major factors affecting the metabonome [261, 346, 348, 349]. However, little is 
known about the metabolic changes in premature babies [261]. Premature babies not only have 
underdeveloped guts but also undergo a different nutrition regime compared to term born babies, are 
exposed to prolonged hospitalisation and antibiotic therapies [350, 351]. When analysing the results 
of the faecal water metabolic profiles it was important to take into account factors which are already 
known to affect metabolic profile in stool or that are linked to changes in gut microbiota and thus may 
lead to changes in metabonome. Those factors include age [38, 86, 352], diet [9, 34, 58, 60, 65, 70, 
71, 77, 85, 93, 353-365], mode of delivery [47, 53, 55, 56, 60, 73-75, 366-372], exposure to 
antibiotics [78, 373-375], and sex of the baby [20, 38, 86, 376]. The detailed explanation of the impact 
of each of those factors on the microbiota profile had been given in the Background chapter (section 
1.2.iii). Ability to understand the influence of early life interventions on the metabolic profile could 
help to improve the care at the hospital and later in life. Prematurity is already known to be associated 
with number of adverse health outcomes like obesity and high blood pressure. This analysis could 
contribute to further understanding of the changes that occur after premature birth [143, 144, 351, 
377, 378]. 
In order to answer this question faecal water was extracted and 
1
H NMR acquisition of all the stool 
samples was performed. After obtaining the spectra an unsupervised Principal Component Analysis 
(PCA) model for the whole data set (including multiple time points for each baby) was created. The 
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samples were coloured according to their class a) gestation age, b) postnatal age), c) sex, d) mode of 
delivery and e) diet. Next, a supervised Orthogonal Partial Least Squares analysis (O-PLS) for those 
classes was performed in order to find discriminant metabolites – biomarkers for each factor. The 
analyses were continued on stratified subgroups of samples in order to control for some of the 
confounding factors.  
5.2 Experimental design  
5.2.i Stool sample preparation 
Faecal water had been extracted from 100mg of stool sample by mixing with 250µl of 25% 
Acetylonitrile (in the molecular grade water). Mixture was homogenized by bead beating for 10s with 
1mm Zirconium beads. Faecal water was collected and aliquoted.  After evaporating the acetonitrile 
from the fraction for the NMR analysis, the powder was resuspended in the starting volume (50µl) of 
D2O and topped-up with the buffer to a final volume of 600µl. Please see the Materials and Methods 
chapter (section 2.2.ii.b) for the detailed sample preparation and the Method Development chapter for 
the details of the protocol validation. 
5.2.ii Nuclear Magnetic Resonance spectra acquisition 
Please see the Materials and Methods chapter (section 2.2.i.b) for the detailed information on the 
acquisition of NMR spectra. The parameters used for the standard pulse sequence of the faecal water 
sample were: P1=11.47µs, Pl1=12.50-dBW, Pl9=46.96dB and O1=2830Hz. 
5.2.iii Sample pre-processing  
Spectra for the NEON faecal water samples were preprocessed and modeled in Matlab. The first step 
was to model all spectra and the quality controls (QCs) in order to check if there are any instrumental 
batch effects. The Principal Component Analysis (PCA) scores plot for the model was calculated for 3 
principal components giving a cumulative R
2
 of 25.7%. The QC samples clustered together in the 
centre of the plot indicating that the analytical data and the chosen normalization method were 
appropriate (Figure 51). The second stage of analysis included modeling only the NEON faecal water 
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samples, without the QCs. The model for the whole data set (also referred to as multiple time points) 
that is presented in the results section (section 5.3) was calculated using 3 principal components (PC) 
giving a cumulative R
2
 of 21.7%. This shows that there is a very high variability between the faecal 
water samples which makes the analysis more difficult.  
 
 
Figure 51: Scores scatter plot of the principal component analysis (PCA) model of faecal water NMR spectral data 
generated from samples collected at multiple time points (whole data set). Quality control samples coloured red. 
 
Initially, all spectra corresponding to multiple time points for 160 babies were modeled to get an 
overview of the dataset. Due to the fact that the samples came from the randomized clinical trial it 
was crucial to firstly assess if there is any difference between the randomised groups. Then, in order 
to identify the factors contributing to the main source of the variation on scores plot, the unsupervised 
models for multiple time points was coloured according to classes obtained from the NEON metadata. 
Those variables included: a) postnatal age, b) gestation age at birth, c) mode of delivery, d) presence 
of labour, e) sex, f) route of nutrition (parenteral or enteral), and g) type of enteral nutrition (formula 
milk or human milk). The second step of preliminary analysis was to perform a supervised analysis 
using the Orthogonal Partial Least Squares model (O-PLS) in order to find discriminant metabolites 
associated with particular classes of samples. The results from those steps help to understand which of 
the known factors have to be controlled for while analysing the influence of the others. In order to do 
so, analysis is continued on several smaller subsets. 
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5.3 Results 
5.3.i Metabolic profiles associated with randomised PN feeding group 
In order to avoid a possible bias from PNA, the analysis on randomised groups was done after 
subtracting samples from the whole data set. Three time points have been chosen: (a) 1
st
 -14
th
 day of 
life when babies were still exposed to parenteral nutrition and high number of samples was available, 
(b) 22
nd
-35
th
 day of life when babies were off parenteral nutrition and large number of samples was 
available, and (c) last sample collected provided it was after 32
nd
 week of life. If there was more than 
one sample available in particular time frame for a baby then the one collected earlier was included. 
All three PCA models were calculated using 3 principal components and the cumulative R
2
 equalled: 
(a) 34.3% (b) 30.6% and (c) 27.9%.  
5.3.i.a Intralipid vs. SMOF lipid 
The scores plots for all of the unsupervised Principal Component Analysis models showed no 
separation based on the type of lipid emulsion (Appendix: Figure 91, Figure 92 and Figure 93). The 
supervised models (O-PLS) confirmed the lack of difference between the randomised groups (Figure 
53). The Q
2
Y value was negative for the PLS model (no orthogonal component) in all three tested 
time points.  
 
Figure 52: The O-PLS models for stool samples comparing the types of lipids. The R2Y and Q2Y values for the O-PLS 
of faecal water metabolic profiles representing samples collected (A) between 1st-14th day of life, (B) between 22nd-35th 
day of life, (C) the last sample prior to discharge.  The dark blue bar presents Q2Y while the light blue – R2Y. The 
bars on the right of each figure show the change after introduction of the orthogonal component.  
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The introduction of the orthogonal component led to the increase of the Q
2
Y value for the first tested 
time point, however it was still below the threshold of 5%. The two remaining time points had a 
negative Q
2
Y value. Those findings suggest that the type of lipid emulsion provided intravenously 
does not influence the metabolic profile of faecal water. It is important to mention that faecal water 
was tested for the presence of lipids with a negative result. 
5.3.i.b Recommended daily intake vs. increasing concentration of amino acid 
The scores plots for the unsupervised models (PCA) showed no separation based on the concentration 
of amino acids (Appendix: Figure 94, Figure 95 and Figure 96). The O-PLS models gave negative 
Q
2
Y values for all tested time points (Figure 53). Such result confirmed the lack of difference between 
the groups randomised according to the concentration of amino acids. 
 
Figure 53: The O-PLS models for stool samples concentration of amino acids. The R2Y and Q2Y values for the O-PLS 
of faecal water metabolic profiles representing samples collected (A) between 1st-14th day of life, (B) between 22nd-35th 
day of life, (C) the last sample prior to discharge.  The dark blue bar presents Q2Y while the light blue – R2Y. The 
bars on the right of each figure show the change after introduction of the orthogonal component. 
 
 
Due to lack of differences between the randomised groups it was acceptable to merge the groups for 
further exploratory analysis.  
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5.3.ii Metabolic profiles associated with gestational age (GA) 
The PCA scores plot for components PC1 vs. PC2 coloured according to gestational age (GA) showed 
no clustering of samples according to class. Components PC3 vs. PC1, which are shown in Figure 55, 
represent the most evidence of clustering according to GA. 
Using the supervised modeling approach to maximize the effect of GA on sample composition it was 
observed that there is a metabolic difference related to the GA. The O-PLS model was built with one 
orthogonal component leading to the increase of the R
2
Y value to 23% and in the Q
2
Y value to 16%. 
The O-PLS score plot, shown in Figure 56, presents the results for the increasing GA from the bottom 
to the top. Metabolites associated with higher GA include two unknown molecules (1.21ppm s, and 
1.84ppm dd, 2.21ppm d, 2.23ppm d), acetate (1.92ppm s), N-acetylated glycoprotein (2.05ppm s), 
glutamate (2.12ppm d, 2.14ppm s, 2.36ppm multi), γ-aminobutyrate (1.90ppm multi, 2.30ppm t, 
3.01ppm t), and aspartate (2.68ppm q, 2.81ppm dd) (Figure 55). There were no metabolites associated 
with lower GA.  
 
Figure 54: PCA Scores Scatter Plot of whole data set of NMR stool spectra. Samples coloured according to gestation 
age (in weeks). 
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In order to confirm the findings, samples were grouped in order to have the same variable for 
postnatal age and the analysis was continued on two subsets of samples: a) collected in the 2
nd
 week 
of life (113 samples) and b) collected in the 3
rd
 week of life (127 samples). Those time points were 
chosen due to the availability of the highest numbers of samples. Samples from 1
st
 week of life, 
although well represented in numbers, were not used due to possible bias from combining normal 
stool samples with meconium. Meconium is a first stool sample passed by the newborn baby. It is 
predominately made of mucus and amniotic fluid therefore its composition varies drastically from the 
normal stool. 
The PCA scores plot for the samples collected on the 2
nd
 week of life was calculated from 3 principal 
components giving a cumulative R
2
 of 30.8%. The PCA scores plot showed no clustering based on 
GA (Appendix: Figure 97) and the Q
2
Y for the O-PLS dropped from 11% for no orthogonal 
component to 9% for the orthogonal component. The orthogonal component was removed and 
supervised PLS analysis was performed. The PLS loadings plot showed that bile acids (1.09ppm s), 
are associated with lower gestation age. At the same time betaine (3.28ppm s, 3.90ppm s) was found 
to be associated with increasing GA. 
The PCA scores plot for the samples collected on the 3
rd
 week of life was also calculated from 3 
principal components and the cumulative R
2 
equaled 29.3%. There was no clustering visible on the 
PCA scores plot (Appendix: Figure 98) and the Q
2
Y for the O-PLS dropped again, this time from 32% 
to 29% after introduction of the orthogonal component. The PLS model was used instead and the 
loadings plot showed that unidentified molecule (1.37ppm s) and N-acetyllysine (1.48ppm multi, 
1.71ppm multi, 1.99ppm s, 3.01ppm t, 3.18ppm t) were associated with lower GA.  No metabolites 
were found to be associated with increasing GA. 
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Figure 55: Orthogonal Partial Least Squares (O-PLS) loadings plot of stool metabolic profiles coming from samples collected at multiple time points and created in accordance to the 
gestational age. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with (increasing – up or decreasing – down) gestational age. Annotated 
metabolites: 1. bile acids, 2. N-acetyllysine, 3. γ-aminobutyrate, 4. acetate, 5. N-acetylated glycoprotein, 6. glutamate, 7. aspartate, and 8. betaine. The insert bottom right: R2Y (light 
blue bar) and Q2Y (dark blue bar) values showing 23% and 16% respectively. P-value from the permutation analysis was 0.01. 
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5.3.iii Metabolic profiles associated with postnatal age (PNA) 
The PCA score plots showed clustering according to postnatal age (PNA) presented in weeks. This 
was especially visible for the components PC3 vs. PC1 (Figure 56). 
 
Figure 56: PCA Scores Scatter Plot of whole data set of NMR stool spectra. Samples coloured according to postnatal age (in weeks) 
 
The O-PLS was calculated with three orthogonal components which suggest that there was a very 
high variability between the samples as orthogonal component are meant to remove the differences 
caused by the natural variability (Figure 57). The final R
2
Y and Q
2
Y values were 66% and 52% 
respectively. The O-PLS scores plot showed that bile acids (0.64ppm s, 0.78 ppm s, 1.09 ppm s, 5.54 
ppm multi) were associated with decreasing PNA. There were no metabolites associated with 
increasing PNA (Figure 57). In order to avoid the possible bias of the gestational age (GA) I have 
chosen two subsets of samples: a) samples from babies born at the 24
th
 week of gestation (94 samples) 
and b) samples from babies born at the 28
th
 week of gestation (142 samples). 
The PCA scores plot for the 24
th
 GA was calculated using 3 principal components giving a cumulative 
R
2
 of 30.9%. No clear separation was visible (Appendix: Figure 99). However, R
2
Y and Q
2
Y for the 
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O-PLS increased after the introduction of the orthogonal component and equaled 85% and 38% 
respectively. The PCA scores plot for the 28
th
 GA was calculated using 3 principal components giving 
cumulative R
2
 of 30.5% (Appendix: Figure 100). The introduction of the orthogonal component in the 
O-PLS analysis increased the R
2
Y and Q
2
Y to 57% and 45% respectively. The O-PLS scores plots 
showed that increasing PNA is associated with alanine (1.48ppm d), acetate (1.92ppm s), 
trimethylamine (2.88ppm s), tyramine (2.93ppm t, 6.91ppm d, 7.23ppm d). Bile acids (0.78ppm s, 
1.09ppm s, 5.54ppm multi) were found to be associated with decreasing PNA. 
In order to avoid a potential bias from the type of enteral nutrition, samples were stratified based on 
the type of milk given. This gave two models, both of which were calculated with 3 principal 
components. The first model (built on samples collected only while exclusively on breast milk) gave 
cumulative R
2
 of 26.7%. The PCA scores plots showed separation according to PNA and the O-PLS 
gave R
2
Y of 46% and Q
2
Y of 38%. The second model built on samples collected only while 
exclusively formula fed gave cumulative R
2
 of 29.1% and. The PCA scores plots showed separation 
according to PNA and the O-PLS gave R
2
Y of 62% and Q
2
Y of 40%. After removing the variability of 
diet the O-PLS scores plots showed that increasing PNA is associated with pantothenate also known 
as vitamin B5 (0.95ppm s), unknown metabolite (0.92ppm multi, 1.39ppm s, 1.98ppm s, 3.01ppm t, 
3.18ppm t), alanine (1.48ppm d), cadaverine (1.45ppm multi, 1.72ppm multi, 3.01ppm t), unknown 
metabolite (2.13ppm d, 2.36ppm multi, 2.80pm d, 2.83ppm d), trimethylamine (2.88ppm s) thiamine 
(3.19ppm t), scyllo inositol (3.35ppm s), unknown metabolite (2.87ppm s, 3.35ppm s, 3.39ppm s, 
3.42ppm s), and an unknown metabolite (2.60ppm s, 2.87ppm s, 5.07ppm , 7.32ppm s, 7.61ppm 
multi). Findings for bile acids (0.64ppm s, 0.78ppm s, 1.09ppm s, 5.54ppm multi) being associated 
with decreasing PNA were confirmed. Since postnatal age has a strong influence on the model, the 
analysis of the other factors was additionally done working on smaller subgroups of samples collected 
on certain weeks of life. 
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Figure 57: Orthogonal Partial Least Squares (O-PLS) loadings plot of stool metabolic profiles coming from samples collected at multiple time points and created in relation to 
postnatal age. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with (increasing – up or decreasing – down) postnatal age. Annotated 
metabolites: 1. bile acids, 2. pantothenate, 3. cadaverine, 4. alanine, 5. acetate, 6. trimethylamie, 7. tyramine, 8. thiamine. The insert bottom right: R2Y (light blue bar) and Q2Y (dark 
blue bar) values showing 66% and 52% respectively. P-value from the permutation analysis was 0.01.
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5.3.iv Metabolic profiles associated with sex 
The PCA scores plots modeled for the whole data set showed no clustering according to sex of the 
baby (Appendix: Figure 101). Additionally the Q
2
Y value in the O-PLS analysis was below 5% which 
indicates a very weak prediction (Figure 58). Controlling for postnatal age found no difference 
between the sexes of the babies while the findings after controlling for the gestational age were 
inconsistent (Figure 58).  
 
Figure 58: O-PLS models for stool samples comparing sex of baby. The R2Y and Q2Y values for the O-PLS of faecal 
water metabolic profiles representing (A) whole sample set; samples collected (B) from babies born at 24th week of 
GA, (C) from babies born at 28th week of GA, (D) at 2nd week of life, (E) 3rd week of life. The dark blue bar presents 
Q2Y while the light blue – R2Y. The bars on the right of each figure show the change after introduction of the 
orthogonal component. 
This strong variability between results suggests that the underlying factors affecting the model were 
not normally distributed between the sexes of the baby. The multiple time points analysis is however 
of no use for assessing the influence of sex on the metabolic profile as prematurity itself is associated 
with sex and males are more likely to be born preterm. There were not enough samples to create a 
subgroup with both GA and PNA variables removed simultaneously. Therefore, obtained results 
suggest that there is no influence of sex of the baby on the metabolic profile of the stool. Yet there 
seems to be a possible association between the sex of the baby and the length of the stay at the unit 
which would explain the bias coming from the unevenly distributed PNA between the samples. 
Therefore controlling for the sex of the baby was not necessary in further analysis of the faecal water 
metabonome.  
Development of gut microbiota and metabolic changes in preterm babies 
 
PhD Thesis                                                    Natalia Przysiezna 139 
 
5.3.v Metabolic profiles associated with mode of delivery 
The NEON dataset provided a detailed information about mode of delivery which was divided into: a) 
vaginal - natural, b) vaginal – with use of forceps, c) Caesarean elected – in labour, d) Caesarean 
elected – not in labour, e) Caesarean emergency – in labour and f) Caesarean emergency – not in 
labour. For the analysis the classification was simplified as either Caesarean section or vaginal 
delivery. 
The PCA scores plots showed no separation based on the mode of delivery (Appendix: Figure 102) 
and the Q
2
Y value in the O-PLS was below 5% which indicated a very weak prediction of the model 
(Figure 59). After controlling for the variables like PNA and GA, the results showed that there is no 
difference between vaginal delivery and Caesarean section when it comes to stool metabolic profile as 
O-PLS retrieved a negative Q
2
Y
 
value (Figure 59). Therefore it suggests that mode of delivery has no 
impact on the metabolic profile of the stool. 
 
Figure 59: The O-PLS models for stool samples comparing mode of delivery. The R2Y and Q2Y values for the O-PLS 
of faecal water metabolic profiles representing (A) whole sample set; samples collected (B) from babies born at 24th 
week of GA, (C) from babies born at 28th week of GA, (D) at 2nd week of life, (E) 3rd week of life. The dark blue bar 
presents Q2Y while the light blue – R2Y. The bars on the right of each figure show the change after introduction of 
the orthogonal component.  
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The same PCA scores plots were coloured according to labour (all vaginal deliveries were classified 
as in labour). There was no separation visible on the PCA scores plots (Appendix: Figure 103) and the 
O-PLS analysis showed a Q
2
Y value below 5% (Figure 60). Similarly as to vaginal delivery vs. 
Caesarean section, the sample subtracting for PNA and GA resulted in negative Q
2
Y in the O-PLS 
analysis (Figure 60).  
 
Figure 60: The O-PLS models for stool samples comparing presence of labour. The R2Y and Q2Y values for the O-
PLS of faecal water metabolic profiles representing (A) whole sample set; samples collected (B) from babies born at 
24th week of GA, (C) from babies born at 28th week of GA, (D) at 2nd week of life, (E) 3rd week of life. The dark blue 
bar presents Q2Y while the light blue – R2Y. The bars on the right of each figure show the change after introduction 
of the orthogonal component. 
 
This suggest that being born while mother was in labour does not significantly affect the metabolic 
profile of stool, compared to being born while mother was not in labour. Those results show that there 
is no need to worry about the bias from the variable mode of delivery or labour while analysing the 
faecal water metabolic profiles. 
5.3.vi Metabolic profiles associated with diet 
Similarly to the urinary metabonome (Urine Metabonome chapter, section 4.3.vi), there are number of 
dietary factors that need assessment. Those include comparison of: a) parenteral nutrition (PN) with 
enteral nutrition (EN), and b) type of milk (human milk vs. formula milk).  
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5.3.vi.a Parenteral nutrition vs. enteral nutrition 
The PCA scores plot for components PC3 vs. PC1 is shown in Figure 61 which presents clustering of 
samples according to route of nutrition. TPN (1) corresponds to total parenteral nutrition which is 
simply a parenteral nutrition without any enteral supplementation. PN + EN (2) are a mixture of 
parenteral nutrition and enteral nutrition while EN (3) is an exclusive enteral nutrition. After removing 
the variables for PNA, and GA, the distinctive clustering based on route of nutrition remained. 
Due to lack of the detailed information on the ratio of EN over PN it was not possible to do the 
supervised analysis for the continuous variable (increasing ratio of enteral nutrition). Exclusion of the 
samples that were collected while the baby was on the mixed PN+EN diet would result in strongly 
unbalanced groups since only 4% of samples were collected during being exclusively on TPN while 
74% of samples while exclusive enteral nutrition. Therefore the analysis was performed comparing 
two groups: a) samples from babies fed only orally, and b) samples from babies on parenteral nutrition 
regardless if were or were not supplemented orally (Figure 62).  
 
Figure 61: PCA Scores Scatter Plot of whole sample set of NMR stool spectra. Samples are coloured according to 
feeding route. Dark blue (1) represents total parenteral nutrition (TPN), light blue (2) is a mixture of parenteral 
nutrition (PN) with enteral nutrition (EN) and yellow (3) is enteral nutrition (EN). 
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Figure 62: PCA Scores Scatter Plot of whole sample set of NMR stool spectra. Samples are coloured according to 
feeding route. Dark blue (1) represents samples collected while the baby was on the support of parenteral nutrition, 
while the light blue (2) are the samples collected while the baby was exclusively on enteral nutrition (EN). 
 
The O-PLS model was built with two orthogonal components giving the final R
2
Y and Q
2
Y values 
59% and 50% respectively. The results showed that the introduction of parenteral nutrition is 
associated with bile acids (0.63-0.83 ppm, 1.09 ppm s, 5.54 ppm s) (Figure 63). 
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Figure 63: Orthogonal Partial Least Squares (O-PLS) loadings plot of stool metabolic profiles coming from samples collected at multiple time points and created in accordance to the 
route of feeding. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with enteral nutrition (up) or parenteral nutrition (down). Annotated 
metabolites: 1. bile acids. The insert bottom right: R2Y (light blue bar) and Q2Y (dark blue bar) values showing 59% and 50% respectively. P-value from the permutation analysis 
was 0.01. 
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5.3.vi.b Human milk vs. formula milk 
The PCA scores plots of the whole data set showed a distinctive separation based on the type of 
enteral nutrition. The R
2
 for PC1, PC2 and PC3 was 16.5%, 5.5% and 4.7% (Figure 64). 
 
 
Figure 64: PCA Scores Scatter Plot of whole sample set of NMR stool spectra. Samples are coloured according to 
type of enteral nutrition. Panel A shows principal components 1 and 2 while panel B principal components 1 and 3. 
The dark blue (1) dots represent the samples collected while the baby was on human milk while the light blue (2) 
represents the samples collected while the baby was fed formula milk.   
 
The supervised O-PLS model was calculated using two orthogonal components and the R
2
Y and Q
2
Y 
values were 46% and 34% respectively (Figure 65). The discriminant metabolites associated with 
human milk include: an N-acetylated glycoprotein (2.04ppm s), and lactose (3.29ppm t, 3.50-4.00ppm 
multi, 4.45ppm d, 4.67ppm d, 5.23ppm d). The formula milk are associated with: pantothenate – vit 
B5 (0.91ppm s and 0.94ppm s), unknown chemical compound (0.92ppm d), N-acetyllysine (1.42ppm 
multi, 1.72ppm multi, 2.02ppm s, 2.98ppm t, 3.00ppm t) and unknown chemical compound (1.52ppm 
multi, 1.59ppm multi, 1.84ppm multi, 1.88ppm multi, 3.12ppm multi, 3.14ppm multi, 3.74ppm multi) 
(Figure 65). 
A B 
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Figure 65: Orthogonal Partial Least Squares (O-PLS) loadings plot of stool metabolic profiles coming from samples collected at multiple time points and created in accordance t type 
of milk. The X axis shows chemical shift in ppm, while the Y axis represents metabolites associated with human milk (up) or formula milk (down). 1. pantothenate, 2. N-acetyllisine, 
3. N-acetylated glycoprotein, 4. lactose. The insert bottom right: R2Y (light blue bar) and Q2Y (dark blue bar) values showing 46% and 34% respectively. P-value from the 
permutation analysis was 0.01. 
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Table 20: The summary of produced models testing the differences in metabolic profile of faecal water 
Accounted for Samples PNA GA Sex Mode of delivery Labour Human milk vs. formula PN vs. EN 
N/A Whole data set Y (3) Y (1) N N N Y (2) Y (2) 
Gestational age 
24
th
 week GA Y (1) X Y (1) N N X X 
28
th
 week GA Y (1) X N N N X X 
Postnatal age 
2
nd
 week of life X Y (0) N N N X X 
3
rd
 week of life X Y (0) N N N X X 
Type of enteral 
nutrition 
Formula milk Y (1) X N N N X Y (1) 
Human milk Y (1) X N N N X Y (1) 
Key: 
Y – difference between the classes, positive Q2Y above the threshold value of 0.05 
N – no difference between the classes, negative Q2Y or below the threshold value of 0.05  
(2) – the value in the brackets indicates the number of orthogonal components used in the model 
X – no data as the analysis was not performed 
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Table 21: The list of discriminant faecal metabolites identified to be associated with each analysed factor. 
Key: GA – gestational age, PNA – postnatal age. 
Factor Association Metabolite Chemical shift 
PNA 
Increasing  
Unknown 0.92ppm multi, 1.39ppm s, 1.98ppm s, 3.01ppm t, 3.18ppm t 
pantothenate 0.95ppm s 
cadaverine 1.45ppm multi, 1.72ppm multi, 3.01ppm t 
Alanine 1.48ppm d 
Acetate 1.92ppm s 
unknown 2.13ppm d, 2.36ppm multi, 2.80pm d, 2.83ppm d 
unknown 2.60ppm s, 2.87ppm s, 5.07ppm , 7.32ppm s, 7.61ppm multi 
unknown 2.87ppm s, 3.35ppm s, 3.39ppm s, 3.42ppm s 
trimethylamine 2.88ppm s 
tyramine 2.93ppm t, 6.91ppm d, 7.23ppm d 
thiamine 3.19ppm t 
Decreasing Bile acids 0.78ppm s, 1.09ppm s, 5.54ppm multi 
GA 
Increasing 
unknown 1.21ppm s 
unknown 1.84ppm dd, 2.21ppm d, 2.23ppm d 
γ-aminobutyrate 1.90ppm multi, 2.30ppm t, 3.01ppm t 
Acetate 1.92ppm s 
N-acetylated glycoprotein 2.05ppm s 
glutamate 2.12ppm d, 2.14ppm s, 2.36ppm multi 
aspartate 2.68ppm q, 2.81ppm dd 
betaine  3.28ppm s, 3.90ppm s 
Decreasing 
bile acids 1.09ppm s 
unknown 1.37ppm s 
N-acetyllysine 1.48ppm multi, 1.71ppm multi, 1.99ppm s, 3.01ppm t, 3.18ppm t 
Parenteral nutrition bile acids 0.63-0.83 ppm, 1.09 ppm s, 5.54 ppm s 
Human milk 
N-acetylated glycoprotein 2.04ppm s 
lactose 3.29ppm t, 3.50-4.00ppm multi, 4.45ppm d, 4.67ppm d, 5.23ppm d 
Formula milk 
pantothenate 0.91ppm s and 0.94ppm s 
unknown 0.92ppm d 
N-acetyllysine 1.42ppm multi, 1.72ppm multi, 2.02ppm s, 2.98ppm t, 3.00ppm t 
unknown 
1.52ppm multi, 1.59ppm multi, 1.84ppm multi, 1.88ppm multi, 3.12ppm multi, 
3.14ppm multi, 3.74ppm multi 
5.4 Discussion 
The metabonomic analysis of the faecal water from preterm babies showed that the diet and postnatal 
age were the strongest contributors to the metabolic changes. In case of diet, not only the route of 
nutrition but also the type of milk caused metabolic differences. Gestational age also contributed to 
the metabolic profile. There were no associations visible between the mode of delivery, presence of 
labour during delivery, sex of the baby and the faecal metabonome.  
The findings for the association of the pantothenate (vitamin B5) in stool with 
increasing postnatal age (PNA) are very interesting as I had reported the same 
findings for association of urinary pantothenate with the PNA (Chapter 4, 
section 4.4). As previously mentioned the presence of vitamin B5 in the human organism can originate 
from dietary sources like breast milk or from bacterial production [277, 279, 281-283, 285, 379, 380]. 
 
 
Pantothenate 
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Our study also found the association of pantothenate with formula milk. To my knowledge, there is no 
literature explaining the possible reason for this. Although the preterm formula milk is supplemented 
with many vitamins, the B5 is not one of them [381]. 
The finding that thiamine (also known as vitamin B1) was associated with 
increasing postnatal age is not surprising as humans (and other animals) are not 
capable of producing it and rely on bacterial biosynthesis or plant consumption [379, 382]. 
Bifidobacteria and Lactobacilli are known to produce thiamine [380, 383]. Therefore, the older the 
baby is the higher the likelihood is of having colonisation of the gut by thiamine-producing bacteria. 
Thiamine has a role in neural function and its deficiency is very dangerous for the health of the brain 
[285, 382].  
Another finding confirming our previous reports (from the urinary 
metabonome) is the association of trimethylamine with increasing postnatal age 
(Chapter 4, section 4.4). As previously mentioned, this compound is a product 
of bacterial decomposition of either choline or carnitinine [264, 285, 288, 292, 294-298, 384]. The 
presence of trimethylamine in the stool of premature baby has not been reported before [385]. In 
animal models the presence of this compound has been associated with diarrhoea (in calves) and 
prematurity (in pigs) [386, 387].  
Acetate was found to be associated with both increasing postnatal age and higher 
gestational age. Acetate is the most common short-chain fatty acid (SCFA) and is a 
well-known end product of bacterial metabolism [388-393]. Its main function in the body is to 
provide fuel for both the liver and muscle metabolism but is also linked to reduced risk of: obesity, 
insulin resistance, and colon cancer [388-394]. The possible explanation for the observed association 
of acetate with increasing postnatal age may be the fact that the older the baby gets, the more bacteria 
colonises the gut thus the higher concentration of the end metabolite – acetate. Additionally, acetate is 
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produced in higher concentration in infants than in adults [394]. No other SCFAs (such as butyrate or 
propionate) were observed associated with increasing postnatal age.  
Alanine, which is associated with increasing postnatal age, is one of the most common 
amino acids [388]. As a non-essential amino acid, alanine can be produced by humans 
and is mainly used in the glucose-alanine cycle which produces energy from the 
protein degradation [388]. One of the possibilities why there is a higher concentration of alanine in the 
stool when the baby gets older can be the fact that older babies have higher muscle mass. 
Tyramine is a derivative of a common amino acid – tyrosine [395-400]. Such 
conversion can be also performed by lactic acid bacteria [395-398, 401]. The 
association of tyramine with increasing postnatal age is probably due to the fact that with increasing 
age, the baby is more likely to be colonised by lactic acid bacteria that can perform the 
decarboxylation of tyrosine to tyramine. Tyramine is biologically relevant as it is a vasoactive amino 
acid and can trigger the nonpsychoactive peripheral sympathomimetic affects [395, 396, 398-400].  
Cadaverine, which was reported associated with increasing postnatal age, is a 
product of protein hydrolysis [402-404]. This molecule originates from the 
amino acid lysine and is usually associated with the putrefaction of dead meat but is also produced in 
small quantities in living organisms and is a common metabolite produced during vaginal bacteriosis 
[405]. A very small concentration of this molecule was observed in the stool and the reason why it 
increases with postnatal age may be related to the increasing muscle mass of the babies, thus 
increased natural metabolism of proteins. Additionally, certain bacterial species that can be found in 
the human gut are capable of facilitating the degradation of lysine to cadaverine [404, 406-409]. 
Therefore it is possible that increased concentration of cadaverine is in fact related to changes of 
bacterial composition that occur over the time. 
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The last molecule associated with increasing postnatal age is scyllo-inositol – a common 
stereoisomer of inositol [310]. As previously mentioned in the Chapter 4 (section 4.4) 
inositol is produced from the glucose and is used as a building block cellular secondary 
messengers [310, 311]. It had also been found to improve the condition of various psychiatric 
disorders [310-312]. Since the human milk contains inositol, and the increasing postnatal age is linked 
with dietary shift from parenteral nutrition to exclusive enteral nutrition, it seems possible that 
increasing levels of scyllo-inositol are caused by the increased volume of enteral nutrition [316, 317].  
Bile acids have been found to be associated with lower postnatal age, lower 
gestational age and parenteral nutrition. Exclusive parenteral nutrition in 
premature babies occurs mostly in the first days of life thus the common metabolic 
finding for both of those factors is not surprising. The association of bile acids with lower gestational 
age had been observed in the urinary metabonome (Chapter 4, section 4.4.). Additionally, it had been 
reported by other studies [273, 274]. As previously described, bile acids are produced either by the 
liver (primary bile acids) or by bacterial metabolism of the primary bile acids (secondary bile acids) 
[5, 33, 337]. The reason for higher concentration of the bile acids in the stool of younger (postnatal 
age-wise) babies may be due to malfunctioning reabsorption of those molecules. The maturing of the 
preterm gut continues after birth and the older the baby, the more functional the gastrointestinal tract 
becomes [351]. Therefore, it is possible that with the increasing postnatal age, the gut improves the 
absorption of bile acids.  
Glutamate, which is associated with increasing gestational age, is non-essential 
amino acid that has an important role as a neurotransmitter [410, 411]. Reduced 
levels of glutamate in premature babies had been found to be associated with the lesions in the white 
matter of the brain [412] and had been found in preterm babies with restricted growth rate [387]. 
Additionally, glutamate is a precursor of an important neurotransmitter – γ-aminobutyric acid 
(GABA) [410, 411, 413, 414]. The transformation of glutamate into GABA can be performed by 
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Lactobacilli and Bifidobacteria which are members of gut microbiota and as previously mentioned are 
commonly found in breast milk and breast fed babies [414-417].  
GABA is another compound found to be associated with increasing gestational 
age. It supports the findings for its precursor – glutamate [410, 413, 414]. 
GABA, in a mature brain is an inhibitory neurotransmitter which reduces the excitability of neurons 
[413]. However, in the developing brain this molecule is responsible for excitement of the developing 
neurons [418-424]. Additionally, until the 32
nd
 week of gestation, 90% of oligodendrocites are still 
immature [425]. The findings of association of GABA with higher gestational age are extremely 
fascinating. This could potentially be one of the explanations why the more premature babies have 
higher chances of neurodevelopmental disorders such as autism [426-430].  
Aspartate, is associated with increasing gestational age, is a non-essential amino 
acid that is produced in ureic cycle from ornithine and citrulline [431, 432]. 
Aspartate can activate the same receptor as glutamate, however with a much 
weaker strength [432]. A study on premature infants found that all the dietary aspartate is metabolised 
and none is lost in the stool [431].  
Betaine, which is associated with gestational age, is a name describing a group of 
molecules which lack hydrogen and have a positively charged cationic functional 
group [285, 433]. The first discovered betaine was trimethylglycine and in this 
study this is the compound that was identified [285, 433]. Betaine is a product of choline oxidation 
whose main function in the organism is to support the methylation [285, 433, 434]. The most 
important metabolites that require methylation are coenzyme Q10, dopamine, serotonine and 
melanine [285, 433]. Betaine can enter the human organism from diet or be produced by gut 
microbiota [285]. A possible explanation why betaine is associated with higher gestational age, may 
be the fact that more premature babies are usually more sick thus are exposed to antibiotics for 
prolonged time. 
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N-acetyllysine, which is associated with lower gestational age and milk other 
than human, is an acetylated form of an amino acid – lysine [435]. The function 
of this molecule is binding to histones which in result regulates the availability 
of DNA for the gene expression [435].   
Lactose is a disaccharide derived from galactose and glucose and is a well-
known component of the human milk [283, 381, 436-450].  Association of 
lactose with breast milk is not a surprising discovery as it had been reported 
before that formula milk has a significantly lower concentration of this sugar than breast milk 
collected from mothers who delivered prematurely. Although the metabonomic analysis were 
performed on the milk samples, not the stool samples of babies that consumed them, it seems logical 
that if breast milk has higher concentration of lactose, then there are higher chances that more of his 
molecule will be disposed undigested. Lactose is an important compound as its role is not only to 
provide nutrition for the baby, but also to promote the growth of healthy microbiota and model the 
immune system [443-446, 448-454]. 
We observed no difference in the stool metabonome in relation to the sex of the baby. Additionally, 
the mode of delivery or the incidence of labour had no influence on the faecal metabolic profile either. 
Perhaps the time frame I analysed was not enough to observe any permanent changes in the 
metabolism. 
5.5 Conclusion 
The findings from this study show that the metabolic profile of faecal water is strongly affected by the 
increasing postnatal age, gestational age at birth, and diet. A number of important molecules such as 
vitamins and neurotransmitters had been positively associated with the increasing maturity (both PNA 
and GA) in newborn babies. The metabolic profile in relation to the types of milk did not surprise as 
lactose is the most prominent sugar in the human milk. 
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Chapter 6 – The development of gut microbiota in the preterm baby 
6.1 Introduction 
Gut microbiota is an essential element in the development and maturation of the human gut. As 
previously described in the Background chapter (section 1.2.iii), there are number of factors affecting 
the development of microbiota. Those include: a) gestational age [61, 64, 79, 455], mode of delivery 
[27, 37, 46-58, 67], route of nutrition [41, 44, 71, 83], type of milk [37, 39, 50, 54, 57, 58, 61-63, 65, 
66, 68-71, 73-76], and exposure to antibiotics [15, 37, 41, 44, 49, 51, 64, 71, 78, 79, 81].  
A detailed report, conducted as a part of systematic review, on what is known for the previously 
mentioned factors and bacterial profiles can be found in the Background chapter (section 1.2.iii). 
Postnatal age is related to the changes in bacterial population due to the fact that at this stage of life 
the gut microbiota is still in the process of development and in the first days of life there is a known 
sequence of bacterial succession, therefore perhaps there are some universal patterns of colonisation 
over the longer period of time. Gestational age may contribute to different patterns of colonisation for 
several reasons. Firstly, premature babies are more likely to be sicker and be on prolonged exposure 
to antibiotics. Additionally, their gut and immune systems are more immature thus they might react 
differently to first colonisers.  
Mode of delivery contributes to the first exposure of the baby to the bacteria outside the womb, and 
since Caesarean section is performed in sterile environment and baby is firstly exposed to the skin and 
environmental bacteria. The current believe is that the gut microbiota of those babies differ from the 
babies born vaginally thus having contact with maternal vaginal and gut microbiota.  
Route of nutrition in this study basically means that baby is either fed intravenously or orally. This 
factor is believed to have a strong impact on the gut bacteria as they require the nutrients in the gut to 
flourish. However, in case of premature babies, the shift of the route of nutrition from total parenteral 
nutrition (TPN) through mixed parenteral (PN) with enteral nutrition to finally fully enteral nutrition 
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(EN), is strongly linked with the postnatal age. Babies in first days of life are on TPN, and then with 
increasing postnatal age the ratio of EN over PN is increasing. 
The effect of the type of milk on the gut microbiota is an interesting subject. There can be two types 
of human milk: mother’s fresh milk and donor’s pasteurized milk. Mother’s fresh breast milk is a rich 
source of bacteria, while the donor’s milk is considered bacteria-free due to the pasteurization 
process. Every type of human milk has oligosaccharides which act as prebiotics not only serving as a 
source of nutrition for the beneficial bacteria but also blocking the receptors on the surface of the 
pathogenic bacteria thus reducing the chance of pathogens colonizing the gut. Additionally, there are 
many different types of preterm formulas. Nutriprem1 – a formula given in Chelsea and Westminster 
Hospital, is a preterm formula rich in prebiotics, however not all the preterm formulas are enriched in 
prebiotics.  
6.2 Experimental design  
6.2.i DNA extraction 
Samples for metataxonomic analysis had been selected if they met both of the criteria: 
1. The matching stool and urine metabolic profile (collected on the same day) must have been 
available 
2. The sample must have been collected from a baby for whom at least 3 samples had met the 
requirements of the 1
st
 criterion and one of those must had come from the first 10 days of life. 
Such strategy allowed us to ensure there would be multiple time points for each included baby and the 
starting point would be in the first 10 days of life. Additionally, the matching spectra would allow us 
to search for potential biomarkers for significant bacteria and bacterial processes. Please see the 
Materials and Methods chapter (section 2.3.ii) for the detailed description of the DNA extraction 
protocol. 214 samples were selected for the DNA extraction. 
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6.2.ii Sequencing 
The sequencing was performed by the Research and Testing Laboratory (USA) on the MiSeq 
platform. The MiSeq platform is a next generation sequencing-by-synthesis method. The first step is 
the attachment of single strands of DNA and multiplication in order to create clusters. Then, with use 
of fluorescently labelled nucleotides, the synthesis of the complementary DNA strand takes place. The 
camera records fluorescent signals which allows the reconstruction of the DNA sequence. More 
details about the MiSeq platform can be found in the Materials and Methods chapter (section 2.3.i.b).  
6.2.iii Sample pre-processing 
The sequencing results were pre-processed and analysed using the Mothur program [254]. After 
assembling the two reads from the paired-end reads (reverse and forward) of the DNA sequence, the 
read depth per sample was analysed and 10 samples with less than 2000 reads were excluded. This 
reduced the number of samples for modeling from 214 to 204. The characteristics of the removed 
samples are presented in the Table 22. Please see the Materials and Methods chapter (section 2.3.iv) 
for the more detailed description of the preprocessing of the sequencing results.  
 
Table 22: The comparison of the characteristics of samples that were included in the modeling and those that were 
excluded from the modeling. 
Sample set 
Postnatal 
age1 
Gestational age 
at birth1 
Sex2 
Mode of 
delivery2 
On 
parenteral 
nutrition2 
Breast milk 
given2,3 
Formula 
milk given2,3 
Included 
(n=204) 
5 
(3.56) 
28 
(1.67) 
Male 
(56%) 
Vaginal 
(42%) 
Yes 
(79%) 
Yes 
(81%) 
Yes 
(31%) 
Excluded 
(n=10) 
5 
(2.23) 
27.5 
(1.16) 
Male 
(50%) 
Vaginal 
(20%) 
Yes 
(10%) 
Yes 
(80%) 
Yes 
(10%) 
Key: 
1 median value and standard deviation given in brackets 
2 Percentage of total population given in brackets 
3 Samples could have been collected when baby was on breast milk, formula milk, both types of milks or none, thus the 
values for the milk do not add up to 100% 
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6.2.iv Data analysis 
6.2.iv.a Analysed factors 
The factors that were analysed include: a) randomised groups b) postnatal age, c) gestational age, d) 
mode of delivery, e) labour f) sex, g) route of nutrition, h) type of milk. The impact of antibiotics on 
the gut microbiota was not assessed as all the babies in this study had been on the broad spectrum of 
antibiotics. 
The first step of the analysis was to check if there are any differences between the randomised groups. 
Postnatal age (in weeks) was regressed against the microbial profiles in order to observe if there are 
any visible patterns of bacterial succession. The time frame of the samples collected from the 1
st
 to the 
15
th
 week of life with the median of samples being collected at 5
th
 week.  Gestational age (in weeks) 
varied from 25
th
 to 31
st
 week with the median for samples collected being from the babies born in the 
28
th
 week of gestation (Table 22). Even though the detailed information on the type of delivery 
(vaginal delivery natural or with forceps, Caesarean section elected or emergency) was available, it 
was decided to keep the analysis simple and group babies according to the mode of delivery as in 
vaginal or Caesarean. For the occurrence of labour babies were divided into those that were not in 
labour (this included emergency caesarean section and elected caesarean section) and those that were 
delivered during the labour (this included spontaneous vaginal delivery, vaginal delivery with forceps,  
emergency caesarean section and elected caesarean section). There have not been enough babies in 
order to look at the influence of the labour for each type of Caesarean section separately. The route of 
nutrition was classified as TPN if there was no enteral nutrition given before, PN if the baby was on 
both enteral nutrition and parenteral nutrition for at least 2 days prior to sample collection, and EN if 
the baby was on the exclusive enteral nutrition for at least 2 days prior to sample collection. Due to a 
high variability in types of milks that the babies were receiving, the primary analysis for this factor 
was to answer the question what impact does the fresh mother’s milk have on the gut microbiota. In 
order to do so mother’s fresh milk (given exclusively or together with any other type of milk) was 
compared with other types of milk.   
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6.2.iv.b Reporting gut microbiota 
The results for the gut microbiota was analysed for all the taxonomic levels: phylum, class, order, 
family and genus. The Figure 67, Figure 68 and Figure 68 show the taxonomic levels for the most 
significant (for this study) bacteria.  
 
 
 
 
 
Figure 66: The most significant for this study members of the Actinobacteria phylum, organized according to their 
taxonomic level.  
Genus 
Family 
Order 
Class 
Phylum Actinobacteria 
Actinobacteria 
Bifidobacteriales 
Bifidobacteriaceae 
Bifidobacteria 
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Figure 67: The most significant for this study members of the Firmicutes phylum, organized according to their taxonomic level.  
 
Figure 68: The most significant for this study members of the Proteobacteria phylum, organized according to their taxonomic level.  
Genus 
Family 
Order 
Class 
Phylum Firmicutes 
Clostridia 
Clostridiales 
Clostridiaceae 
Clostridium 
Negativicutes 
Selenomonadales 
Veilonellaceae 
Veillonella 
Bacilli 
Bacillales 
Staphylococcaceae 
Staphylococcus 
Lactobacillales 
Enterococcaceae 
Enterococcus 
Streptococcaceae 
Streptococcus 
Genus 
Family 
Order 
Class 
Phylum Proteobacteria 
Gammaproteobacteria 
Pseudomonadales 
Pseudomonadaceae 
Pseudomonas 
Enterobacteriales 
Enterobacteriaceae 
E.coli Enterobacter Klebsiella Shigella 
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6.3 Results 
The Principal Coordinates Analysis (PCoA) plots showed that there are 3 most abundant phyla, and 3 
most abundant genera (Figure 69). The phyla were identified as Proteobacteria, Firmicutes and 
Actinobacteria. While the genera were Enterobacteria (belonging to the Proteobacteria phylum), 
Staphylococci (belonging to the Firmicutes phylum) and Bifidobacteria (belonging to the 
Actinobacteria phylum). The 79.2% of variability between the samples was due to the difference in 
the relative abundance of Proteobacteria and Firmicutes. While 18.5% was due to the changes of the 
relative abundance of Actinobacteria phylum. On the genus level the 61.8% of variability was 
explained by the relative abundance of Enterobacteria while the 20.4% of variability was caused by 
the difference in the relative abundance of Bifidobacteria and Staphylococci. 
    
Figure 69:  The Principal Coordinates Analysis plots presenting the separation based on the relative abundance of 
(A) phyla and (B) genera.  
 
Proteobacteria was the most dominant of the all phyla with the average relative abundance of 65% 
(Figure 70). Second most abundant phylum was Firmicutes with the average relative abundance of 
24%. Actinobacteria had average relative abundance of 10%. The remaining 1% of relative 
abundance was distributed between the remaining phyla: Acidobacteria, Bacteroidetes, Fusobacteria, 
Terenicutes and Verrucomicrobia. The most abundant families were: Enterobacteriaceae (64% of the 
average relative abundance), Staphylococcaceae (11%), Bifidobacteriaceae (10%), Enterococcceae 
A B 
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(7%), Streptococcaceae (2%), and Veillonellaceae (2%). All the remaining families had the average 
relative abundance below 1%. 
 
Figure 70: The relative abundance (Y axis) of the Proteobacteria (blue), Actinobacteria (red), and Firmicutes (green) 
phyla among all the samples collected from premature babies (X axis).  
 
The results from qPCR were difficult to interpret without daily information on the antibiotic exposure. 
There were visible patterns suggesting that the bacterial loads were affected by the antibiotics as the 
concentration of bacteria was low (often below the detection threshold) at the birth for every baby. In 
the consecutive weeks the concentration of bacteria was increasing. In some babies there were 
occasions of sudden drop of bacterial load followed by the slow regrowth of the community. Because 
of that, the results of the qPCR will not be mentioned in the further subsections of this chapter. 
6.3.i Randomised groups 
No microbial differences have been observed for any of the randomised groups. The richness (Chao 
index) analysis showed that there was no difference between the types of lipids (11.5 for Intralipid 
and 11 for SMOF lipid) or the two concentrations of amino acids (10.87 for incremental and 12 for 
recommended daily intake). The diversity (Shannon’s index) of the gut microbiota did not differ for 
amino acids (0.66 for incremental and 0.61 for RDI). However, the samples collected from babies on 
SMOF lipid had more diverse gut microbiota (Shannon’s index = 0.73) than samples from babies on 
Intralipid (Shannon’s index = 0.40). 
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6.3.ii Gut microbiota associated with gestational age (GA) 
In order to analyse the association of gut microbial profiles with gestational age, samples were 
grouped according to the GA of the baby at birth. This meant that there had been samples collected at 
different time points. The sample size was not allowing creating classes with the same distribution of 
factors that would cause possible bias for the analysis. There were 20 samples for the 25
th
 week of 
GA, 52 samples for the 26
th
 week, 15 samples for the 27
th
 week, 35 samples for the 28
th
 week, 48 
samples for the 29
th
 week, and 34 samples for the 30
th
 week. After analysing the groups using the 
Kruskal-Wallis H-test few interesting features were observed. At the phylum level, babies born before 
the 28
th
 week of gestation had significantly lower relative abundance of the Actinobacteria. After 
investigating all the taxonomic levels, it was discovered that this trend was due to the Bifidobacteria 
genus (Figure 71). At the same time the relative abundance of the Proteobacteria phylum was much 
more constantly higher in babies born below the 26
th
 week of gestation. The Enterobacteriaceae 
family contributed to this trend (Figure 71). No other microbial differences were observed. 
 
Figure 71: The relative abundance of the (A) Bifidobacteria genus and (B) Enterobacteriaceae family among samples 
collected from babies born at different gestational age. 
 
6.3.iii Gut microbiota associated with postnatal age (PNA) 
Comparing the gut microbiota association with postnatal age at the sample collection was also done 
using the Kruskal-Wallis H-test. Unfortunately some of the groups had less than required by the test 5 
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samples. The number of samples collected in each week of life were: 22 (week 1), 28 (week 2), 28 
(week 3), 22 (week 4), 23 (week 5), 14 (week 6), 18 (week 7), 6 (week 8), 9 (week 9), 10 (week 10), 7 
(week 11), 7 (week 12), 5 (week 13), 4 (week 14), 1 (week 15).  The differences in PNA at five 
different levels: a) phylum, b) class, c) order, d) family, and e) genus were looked at. This gave a 
much deeper understanding of the development of gut microbiota over time.  
There was no significant difference between the relative abundance at any of the taxonomic levels 
(phyla/classes/orders/families/genera). It was however possible to observe, that at the phylum level 
the relative abundance of Firmicutes had increased in the 1
st
 week of life reaching its peak at the 2
nd
 
week after which it started to drop until the 10
th
 week of life when the relative abundance started to 
increase again (Figure 72).  
 
Figure 72: The relative abundance of Firmicutes.  
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After looking at the other taxonomic levels it was observed that the same was observed for the Bacilli 
class. The interesting shape of the relative abundance of this class was caused by two different genera 
Staphylococcus and Clostridium (Figure 73). There was no other difference visible. 
 
Figure 73: The relative abundance of the (A) Staphylococcus, and (B) Clostridia grouped according to the postnatal 
age of the baby at the time of sample collection. Please note that the scale for the relative abundance of 
Staphylococcus (segment A) is up to 100% while the scale for Clostridium (segment B) is up to 45%. 
 
 
6.3.iv Gut microbiota associated with sex 
There had been no significant difference at any of the taxonomic levels. The richness of the gut 
microbiota was slightly higher in females than in males with Chao alpha diversity being 12.5 and 11 
respectively. The Shannon’s diversity index was however similar in females (0.67) and in males 
(0.63).  
6.3.v Gut microbiota associated with mode of delivery 
At the phylum level, Proteobacteria was significantly associated with vaginal delivery while 
Firmicutes with Caesarean section (Panel A of Figure 74). At the class level, Gammaproteobacteria 
were identified as associated with vaginal delivery, while at the genus level Clostridium and 
Staphylococcus were found to be associated with Caesarean section (Panel B and C of Figure 74).   
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Figure 74: The (A) phyla, (B) classes, and (C) genera found to be significantly associated with the mode of delivery of 
the baby. Green represents babies born by caesarean section while orange babies born by vaginal delivery. 
 
The richness and the diversity of the gut microbiota was similar in babies born by vaginal delivery 
(Chao index = 11.25; Shannon’s index = 0.63) and in those born by Caesarean section (Chao index = 
11; Shannon’s index = 0.65). 
6.3.vi Gut microbiota associated with occurrence of labour 
There was no difference between the relative abundance of any of the groups of bacteria (tested at all 
the taxonomic levels). The richness of the microbiota was similar between samples collected from 
babies that were born during the labour (Chao index 0.62) and samples from babies that were not born 
during the labour (Chao index 0.68). The diversity was also similar with the Shannon’s index 
equalling 11 and 12 for labour and non-labour respectively. 
6.3.vii Gut microbiota associated with diet 
The results from this study show that gut microbiota had been found to be associated with both the 
route of nutrition and the type of milk. The detailed nutrition metadata collected for the NEON study 
allowed proper classification of the samples according to the feeding.  
6.3.vii.a Parenteral nutrition vs. enteral nutrition 
The analysis of association of gut microbiota with route of nutrition was done after classifying the 
samples as either collected during: a) exclusive parenteral nutrition (TPN), b) mix of parenteral and 
A 
B 
C 
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enteral nutrition (PN), or c) exclusive enteral nutrition (EN). The classification process is explained in 
detail in the 6.2.iv.a section of this chapter. 
At the phylum level, the results showed that the relative abundance of the Firmicutes was increasing 
after the introduction of enteral nutrition, while the relative abundance of Proteobacteria started to 
decrease after the babies were orally fed (Figure 75). 
In order to fully investigate the difference between the enteral nutrition and parenteral nutrition the 
analysis was continued comparing only two groups: the TPN group with the EN one.  
The results confirmed the findings for the Proteobacteria and Firmicutes phyla (Figure 76). After 
investigating the other taxonomic levels, this difference between Proteobacteria and Firmicutes was 
explained by the relative abundance of two families:  Staphylococcaceae (belonging to Firmicutes and 
associated with EN) and Enterobacteriaceae (belonging to the Proteobacteria and associated with 
TPN) families (Figure 76). There were no other differences in association to the route of nutrition at 
any of the taxonomic levels. 
Both the richness and diversity were higher in samples collected while baby was on total parenteral 
nutrition (Chao index = 0.96; Shannon’s index = 18.75) compared to the samples collected while 
babies were on exclusive enteral nutrition (Chao index = 0.63; Shannon’s index = 13). 
 
Figure 75: The relative abundance of  (A) Proteobacteria phylum, and (B) Firmicutes phylum grouped according to 
the route of nutrition that the baby was on during the sample collection (pink = exclusive parenteral nutrition (TPN), 
purple = mix of parenteral and enteral nutrition (PN), blue = exclusive enteral nutrition (EN)). 
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Figure 76: The (A) phyla and (B) families found to be significantly associated with the route of nutrition. Pink 
represents exclusive parenteral nutrition, while blue – exclusive enteral nutrition. 
 
6.3.vii.b Breast milk vs. other milk 
Samples had been classified as breast milk, or other milk based on the feeding for the seven days prior 
to the sample collection. Seven days are known to be enough to fully reprogram gut microbiota after 
the shift of diet. This gave 165 samples collected while on breast milk and 39 samples while the baby 
was not breast fed. 
At the phylum level only Proteobacteria significantly differed in relation to presence or lack of breast 
milk (Figure 77). The investigation of the lower taxa found that this association was due to the higher 
relative abundance of Enterococcaceae in the samples obtained from babies that had been breast fed 
(Figure 77).   
            
 
 
Figure 77: The (A) phylum and (B) family found to be significantly associated with the breast milk (dark blue). The 
samples collected while baby had been on any other milk for at least 7 days are presented in red. 
 
The richness of the gut microbiota was lower in samples collected while baby was on breast milk than 
in those from babies on other milk (Chao index: 10 and 16.5 respectively). The diversity of the gut 
A 
B 
A 
B 
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microbiota was also lower in babies on breast milk (Shannon’s index = 0.60) than those on other milk 
(Shannon’s index = 1.09). 
6.3.viii Regression of the stool metabolites against gut microbiota 
The first analytical approach – using the O-PLS regression showed no discriminant metabolites for 
any of the bacteria of interest. However, the analysis performed by Daniel Homola found that 
Enterococcus was positively correlated with acetate, and Bifidobacterium was positively correlated 
with GABA.  
6.4 Discussion 
In this study it was observed that Proteobacteria are the most abundant phylum in the guts of the 
premature newborn babies. There are reports in the literature supporting our findings [371]. A recent 
study by Dogra et al. observed high levels of Enterobacteriaceae in the first week of life, which 
started to decline with the increasing postnatal age [456]. Additionally,  Parm et al. reported  that 
hospitalisation in the Neonatal Intensive Care Unit led to higher chances of being colonised by 
Enterobacteriaceae, a family that belongs to the Proteobacteria phylum [44]. In adults the most 
prominent phyla are Firmicutes and Bacteroides and their ratio is known to be related to the 
eubiosis/dysbiosis balance which is linked to the health outcomes [6, 457]. Bacteroides do not seem to 
play any role in the gut of premature babies, at least in this sample set, since they were almost absent 
or below the limits of detection.  
The randomised groups did not have significantly different microbiologic profiles. However, a higher 
diversity of gut microbiota in samples of babies that had been randomised to receive the 20% SMOF 
lipid solution was observed when compared to babies randomised to receive the 20% Intralipid 
solution. To our knowledge, there is no biological explanation of this and a decision was made that 
the groups can be merged for further analysis. 
Looking at the results it seems that the abundance of Firmicutes is more or less stable over the first 14 
weeks of life; however, the members of this phylum change. In the first weeks Staphylococci are 
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responsible for the high representation of Firmicutes, but as their relative abundance start to decline, 
the Clostridia start to take over, which results in stable levels of Firmicutes. As shown in the above 
example, it is very important to analyse bacterial populations on all taxonomic levels as the crucial 
changes may go unnoticed when looking only at the higher taxa. The high abundance of the 
Staphylococcus genus in the first weeks of life can be explained by the fact that this genus had been 
previously reported as one of the first colonisers of the gut [36]. The reason for this may be in the 
localisation of Staphylococcus, which is mostly found on the human skin [458]. The contact with 
mother, especially during breast feeding, would expose the baby to this bacterium early on in life [39, 
72, 73, 76]. Since the gut at this stage does not have a stable microbiota, it creates a perfect niche for 
Staphylococci to grow. After some time, when more oxygen is removed and the environment becomes 
anoxic, the facultative anaerobes which are Staphylococci may lose their influence in the presence of 
the anaerobic bacteria [36]. Alternatively, the gut may be colonised with bacteria which exclude and 
prevent colonisation of the gut by Staphylococci. 
There was no significant microbial change observed in relation to gestational age at birth. However, 
there had been two trends observed. A higher relative abundance of the Bifidobacteria was visible 
after the 28
th
 week of gestation. Dogra et al. had recently reported a similar observation [456]. 
Additionally, it had been reported before that full-term babies have in general a much higher relative 
abundance of Bifidobacteria than the preterm neonates [87]. One of the possible explanations may be 
the fact that mothers who went into the early premature labour may experience the problems with 
lactation more often thus their babies will not receive the fresh breast milk, which is a source of 
bacteria [451, 459]. Instead the early premature babies are often given the donor’s milk which is 
pasteurised thus has no living bacteria in them. Such milk would not support the growth of 
Bifidobacteria at the same level as fresh breast milk or formula milk with prebiotics. The other 
possibility is that since more premature babies are usually sicker, they require receiving antibiotics 
more frequently thus their microbiota is more at risk.  
As suggested by our hypothesis, mode of delivery is associated with changes in the gut microbiota. 
The association of Gammaproteobacteria with vaginal delivery have been reported before, especially 
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for Enterobacter [48, 50], E. coli [44, 48, 49, 53, 55, 59] and Klebsiella [46, 53, 55]. All of those 
genera are considered normal members of the maternal gut microbiota and when a baby is born by 
vaginal delivery the first exposure to bacteria from the outside world is during the passage through the 
birth canal thus the baby is exposed to maternal perianal bacteria [44, 46, 48-50, 53, 55, 59]. Babies 
born by caesarean delivery are exposed to environmental and skin microbiota which explains the 
higher abundance of the Staphylococcus genus [48, 50, 56]. There have also been previous reports 
supporting the association of Clostridium with caesarean section [37, 47-50]. However, some 
researchers found that specific species of Clostridia (C. perfringens, C. leptum and C. difficille) are 
not affected by the mode of delivery [47, 57, 58]. In accordance to the findings from the literature, in 
our study the population of Streptococci [48, 50, 56-58] and Lactobacilli [57, 58, 67] did not differ 
between the babies in regard to mode of delivery. However, contrary to other studies, this study did 
not find any difference in the relative abundance of Bacteroides [37, 46-49, 57, 58], Bifidobacterium 
[27, 37, 46, 47, 49-55, 456], Bacillus or Atopobium [48, 50, 56-58]. The reports from the literature 
regarding the diversity and richness of the gut bacterial population in newborn babies are 
contradictory. I had not observed any difference in relation to mode of delivery, however three studies 
had reported higher diversity in samples from babies born by Caesarean section [48, 59, 83] and one 
study found stool of vaginally delivered babies to be more diverse [46]. 
The introduction of enteral nutrition, as predicted, s associated with a change in microbial profile of 
the premature baby’s gut. The genera found to contribute to the difference between the total parenteral 
nutrition (TPN) and enteral nutrition (EN) were Enterobacteriaceae and Staphylococci respectively. 
One of the reasons why the relative abundance of Staphylococci is higher when babies are fed orally 
could be due to at least two reasons. Since the majority of the babies in this analysis were breast fed, 
one of the reasons for a higher relative abundance of Staphylococci could be due to the contact with 
maternal skin during feeding [364]. Additionally, human milk oligosaccharides are known to promote 
the development of Staphylococci [363]. Enterobacteriaceae, as previously mentioned, are the 
bacteria colonising the baby’s gut straight after the birth. And since there is limited consumption of 
the bacteria, the primary community may not be affected until the enteral nutrition takes place. The 
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results for Staphylococci being associated with EN, and the non-significant trend was observed of this 
family’s relative abundance increasing drastically after the first week of postnatal life may be linked 
to it. Total parenteral nutrition occurs usually only in the first few days of life (1
st
 week of PNA). 
Therefore it is possible that the interesting trend for the Staphylococci in accordance to the postnatal 
age is in fact related to the introduction of enteral nutrition. It is however surprising that no significant 
difference between the abundance of Lactobacilli or Bifidobacteria was observed as those are the 
species known to be correlated with both breast and formula milk [42, 52, 68, 81, 437, 438, 460]. 
Unfortunately, there are very few studies comparing gut microbiota of preterm babies on TPN vs. 
those on EN. In the systematic review that I had conducted in 2012 only 4 studies, which looked at the 
route of nutrition in premature babies were identified [41, 44, 71, 83]. All of those studies reported a 
lower bacterial diversity when baby was on TPN [41, 44, 71, 83]. Our study reported the opposite 
findings. The explanation why the gut microbiota becomes less diverse after the introduction of 
enteral nutrition could be that milk (regardless if human or formula) provides nutrition for selected 
bacteria which leads to a stable but not diverse microbiota. This argument is supported by the 
metabonomic analysis as I had observed the reduction in diversity of metabolic profiles in both urine 
and stool samples after the introduction of enteral nutrition.  
When analysing the influence of breast milk on the gut microbiota, a significant difference at the 
phylum level was observed. Proteobacteria were more abundant among the breast fed babes than 
among those fed with other types of milk. Ward et al. had reported a similar finding before [451]. In 
our study, the higher relative abundance of Proteobacteria was due to the Enterobacteriaceae family. 
A higher relative abundance of Enterobacteriaceae in breast fed babies does not comply with the 
other research, which had reported this family to be associated with formula feeding [39, 50, 57, 58, 
65, 71, 72, 76]. However, Neut et al. observed the same association as reported in this study [73]. In 
contrary to other studies, no difference between the type of milk and the abundance of Clostridia [37, 
66, 69, 72-76, 86], Lactobacilli [63, 66, 67, 70, 76] (though three studies found no difference [57, 58, 
73]), Streptococcus [50, 66, 72, 73] and Bifidobacteria [42, 51, 54, 57, 58, 61-63, 66, 68-70, 72-76] 
was found. It is important to remember that the majority of the studies comparing breast milk with 
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formula milk have been done on full term babies and often using different to our method of bacterial 
detection. A recent study done by Khodayar-Pardo et al. found that mothers who went into a 
premature labour had significantly lower concentration of Bifidobacteria in their breast milk than 
women who gave birth in term [461]. Additionally, it was observed that adding oligosaccharides to 
the preterm formula milk increases the counts of Bifidobacteria in the stool samples of babies fed 
with this milk [460]. What is more, the relative abundance of Bifidobacteria in the whole sample set 
was 10%. Similar finding has been observed in preterm babies that participated in a probiotic study 
done by Underwood et al. [462]. The babies selected for our analysis had not been supplemented with 
any probiotics. Our findings regarding the lower diversity and richness of gut microbiota in babies on 
breast milk confirm the reports from the literature [66, 68, 87, 463]. Breast milk introduces a very 
limited number of bacterial species which may contribute to the lower diversity of the microbiota in 
the baby. Additionally, as mentioned before, breast fed babies were predominately colonised by 
Enterobacteriaceae thus if one family of bacteria contributed to the highest relative abundance, there 
was not much diversity in the gut.   
The sex of the baby had no association with changes of gut microbiota profiles. Additionally neither 
the richness nor diversity differed between the males and females. This suggests that at this stage of 
life, there are no differences between male and female babies when it comes to the colonisation and 
development of gut microbiota. The reasons why adult females and males have differences in the gut 
microbial profiles are probably due to the hormonal changes that are triggered during puberty.  
We also did not observe any microbiological differences in accordance to the presence or lack of 
labour during the delivery. It is however important to mention that the labour group consisted of 
vaginal delivery, emergency caesarean section and elective caesarean section, while the non-labour 
deliveries included only the latter two options. The numbers of the babies were too small to look at 
the labour vs. non-labour issue in each of the groups separately.  
We also observed that both the baby that developed sepsis (positive blood culture – coagulase-
negative Staphylococci) and the baby that was tested for sepsis but had negative result showed the 
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same pattern of microbial changes – increasing relative abundance of Enterobacteriaceae that started 
one week prior to the blood culture taken, and resulted in almost 100% of bacteria belonging to this 
family. 
The regression of discriminant metabolites against the relevant genera showed that Enterococcus was 
positively associated with the presence of acetate [464, 465]. Similar finding has been observed by my 
colleagues in their sample sets (data not published).  The fact that GABA was positively associated 
with the presence of Bifidobacteria is an interesting finding as there had been reports suggesting that 
those bacteria are able to produce GABA [466, 467].  
6.5 Conclusion 
Our hypothesis that mode of delivery and type of diet affect the microbial community has been 
confirmed. The visible pattern of gut microbial changes over the time is probably associated with the 
transition from the parenteral to enteral nutrition. The introduction of enteral nutrition leads to the 
reduction in the diversity of gut microbiota which is in accordance with the metabonomic results. The 
differences in the gut microbial profiles in relation to mode of delivery are probably caused by the 
different exposure to the environmental/maternal bacteria straight after birth. The metataxonomic 
analysis on the samples collected as a part of the NEON trial had proved that early life interventions 
contribute to the changes in the gut microbiota of the premature babies. 
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Chapter 7 – General discussion 
The aim of this PhD project was to investigate how microbial and metabolic profiles develop in 
preterm babies. Factors such as type of parenteral nutrition (the randomised feeding groups of the 
NEON study), route of nutrition (parenteral nutrition vs. enteral nutrition), type of milk, mode of 
delivery, mother being in labour during delivery, gestational age and postnatal age and their effect on 
the gut microbiota and metabolic profiles were investigated. I did not investigate the influence of 
antibiotics as all the babies were given broad spectrum antibiotics in the neonatal intensive care unit 
(NICU).  
The results from this study show that the biggest contributors to the changes in metabolic profiles of 
both stool and urine were postnatal age (PNA), gestational age (GA) and route of nutrition. However, 
it is important to remember that the route of nutrition in premature babies is linked to the postnatal 
age, so the shift from total parenteral nutrition (TPN) through mixed parenteral nutrition (PN) with 
enteral nutrition to fully enteral nutrition (EN) is linked with postnatal age. Preterm babies are on TPN 
for only the few first days of life and for the majority of their stay in NICU (at least in this study) they 
are on both PN and EN. The ratio of EN over PN increases with postnatal age until the baby is ready 
to be fully on EN. The start of enteral nutrition not only introduces chemical compounds in to the gut, 
but also stimulates the development of the gut microbiota [41, 503, 510-512]. Metabolites such as 
sugars and bile acids were observed to be associated with both early parenteral age and TPN, and as 
described in previous chapters both of those factors (lack of enteral nutrition, and early postnatal age) 
can on their own have a biological explanation for such metabolic changes. Therefore, it is very 
difficult to decide which of the factors – postnatal age or route of nutrition, is in fact responsible for 
observable metabolic changes. On the other hand, it is not really a limitation as such situation is a 
representation of what is happening to the premature baby while in NICU.  
In general, the major metabolic and microbiota changes over time represented themselves as 
metabolites which can be linked either to bacterial activity or composition of human milk. Since 
babies are more likely to go on full enteral nutrition when they are older (higher postnatal age) it 
makes biological sense why there are metabolites known to be present in human milk (such as vitamin 
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B5, inositol, carnitine) to be associated with increasing postnatal age. The bacterial changes over time, 
for example the sudden increase in the relative abundance of staphylococci from the second week of 
life, can also be explained by the changes in the nutrition pattern. In the 2
nd
 week of life babies were 
supplemented orally with either breast or formula milk (81% of samples were collected while the 
baby was breast fed). Since breast feeding is associated with colonisation by staphylococci (present on 
skin and in the milk, and having their growth supported by the human milk oligosaccharides [363]) 
the changes of microbial profiles over time closely mirror the timeline of feeding. The influence of the 
type of milk on the metabolic profile gave expected results of lactose being positively associated with 
breast milk. Marincola et al. compared the metabolic profiles of breast milk expressed from women 
that delivered babies preterm with formula milk. The results showed that breast milk has a 
significantly higher concentration of lactose than formula milk [513]. The same study also found 
differences in the composition of breast milk depending on the gestational age when the preterm birth 
occurred. This difference in the chemical composition of milk linked with the level of prematurity of 
the baby may in fact be a key to understanding why there are observable metabolic and microbiota 
differences related to the gestational age. Results reported in this study show that babies born below 
the 28
th
 week of gestation had significantly lower relative abundance of the beneficial bifidobacteria. 
This low abundance could be caused by one (or all) of the following factors: different composition of 
milk depending on the gestational age, the numbers of bifidobacteria in the breast milk are positively 
associated with the increasing gestational age, and last but not least higher exposure to antibiotics of 
more premature babies due to their more advanced health problems. Additionally, the average relative 
abundance of Bifidobacteriaceae in stool samples collected from the babies in this study was on the 
level of 10%. The studies conducted on full term babies report the relative abundance of 
bifidobacteria at the levels from 18% to 75% [514, 515]. Moreover, the results showing that the 
assumption that premature babies exclusively breast fed will have high abundance of bifidobacteria is 
wrong. The high exposure to antibiotics is probably the leading cause of lower relative abundance of 
bifidobacteria, when compared to full term babies. Though, it is important to remember that this study 
was not designed for the analysis of the influence of gestational age at birth with the abundance of 
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Bifidobacteria and in order to confirm this hypothesis a properly designed study on both preterm and 
full term babies should be conducted.  
Another interesting finding is that neither being in labour during delivery nor the mode of delivery 
affected the metabolic profile of the babies, even though the latter factor had been found to be 
associated with changes in the gut microbiota. One possible reason for this is that the changes in gut 
microbiota in relation to the mode of delivery do not have any metabolic effect on the babies, at least 
in this time frame. It is possible that the bacteria that had been found to differ – Staphylococcaceae for 
Caesarean section and Enterobacteriaceae for vaginal delivery, have similar metabolic activity. 
Perhaps the general function of those bacteria is stable regardless of the species that comprise it. This 
similarity would mean that even though there are different bacteria present in the gut, their 
metabolism and the metabolites produced are similar. Another option is that the discriminant bacteria 
produce different metabolites which are used by other species common in both groups of the babies, 
and what we observe as a metabolic profile are simply the end products of the long bacterial 
metabolic chain. Our metataxonomic results did, however, support what had been previously reported 
in full-term babies and thus supports the theory that the gut microbiota is affected by the first 
environment with which the baby has contact after birth [37, 47-50, 56]. Enterobacteriaceae are 
common bacteria found in maternal perianal area and vaginally delivered babies have a profound 
contact with this area. At the same time, babies born by caesarean section are not exposed to maternal 
gut microbiota and have in fact higher relative abundance of staphylococci which are known to be a 
member of the skin microbiota.  
It is difficult to compare the findings from this present study with the literature as the majority of 
observations were done in full-term babies. The development of gut microbiota and the factors 
affecting it have been investigated since the 80’s [37, 39, 41, 43, 46, 61, 62, 501-505],  but very few 
have been conducted in premature babies [220, 506-509]. Additionally, even if a study was conducted 
on preterm babies, factors such as time of sample collection (postnatal age), analytical technique for 
microbiota analysis or even choice of bacterial DNA extraction kit, and the primers used for the 
amplification of a one of many variable regions of the 16S rRNA gene could lead to different results. 
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Therefore it is difficult to directly compare results found in the literature with this study as there are 
many factors that can affect the result. 
The limitations of this study were that it was not designed to look into the factors that have ultimately 
been analysed. Since there was no microbial or metabolic difference between the randomised groups 
exploratory analysis was conducted to look at all the other early life interventions that could have 
interesting results with full awareness that the study was not created for it. The study was randomised 
for type of parenteral nutrition and it had an equal distribution of all other factors between the four 
randomised groups. However, because principal component analysis was used, which is an 
unsupervised model; the interference of the other factors may be observed (which would be corrected 
for in the standard statistical approach). Therefore in order to remove any possible interference the 
subgroups must be individually compared (e.g. analyse mode of delivery in samples collected from 
the same week of postnatal age from the babies born at the same gestational age). This quite often 
resulted in a sample size too small to apply any meaningful statistics on therefore certain 
compromises had to occur.   It is important to remember that metabonomic analysis of human samples 
is extremely challenging. Humans are by nature diverse and trying to compare metabolic differences 
between two groups as an effect of an intervention/event is difficult. The analytical approach, 
although perhaps was not perfect, was the best that could have been done in those circumstances.  
The major strength of this study is that samples were collected as part of a clinical trial therefore 
providing very detailed high quality data. The babies were assessed on a daily basis and access to the 
feeding diaries for each day of their lives was available up until the point of discharge. This allowed 
for efficient classification of the samples, i.e. not purely based on the feeding that the baby had 
received on the day of sample collection but also based on the type of feeding from the previous days. 
The gut microbiota requires a certain amount of time to shift – 24h to shift as a result of change from 
TPN to EN and 7 days in adults to shift as a result of dietary change. Over 1000 urine samples and 
another 1000 stool samples were collected from 160 babies giving the opportunity to build strong 
models and even work on preselected features. The sample collection was standardised and efficient 
and gave a good representation of samples coming from the same baby from consecutive weeks which 
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gave an interesting opportunity to look into the development of gut microbiota over time (postnatal 
age). Additionally, the gold standard methods for the microbial analysis, (16S rRNA gene 
sequencing) was used which means that the results should be easily comparable with future studies 
conducted on preterm babies. Last but not least, in contrary to many other studies in the field of gut 
microbiota, the bacterial populations were assessed alone but also in context of their ecosystem. The 
metabolic profiling combined with bacterial identification builds a whole story of the changes 
occurring in the gut of the baby. It is far more informative when we know not only who the gut 
inhabitants are but also what they are doing. Microbial profiling on its own is not as reliable as many 
of the identified species (especially when culture independent identification methods are used) may 
have been dead for a while or simply inactive therefore not having any impact on the gut 
environment.  
In conclusion, the results of this study contribute strongly to the scientific field. Our results are in 
accordance with what is considered the most accurate techniques available on the market and the 
samples came from a clinical trial. Evaluation of the association between the early life interventions 
and both microbial and metabolic changes were investigated. Previous findings have been re-
confirmed on the microbiota and association with the mode of delivery, and commenced a new 
discussion on why the microbiota changes are not accompanied by the metabolic changes. 
Additionally, it has been shown that there exists a strong link between the first several weeks of life 
post-partum (in preterm babies) and the shift in the route of nutrition. The fact that introduction of 
fully enteral nutrition leads to a more unified microbial and metabolic profiles (lower diversity of 
bacteria and higher clustering of metabolic profiles on principal component analysis) is another 
argument in support of the approach of introducing enteral nutrition as soon as it is safe and possible.  
The future studies should conduct a further investigation into the link between the factors associated 
with altered microbiota and long term functional clinical outcomes. So far it is known that the gut 
microbiota is an important component of the mammalian organism and that it can influence the 
maturation of the gut and the development of the immune system [3, 10-13, 23, 25, 468-477]. There 
are a number of health complications that are linked to the alteration in gut microbiota, however, it is 
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not yet certain if this is merely an association or a correlation with a direct causality [1, 6, 28, 137-
140, 146, 318, 457, 473, 478-500]. There are three possible hypotheses regarding this aspect, and they 
should be investigated in greater detail by future research. 
The first hypothesis suggests that the dysbiosis (alteration in the gut microbiota) affects the host 
organism causing metabolic changes which result in functional clinical outcomes. This hypothesis is 
usually supported by the results obtained from the animal studies, especially those performed on germ 
free subjects. However, it is important to remember that animal species differ from each other and the 
mechanism observed in mice may not reflect that in humans. The other approach to investigate the 
potential effect of alteration of gut microbiota on the health is to design a prospective study. Such 
studies require a large number of participants and regular gut microbiota examination over a 
prolonged period of time with hope that an appropriate number of participants will develop a certain 
disorder. Such studies are expensive and due to prolonged time, they are at risk of high drop-out rate 
which as a result decreases the chances of observing the outcome of interest. 
The second hypothesis is that the correlation between the alteration of microbiota and functional 
clinical outcomes is reversed and therefore suggests that gut microbiota changes are as a result of a 
functional clinical outcome. Again, the best way to investigate this hypothesis is by a prospective 
large scale study. So far the majority of the studies in the field have either a very small sample size or 
are retrospective therefore the causality cannot be determined. 
The third popular hypothesis is that there is a common factor causing both the shift in microbiota and 
the functional clinical outcome. This hypothesis is the most difficult to investigate due to the fact that 
if any of the above hypotheses are supported,  it would still not answer the question whether or not 
there is an unknown underlying factor or factors. It is possible that all of the above hypotheses are 
correct and that different functional clinical outcomes have a different type of correlation/association 
with altered gut microbiota. 
Since we already know how the gut microbiota is affected by various early life interventions it is 
possible to design a study that would account for the factors causing potential bias, thus the models 
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can be adjusted leading to obtaining more reliable and accurate results. Since the animal studies have 
reported a strong impact that the first colonisers of the gut have on the immune system and the gut 
itself, more and more interest has been put on the development of the microbiota in humans. 
Researchers believe that understanding the mechanism of gut colonisation and programming of the 
immune system to differentiate between the beneficial bacteria and pathogens may hold the answer to 
the causality of allergies and potentially lead to the elimination of this disorder [10, 23, 477].  
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Appendix 
 
The permission for the reprint of the figures number 2 and 3 was obtained in accordance with the requirements 
of the New England Journal of Medicine: “Content (full-text or portions thereof) may be used in print and 
electronic versions of your dissertation or thesis without formal permission from the Massachusetts Medical 
Society, Publisher of the New England Journal of Medicine”. 
 
Urinary Metabonome 
 
Figure 78: PCA Scores Scatter Plot of NMR spectra of urine samples collected in the 1st week of life. Samples are 
coloured according to type of intravenous lipid solution. Dark blue (1) represents Intralipid while light blue (2) 
corresponds to SMOF lipid. 
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Figure 79: PCA Scores Scatter Plot of NMR spectra of urine samples collected in the 3rd week of life. Samples are 
coloured according to type of intravenous lipid solution. Dark blue (1) represents Intralipid while light blue (2) 
corresponds to SMOF lipid. 
 
 
Figure 80: PCA Scores Scatter Plot of NMR spectra of the last urine samples collected. Samples are coloured 
according to type of intravenous lipid solution. Dark blue (1) represents Intralipid while light blue (2) corresponds to 
SMOF lipid. 
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Figure 81: PCA Scores Scatter Plot of NMR spectra of urine samples collected in the 1st week of life. Samples are 
coloured according to concentration of amino acids in parenteral nutrition. Dark blue (1) represents increasing 
concentration while light blue (2) corresponds to recommended daily intake. 
 
 
Figure 82: PCA Scores Scatter Plot of NMR spectra of urine samples collected in the 3rd week of life. Samples are 
coloured according to concentration of amino acids in parenteral nutrition. Dark blue (1) represents increasing 
concentration while light blue (2) corresponds to recommended daily intake. 
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Figure 83: PCA Scores Scatter Plot of NMR spectra of the last urine samples collected. Samples are coloured 
according to concentration of amino acids in parenteral nutrition. Dark blue (1) represents increasing concentration 
while light blue (2) corresponds to recommended daily intake. 
 
 
Figure 84: PCA Scores Scatter Plot of NMR spectra of urine samples collected in the 1st week of life. Samples are 
coloured according to the gestational age at birth (in weeks). 
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Figure 85: PCA Scores Scatter Plot of NMR spectra of urine samples collected in the 3rd week of life. Samples are 
coloured according to the gestational age at birth (in weeks). 
 
 
Figure 86: PCA Scores Scatter Plot of NMR spectra of urine samples collected from babies born in 24th week of 
gestation. Samples are coloured according to the postnatal age given in weeks. 
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Figure 87: PCA Scores Scatter Plot of NMR spectra of urine samples collected from babies born in 28th week of 
gestation. Samples are coloured according to the postnatal age given in weeks. 
 
 
Figure 88: PCA Scores Scatter Plot of whole data set of NMR urine spectra. Samples are coloured according to the 
sex of the baby with dark blue (1) representing females while light blue (2) males. 
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Figure 89: PCA Scores Scatter Plot of whole data set of NMR urine spectra. Samples are coloured according to the 
mode of delivery with dark blue (1) vaginal delivery while light blue (2) caesarean section. 
 
 
Figure 90: PCA Scores Scatter Plot of whole data set of NMR urine spectra. Samples are coloured according to the 
presence of labour during delivery with dark blue (1) representing labour while light blue (2) lack of thereof. 
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Stool Metabonome 
 
Figure 91: PCA Scores Scatter Plot of NMR spectra of stool samples collected in the 1st week of life. Samples are 
coloured according to type of intravenous lipid solution. Dark blue (1) represents Intralipid while light blue (2) 
corresponds to SMOF lipid. 
 
 
Figure 92: PCA Scores Scatter Plot of NMR spectra of stool samples collected in the 3rd week of life. Samples are 
coloured according to type of intravenous lipid solution. Dark blue (1) represents Intralipid while light blue (2) 
corresponds to SMOF lipid. 
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Figure 93: PCA Scores Scatter Plot of NMR spectra of the last stool samples collected. Samples are coloured 
according to type of intravenous lipid solution. Dark blue (1) represents Intralipid while light blue (2) corresponds to 
SMOF lipid. 
 
 
Figure 94: PCA Scores Scatter Plot of NMR spectra of stool samples collected in the 1st week of life. Samples are 
coloured according to concentration of amino acids in parenteral nutrition. Dark blue (1) represents increasing 
concentration while light blue (2) corresponds to recommended daily intake. 
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Figure 95: PCA Scores Scatter Plot of NMR spectra of stool samples collected in the 3rd week of life. Samples are 
coloured according to concentration of amino acids in parenteral nutrition. Dark blue (1) represents increasing 
concentration while light blue (2) corresponds to recommended daily intake. 
 
 
Figure 96: PCA Scores Scatter Plot of NMR spectra of the last stool samples collected. Samples are coloured 
according to concentration of amino acids in parenteral nutrition. Dark blue (1) represents increasing concentration 
while light blue (2) corresponds to recommended daily intake. 
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Figure 97: PCA Scores Scatter Plot of NMR spectra of stool samples collected in the 1st week of life. Samples are 
coloured according to the gestational age at birth (in weeks). 
 
 
Figure 98: PCA Scores Scatter Plot of NMR spectra of stool samples collected in the 3rd week of life. Samples are 
coloured according to the gestational age at birth (in weeks). 
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Figure 99: PCA Scores Scatter Plot of NMR spectra of stool samples collected from babies born in 24th week of 
gestation. Samples are coloured according to the postnatal age given in weeks. 
 
 
Figure 100: PCA Scores Scatter Plot of NMR spectra of stool samples collected from babies born in 28th week of 
gestation. Samples are coloured according to the postnatal age given in weeks. 
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Figure 101: PCA Scores Scatter Plot of whole data set of NMR stool spectra. Samples are coloured according to the 
sex of the baby with dark blue (1) representing females while light blue (2) males. 
 
 
Figure 102: PCA Scores Scatter Plot of whole data set of NMR stool spectra. Samples are coloured according to the 
mode of delivery with dark blue (1) vaginal delivery while light blue (2) caesarean section. 
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Figure 103: PCA Scores Scatter Plot of whole data set of NMR stool spectra. Samples are coloured according to the 
presence of labour during delivery with dark blue (1) representing labour while light blue (2) lack of thereof. 
 
 
 
